GLP-1 Market
LLY $1415.55 ▼ -1.1% NVO $40.70 ▼ -2.2% PFE $28.47 ▼ -1.4% VKTX $26.88 ▲ +0.3% KLRA $12.20 ▼ -2.9% GPCR $18.17 ▼ -2.2% RHHBY $60.28 ▼ -1.1%
Market data delayed up to 20 min · Source: Twelve Data
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Antipsychotic drugs

Company
Université de Sherbrooke
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
75 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

75 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Nov 18, 2026

Find a Clinical Trial Near Me

See recruiting studies for Antipsychotic drugs and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT01246765

    National Pregnancy Registry for Psychiatric Medications

    Massachusetts General Hospital 5000 participants Est. completion 2033-12 1 site
    Other conditions: Pregnant Women, Psychotropic Drugs
    View official trial listing →
  • Recruiting NCT NCT02640911

    An Observational Study on Atypical Antipsychotics Long-term Treatment Patients With Schizophrenia

    Shanghai Mental Health Center 3000 participants Est. completion 2033-05 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Recruiting NCT NCT03495024

    Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates

    Not yet reported Corporal Michael J. Crescenz VA Medical Center 10 participants Est. completion 2020-06-30 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Tobacco Smoking, Tardive Dyskinesia, Parkinsonism
    View official trial listing →
  • Recruiting NCT NCT03911726

    Do Antipsychotic Agents Induce Supersensitivity in Humans: A Combined PET/MRI Study in Patients With Schizophrenia

    Not yet reported Central Institute of Mental Health, Mannheim 140 participants Est. completion 2028-06 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Recruiting NCT NCT04370730

    Dimensional and Developmental Profiles of Psychosis in Children and Adolescents

    Not yet reported Assistance Publique - Hôpitaux de Paris 200 participants Est. completion 2026-10-01 6 sites
    Other conditions: Schizophrenia, Psychotic Disorders
    View official trial listing →
  • Recruiting NCT NCT04373317

    Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis

    Not yet reported VA Office of Research and Development 358 participants Est. completion 2028-08-24 24 sites
    Other conditions: Parkinson's Disease Psychosis
    View official trial listing →
  • Recruiting NCT NCT04478838

    "Extended" (Alternate Day) Antipsychotic Dosing

    Not yet reported Centre for Addiction and Mental Health 120 participants Est. completion 2028-09-30 1 site
    Other conditions: Schizophrenia and Related Disorders, Drug Administration Schedule, Drug Therapy, Antipsychotic Agents
    View official trial listing →
  • Recruiting NCT NCT04580134

    CLOZAPINE Response in Biotype-1

    Not yet reported University of Texas Southwestern Medical Center 524 participants Est. completion 2027-04-30 5 sites
    Other conditions: Schizophrenia, Schizoaffective Disorder, Bipolar 1 Disorder
    View official trial listing →
  • Recruiting NCT NCT04996433

    A Comparison of Two Psychotherapy Programs in Persistently Depressed Treatment-Resistant Inpatients

    Not yet reported University of Greifswald 396 participants Est. completion 2028-04 8 sites
    Other conditions: Persistent Depressive Disorder, Treatment-resistant Depression
    View official trial listing →
  • Recruiting NCT NCT05184335

    Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

    Not yet reported Reviva Pharmaceuticals 690 participants Est. completion 2025-02 18 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Recruiting NCT NCT05208190

    Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial

    Not yet reported New York State Psychiatric Institute 280 participants Est. completion 2028-12-31 7 sites
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Recruiting NCT NCT05431595

    Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing Strategy

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 42 participants Est. completion 2027-02-02 1 site
    Other conditions: Delirium, Epileptics, Neuroleptics
    View official trial listing →
  • Recruiting NCT NCT05590637

    Comparing Antipsychotic Medications in LBD Over Time

    Not yet reported The University of Texas Health Science Center at San Antonio 94 participants Est. completion 2027-02 2 sites
    Other conditions: Parkinson's Disease Psychosis, Dementia With Lewy Bodies
    View official trial listing →
  • Recruiting NCT NCT05669742

    Empagliflozin Addition in Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients

    Not yet reported Tanta University 40 participants Est. completion 2026-12 1 site
    Other conditions: Sodium-glucose Transport Protein Two Inhibitor (SGLT2),Metabolic Deficits Caused by Antipsychotics
    View official trial listing →
  • Recruiting NCT NCT05728138

    Psychosocial Intervention for Suicidal Ideation in Individuals With FEP: A Feasibility Trial

    Not yet reported Pakistan Institute of Living and Learning 80 participants Est. completion 2025-10-30 1 site
    Other conditions: Self Harm, First Episode Psychosis
    View official trial listing →
  • Recruiting NCT NCT05744479

    Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual Disability

    Not yet reported Centre for Addiction and Mental Health 100 participants Est. completion 2027-03-01 1 site
    Other conditions: Intellectual Disability, Developmental Disability, Obesity
    View official trial listing →
  • Recruiting NCT NCT05783063

    iTBS for Increased Appetite Induced by Antipsychotics

    Not yet reported Central South University 60 participants Est. completion 2026-08-01 2 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Recruiting NCT NCT05796401

    Efficiency of a Composite Personalised Care on Functional Outcome in Early Psychosis

    Not yet reported Centre Hospitalier St Anne 500 participants Est. completion 2029-02-15 13 sites
    Other conditions: Psychosis
    View official trial listing →
  • Recruiting NCT NCT05942716

    Serotonin Control of Impulsivity in Tourette Disorder

    Not yet reported Hospices Civils de Lyon 25 participants Est. completion 2028-09-24 2 sites
    Other conditions: Tourette Disorder
    View official trial listing →
  • Recruiting NCT NCT05951660

    Sex, Psychopharmacology, and Diabetes

    Not yet reported Zealand University Hospital 256 participants Est. completion 2025-07-31 1 site
    Prediabetes Other conditions: Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders, Diabetes Mellitus, Sexual Dysfunction, Drug-Related Side Effects and Adverse Reactions, Education
    View official trial listing →
  • Recruiting NCT NCT05958875

    The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.

    Not yet reported Dr. Inge Winter 418 participants Est. completion 2028-06-30 13 sites
    Other conditions: Schizophrenia and Related Disorders, Early Treatment-Resistance
    View official trial listing →
  • Recruiting NCT NCT05999240

    Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder

    Not yet reported New York State Psychiatric Institute 30 participants Est. completion 2027-12-31 2 sites
    Other conditions: Autism Spectrum Disorder
    View official trial listing →
  • Recruiting NCT NCT06049953

    Maternal And Infant Antipsychotic Study

    Icahn School of Medicine at Mount Sinai 74 participants Est. completion 2028-01-01 1 site
    Other conditions: Antipsychotics, Pregnancy
    View official trial listing →
  • Recruiting NCT NCT06054321

    Psychopharmacotherapy for Depressive Patients

    Not yet reported Chonnam National University Hospital 400 participants Est. completion 2030-12-31 1 site
    Other conditions: Major Depressive Disorder
    View official trial listing →
  • Recruiting NCT NCT06123897

    Establishing a Clinical Database and Biobank for Schizophrenia:A Cohort Study

    Central South University 2000 participants Est. completion 2028-12-31 4 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Recruiting NCT NCT06221852

    Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder

    Not yet reported Mclean Hospital 50 participants Est. completion 2027-12-30 1 site
    Other conditions: Bipolar I Disorder, Psychosis, Schizoaffective Disorder
    View official trial listing →
  • Recruiting NCT NCT06333990

    Quetiapine to Reduce Post Concussive Syndrome After Mild Traumatic Brain Injury (mTBI)

    Not yet reported Foundation for Advancing Veterans' Health Research 146 participants Est. completion 2028-06 2 sites
    Other conditions: Mild Traumatic Brain Injury
    View official trial listing →
  • Recruiting NCT NCT06431009

    The Danish Region Midt Schizophrenia Cohort

    University of Aarhus 350 participants Est. completion 2026-12-31 5 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Recruiting NCT NCT06451952

    Virtual Darkness Theraphy for Agitation in Dementia

    Not yet reported University of Bergen 72 participants Est. completion 2027-12-31 1 site
    Other conditions: Agitation in Dementia, Including Alzheimer's Disease
    View official trial listing →
  • Recruiting NCT NCT06456983

    Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial

    Not yet reported Central Institute of Mental Health, Mannheim 140 participants Est. completion 2028-07 14 sites
    Other conditions: Schizophrenia, Treatment Resistant Schizophrenia
    View official trial listing →
  • Recruiting NCT NCT06482554

    Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.

    Not yet reported Louisiana State University Health Sciences Center Shreveport 80 participants Est. completion 2026-12 1 site
    Other conditions: Apathy, Schizophrenia, Schizophrenia; Psychosis
    View official trial listing →
  • Recruiting NCT NCT06560957

    SYNCED - SYNChronized Eating in Bipolar Depression Study

    Not yet reported University of Ottawa 40 participants Est. completion 2027-02-26 1 site
    Other conditions: Bipolar Depression, Bipolar I Disorder, Bipolar II Disorder
    View official trial listing →
  • Recruiting NCT NCT06580860

    Psychiatric Multi-omics and Neuroimaging Project

    mingjun Zhong 1899 participants Est. completion 2027-01 1 site
    Other conditions: Mental Disorders, Healthy Control
    View official trial listing →
  • Recruiting NCT NCT06581302

    Magnetic Seizure Therapy for Psychotic Disorders

    Not yet reported Shanghai Jiao Tong University School of Medicine 50 participants Est. completion 2025-12-30 2 sites Stand-alone
    Other conditions: Psychotic Disorders
    View official trial listing →
  • Recruiting NCT NCT06613334

    Voice-Based Biomarkers: A Novel Approach to Monitoring and Predicting Schizophrenia Relapses

    Not yet reported Centre Hospitalier St Anne 200 participants Est. completion 2027-10 2 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Recruiting NCT NCT06617806

    Advanced Practice Nurses for Fall Incidence PrevenTion in Very Old Robust Adults

    Not yet reported Nantes University Hospital 386 participants Est. completion 2027-10-31 1 site
    Other conditions: Fall Prevention, Autonomy of Older People, Frail Elderly, Advanced Practice Nursing
    View official trial listing →
  • Recruiting NCT NCT06624462

    Effectiveness of a Pragmatic, Metabolic Care Clinic for Patients With Severe Mental Illness - The Meta Care Clinic

    Not yet reported Bjorn H. Ebdrup 84 participants Est. completion 2026-12-31 1 site
    Other conditions: Severe Mental Disorder, Metabolic Complication, Side-Effect;Medication, Schizophrenia Spectrum and Other Psychotic Disorders, Bipolar Disorder
    View official trial listing →
  • Recruiting NCT NCT06651112

    The ATP Project (Antipsychotic-TEP-Psychosis)

    Université de Sherbrooke 18 participants Est. completion 2028-06-01 1 site
    Other conditions: First Episose Psychosis, Metabolic Disease, Psychosis; Episode
    View official trial listing →
  • Recruiting NCT NCT06687694

    Immune Mechanisms of Antipsychotic Treatment Response

    King's College London 500 participants Est. completion 2031-07 1 site
    Other conditions: Psychosis
    View official trial listing →
  • Recruiting NCT NCT06729541

    Development and Application of Precision Treatment Strategies for Common Mental Disorders

    Not yet reported Peking University 600 participants Est. completion 2026-12 1 site
    Other conditions: Depression - Major Depressive Disorder, Schizophrenia Disorders, Bipolar Disorder (BD)
    View official trial listing →
  • Recruiting NCT NCT06729671

    A Probiotic Strategy for Antipsychotic-induced Metabolic Dysfunction

    Not yet reported University College Cork 70 participants Est. completion 2026-11-30 2 sites
    Other conditions: Psychosis
    View official trial listing →
  • Recruiting NCT NCT06740890

    Exercise and Olanzapine-samidorphan

    Not yet reported New York State Psychiatric Institute 30 participants Est. completion 2027-04 1 site
    Other conditions: Schizophenia Disorder, Schizoaffective Disorder, Bipolar Disorder I or II, Bipolar Disorder NOS
    View official trial listing →
  • Recruiting NCT NCT06743711

    Validation and Impact of Cardiorespiratory Fitness in Severe Mental Illness - the Heart in Mind Project

    Bjorn H. Ebdrup 75 participants Est. completion 2026-06-30 1 site
    Other conditions: Severe Mental Illness, Schizophrenia Spectrum &Amp; Other Psychotic Disorders, Bipolar Affective Disorder
    View official trial listing →
  • Recruiting NCT NCT06754319

    Pathogenesis of Pediatric Obsessive-compulsive Disorder: Based on the Microbiota-gut-brain Axis

    Shanghai Mental Health Center 125 participants Est. completion 2027-12-31 1 site
    Other conditions: Obsessive-Compulsive Disorder, Tic Disorder
    View official trial listing →
  • Recruiting NCT NCT06756139

    Effects of Cognitive Behavioral Therapy Through a Mobile App on Patients With Refractory Functional Dyspepsia

    Not yet reported Air Force Military Medical University, China 88 participants Est. completion 2025-11-01 7 sites
    Other conditions: Functional Dyspepsia, Self-help Mobile Cognitive Behavioral Therapy, Antipsychotic Drug
    View official trial listing →
  • Recruiting NCT NCT06814314

    AP Metabolism Transcriptomics

    IRCCS Eugenio Medea 100 participants Est. completion 2026-05 1 site
    Other conditions: Neurodevelopmental Disorders, Irritability
    View official trial listing →
  • Recruiting NCT NCT06831942

    Attempted Suicide Short Intervention Program for Older Adults (ASSIP-OA): An Evaluation of a Psychosocial Intervention for Suicidal Adults Aged 65+

    Not yet reported Vastra Gotaland Region 132 participants Est. completion 2031-06 2 sites
    Other conditions: Suicidal Ideation, Suicide Attempt, Suicide
    View official trial listing →
  • Recruiting NCT NCT06904079

    Prediction and Intervention Effect of Rehabilitation Status for Severe Mental Disorder Patients Based on Multimodal Analysis and AI Agents

    Not yet reported Shanghai Mental Health Center 82 participants Est. completion 2026-06-30 1 site Stand-alone
    Other conditions: Severe Mental Disorder, Schizophrenia, Schizoaffective Disorder, Paranoid Psychosis, Bipolar Affective Disorder, Mental Disorders Due to Epilepsy, Mental Retardation Accompanied by Mental Disorders
    View official trial listing →
  • Recruiting NCT NCT06936137

    : EFFECT OF PROBIOTIC SUPPLEMENTATION ON ATYPICAL ANTIPSYCHOTIC INDUCED WEIGHT GAIN IN PATIENTS ATTENDING PSYCHIATRIC CLINICS AT AINSHAMS UNIVERSITY HOSPITALS (A RANDOMIZED CONTROLLED TRIAL)

    Not yet reported Ain Shams University 180 participants Est. completion 2026-12-20 1 site
    Other conditions: Antipsychotic Induced Weight Gain
    View official trial listing →
  • Recruiting NCT NCT06961968

    Randomized Withdrawal Study in Patients With Schizophrenia

    Not yet reported Vanda Pharmaceuticals 400 participants Est. completion 2027-11 22 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Recruiting NCT NCT06978803

    HYEEG Discourse in Psychosis: A Neurobehavioural Study

    Douglas Mental Health University Institute 110 participants Est. completion 2026-12-31 1 site
    Other conditions: Psychosis, Schizophrenia Disorders
    View official trial listing →
  • Recruiting NCT NCT06997198

    Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities

    Not yet reported University Hospitals Cleveland Medical Center 25 participants Est. completion 2027-10-01 1 site
    Other conditions: Tardive Dyskinesia, Intellectual Disability, Developmental Disabilities
    View official trial listing →
  • Recruiting NCT NCT07008235

    Effect of Amitriptyline and Trifluoperazine on Patients With Functional Dyspepsia

    Not yet reported, Not yet reported Md. Moktadirul Hoque Shuvo 120 participants Est. completion 2026-06 1 site
    Other conditions: Functional Dyspepsia
    View official trial listing →
  • Recruiting NCT NCT07025590

    Effect of Exercise on Tapering Antipsychotics in Patients With Psycho-cardiological Disease(EXTRA-study)

    Not yet reported Guangdong Provincial People's Hospital 106 participants Est. completion 2027-03-31 1 site
    Cardiovascular disease Other conditions: Depression Anxiety Disorder
    View official trial listing →
  • Recruiting NCT NCT07055204

    Cognitive Remediation Method Using Rhythmic, Vocal and Corporal Musical Learning for Schizophrenia

    Not yet reported University Hospital, Toulouse 120 participants Est. completion 2028-12-31 6 sites
    Other conditions: Schizophrenia Disorders
    View official trial listing →
  • Recruiting NCT NCT07085923

    Norwegian Mental Illness Heart Health Study

    Not yet reported Madeleine Elisabeth Angelsen 70 participants Est. completion 2028-06-30 1 site
    Metabolic syndrome Other conditions: Cardio Vascular Disease, Severe Mental Disorder, Schizophrenia and Schizophrenia Spectrum Psychosis, Bipolar Disease Type I, Overweight and/or Obesity, CVD Risk Factors, Severe Mental Illness
    View official trial listing →
  • Recruiting NCT NCT07109245

    Do Antipsychotics Block Insulin Action in the Brain: is it a Class Effect?

    Not yet reported Centre for Addiction and Mental Health 35 participants Est. completion 2028-12 1 site
    Other conditions: Brain Insulin Sensitivity, Healthy Controls, Cognition
    View official trial listing →
  • Recruiting NCT NCT07122531

    Recovery With Exogenous Ketones and Antipsychotics

    Not yet reported Université de Sherbrooke 15 participants Est. completion 2027-08-15 1 site
    Other conditions: First Episode Psychosis
    View official trial listing →
  • Recruiting NCT NCT07139171

    Study on the Role and Mechanism of Plasma Exosome microRNAs in Cognitive Impairment in First-episode Schizophrenia

    Tianjin Anding Hospital 300 participants Est. completion 2025-12-31 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Recruiting NCT NCT07184619

    Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia

    Not yet reported Newron Pharmaceuticals SPA 400 participants Est. completion 2027-03-31 25 sites
    Other conditions: Treatment-resistant Schizophrenia
    View official trial listing →
  • Recruiting NCT NCT07244640

    Non-Invasive Fundus Retinal Detection Technology for Early Diagnosis of Parkinson's Disease

    Second Affiliated Hospital, Zhejiang University, School of Medicine 200 participants Est. completion 2028-12 1 site
    Other conditions: Parkinson's Disease (PD)
    View official trial listing →
  • Recruiting NCT NCT07246044

    HD-tDCS for Adolescent Bipolar Depression Targeting S1

    Not yet reported Jiangsu Province Nanjing Brain Hospital 100 participants Est. completion 2027-12-31 1 site
    Other conditions: Adolescent, Bipolar Depression, tDCS, Primary Somatosensory Cortex, Bipolar Disorder Depression
    View official trial listing →
  • Recruiting NCT NCT07343193

    Deprescribing Antipsychotics: a Multiple Case Study

    University Hospital, Strasbourg, France 30 participants Est. completion 2026-09-09 1 site
    Other conditions: Psychotic Disorder
    View official trial listing →
  • Recruiting NCT NCT07360665

    Multimodal Physical Exercise Program (Physical Exercise for Psychosis) for People With Psychosis Treated With Long-Acting Injectable Antipsychotics

    Not yet reported University of Trás-os-Montes and Alto Douro 44 participants Est. completion 2026-11-30 1 site
    Other conditions: Psychotic Disorders, Schizophrenia Spectrum Disorders (SSD), Severe Mental Illness
    View official trial listing →
  • Recruiting NCT NCT07363577

    Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia

    Not yet reported LB Pharmaceuticals Inc. 456 participants Est. completion 2027-10 13 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Recruiting NCT NCT07402928

    Optimistic and Pessimistic Dopamine Signals in the Human Brain: a Mapping and Modelling Study in Health and Parkinson's Disease

    Danish Research Centre for Magnetic Resonance 140 participants Est. completion 2027-06-30 1 site
    Other conditions: Healthy, Parkinson, Medication Administration
    View official trial listing →
  • Recruiting NCT NCT07483294

    Cerebellum-based Imaging Neural Markers for Antipsychotic Response

    Not yet reported Northwell Health 120 participants Est. completion 2030-06-01 1 site
    Other conditions: Psychosis; Acute
    View official trial listing →
  • Recruiting NCT NCT07565428

    Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications

    Not yet reported Minerva Neurosciences 380 participants Est. completion 2028-12 13 sites
    Other conditions: Negative Symptoms of Schizophrenia
    View official trial listing →
  • Recruiting NCT NCT07606014

    No Guts No Glory Probiotics

    Not yet reported, Not yet reported University Medical Center Groningen 112 participants Est. completion 2029-05-01 3 sites
    Other conditions: Patients Using Olanzapine, Quetiapine, Risperidone or Clozapine
    View official trial listing →
  • Recruiting NCT NCT07696000

    The Effect of Structured Medical Nutrition Therapy on Systemic Inflammation Index in Patients With Schizophrenia Receiving Antipsychotic Therapy

    Not yet reported DINA KEUMALA SARI 100 participants Est. completion 2026-10-30 1 site
    Other conditions: Schizophrenia / Schizoaffective Disorder
    View official trial listing →
  • Recruiting NCT NCT07795554

    The Safety and Effectiveness of dTMS for Reducing Antipsychotic-induced Weight Gain

    Not yet reported Second Xiangya Hospital of Central South University 60 participants Est. completion 2027-06-01 1 site
    Other conditions: Schizophrenia Spectrum, Schizophrenia, Antipsychotic Induced Weight Gain
    View official trial listing →
  • Recruiting NCT NCT07805980

    A Relation Between Craving Induction and Treatment Response in Deep Transcranial Magnetic Stimulation (dTMS) for Reducing Antipsychotic-induced Weight Gain in Schizophrenia

    Not yet reported Second Xiangya Hospital of Central South University 30 participants Est. completion 2027-06-01 1 site
    Other conditions: Schizophrenia, Antipsychotic Induced Weight Gain
    View official trial listing →
  • Recruiting NCT NCT07817069

    Effects of Nitraria Retusa Infusion on Clozapine-induced Metabolic Side Effects

    Not yet reported Faculty of Medicine, Sousse 30 participants Est. completion 2028-12 1 site
    Other conditions: Treatment Resistant Schizophrenia, Obesity & Overweight, Abdominal Obesity
    View official trial listing →
  • Recruiting NCT NCT07858565

    Quality of Life, Safety and Compliance of Patients Using Monotherapy or Combinatorial Therapy With Quetiapine for Treatment of Schizophrenia or Bipolar Affective Disorder

    Bosnalijek D.D 500 participants Est. completion 2027-05 1 site
    Other conditions: Schizophrenia, Bipolar Affective Disorder
    View official trial listing →
  • Recruiting NCT NCT07918222

    Sequential Treatment Approaches for Treatment-Resistant Schizophrenia

    Not yet reported Shanghai Mental Health Center 300 participants Est. completion 2030-12-01 1 site
    Other conditions: Treatment-resistant Schizophrenia
    View official trial listing →
  • Completed NCT NCT00000371

    Trial of D-Cycloserine in Schizophrenia

    Not yet reported Massachusetts General Hospital 60 participants Est. completion 2002-04
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00000373

    Treatment of Obsessive-Compulsive Disorder

    Not yet reported University of Florida 74 participants Est. completion 2003-07 2 sites
    Other conditions: Obsessive-Compulsive Disorder
    View official trial listing →
  • Completed NCT NCT00000374

    Treatment for First-Episode Schizophrenia

    Not yet reported Northwell Health 125 participants Est. completion 2007-05 2 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00001656

    Comparison of Clozapine vs Olanzapine in Childhood-Onset Psychotic Disorders

    Not yet reported National Institute of Mental Health (NIMH) 25 participants Est. completion 2008-06 1 site
    Other conditions: Childhood Schizophrenia, Psychotic Disorder, Schizophrenia
    View official trial listing →
  • Completed NCT NCT00014001

    CATIE- Schizophrenia Trial

    Not yet reported National Institute of Mental Health (NIMH) 1600 participants Est. completion 2004-12 54 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00015548

    CATIE-Alzheimer's Disease Trial

    Not yet reported National Institute of Mental Health (NIMH) 450 participants Est. completion 2004-10 34 sites
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT00018668

    Antipsychotic Response in Schizophrenia

    Not yet reported US Department of Veterans Affairs Est. completion 2004-09 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00034762

    Efficacy and Safety of Risperidone Compared With Placebo in the Treatment of Psychotic Symptoms in Patients With Alzheimer's Disease

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 473 participants Est. completion 2003-01
    Other conditions: Dementia, Alzheimer Disease, Mental Disorders
    View official trial listing →
  • Completed NCT NCT00034775

    A Study to Assess Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-acting Injectable Risperidone in Patients With Schizophrenia.

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 141 participants Est. completion 2002-10
    Other conditions: Schizophrenia, Psychotic Disorders
    View official trial listing →
  • Completed NCT NCT00044655

    Switching Medication to Treat Schizophrenia

    Not yet reported Icahn School of Medicine at Mount Sinai 219 participants Est. completion 2009-03
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00044681

    A Study of the Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant Depression

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 258 participants Est. completion 2004-03
    Other conditions: Depressive Disorder, Depressive Disorder, Major, Depression
    View official trial listing →
  • Completed NCT NCT00056472

    Study of Pharmacotherapy of Psychotic Depression

    Not yet reported Weill Medical College of Cornell University 259 participants Est. completion 2008-06 4 sites
    Other conditions: Major Depressive Disorder With Psychotic Features
    View official trial listing →
  • Completed NCT NCT00057135

    Improving Antipsychotic Adherence Among Patients With Serious Mental Illness

    Not yet reported US Department of Veterans Affairs 150 participants Est. completion 2006-09 5 sites
    Other conditions: Schizophrenia, Schizoaffective Disorder, Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00057408

    A Controlled Study of Olanzapine in Children With Autism

    Not yet reported FDA Office of Orphan Products Development 78 participants Est. completion 2005-09 1 site
    Other conditions: Autistic Disorder
    View official trial listing →
  • Completed NCT NCT00061802

    Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective Disorder

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 225 participants Est. completion 2004-02 13 sites
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT00065273

    Atypical Neuroleptic Drugs in People With Mental Retardation/Developmental Delay

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 50 participants Est. completion 2001-06 1 site
    Other conditions: Mental Retardation, Developmental Delay Disorder
    View official trial listing →
  • Completed NCT NCT00065286

    Akathisia (Restless Legs Syndrome) in People With Schizophrenia and Mental Retardation

    Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Est. completion 1999-11 2 sites
    Other conditions: Akathisia
    View official trial listing →
  • Completed NCT NCT00073164

    Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone in the Treatment of Schizophrenia

    Not yet reported Abbott 400 participants 35 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00073320

    Intramuscular Injections of Paliperidone Palmitate in the Arm or Buttock of Subjects With Schizophrenia

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 88 participants Est. completion 2004-05
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00074477

    Safety and Efficacy of an Anti-Psychotic in Patients With Schizophrenia

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 250 participants Est. completion 2004-07
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00077727

    A Study of the Effectiveness and Safety of Galantamine Hydrobromide on Cognitive Impairment in Patients With Schizophrenia.

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 107 participants Est. completion 2005-02
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00081380

    Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder

    Not yet reported AstraZeneca 710 participants Est. completion 2006-09 94 sites
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00083668

    Trial Evaluating Three Fixed Doses of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 619 participants Est. completion 2005-05
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00086112

    Study Comparing Risperidone vs Placebo as add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-optimally Responding to Standard Therapy.

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 301 participants Est. completion 2005-06
    Other conditions: Anxiety Disorders
    View official trial listing →
  • Completed NCT NCT00086593

    Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia

    Not yet reported GlaxoSmithKline 209 participants Est. completion 2005-07 39 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00088751

    Treatment Study of Frontotemporal Dementia

    National Institute of Neurological Disorders and Stroke (NINDS) 20 participants Est. completion 2009-06-01 1 site
    Other conditions: Frontotemporal Lobar Degeneration
    View official trial listing →
  • Completed NCT NCT00096863

    The MIND Study: Modifying the INcidence of Delirium

    Not yet reported Vanderbilt University 102 participants Est. completion 2007-07 5 sites
    Other conditions: Delirium, Cognition Disorders
    View official trial listing →
  • Completed NCT NCT00097942

    Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment in Schizophrenia Patients

    Not yet reported Forest Laboratories 138 participants Est. completion 2005-09 13 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00101634

    Efficacy and Safety of a Long Acting Anti-Psychotic Versus Placebo in Patients With Schizophrenia

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 518 participants Est. completion 2006-03
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00107939

    Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder

    Not yet reported Novartis Pharmaceuticals 453 participants Est. completion 2007-04 22 sites
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00108368

    The Effects of Risperidone and Olanzapine on Thinking

    Not yet reported US Department of Veterans Affairs Est. completion 2006-03 1 site
    Other conditions: Schizophrenia, Psychotic Disorders
    View official trial listing →
  • Completed NCT NCT00111189

    A Study of the Efficacy (Effectiveness) of Paliperidone Palmitate in the Prevention of Recurrence of the Symptoms of Schizophrenia.

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 414 participants Est. completion 2008-02 55 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00122070

    Quetiapine Treatment for Symptoms Associated With Borderline Personality Disorder

    Not yet reported University of Medicine and Dentistry of New Jersey 15 participants Est. completion 2008-05 1 site
    Other conditions: Borderline Personality Disorder
    View official trial listing →
  • Completed NCT NCT00132314

    Long-Acting Injectable Risperidone in the Treatment of Schizophrenia

    Not yet reported US Department of Veterans Affairs 382 participants Est. completion 2009-09 19 sites
    Other conditions: Schizoaffective Disorder, Schizophrenia
    View official trial listing →
  • Completed NCT NCT00137020

    Clinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizoaffective Disorder

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 294 participants Est. completion 2006-04 27 sites
    Other conditions: Schizophrenia, Psychotic Disorders
    View official trial listing →
  • Completed NCT NCT00140426

    A Double-blind, Placebo Controlled Trial of Risperidone for the Treatment of Anorexia Nervosa

    Not yet reported University of Colorado, Denver 41 participants Est. completion 2009-12 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Status unknown NCT NCT00141947

    Bexarotene Treatment in Schizophrenia

    Not yet reported Beersheva Mental Health Center 15 participants Est. completion 2006-09 2 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00144027

    Patient-Centered Medication Adherence Intervention for Schizophrenia

    Not yet reported US Department of Veterans Affairs 75 participants Est. completion 2009-07 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00148564

    Energy Homeostasis Under Treatment With Atypical Antipsychotics

    Not yet reported Charite University, Berlin, Germany 40 participants Est. completion 2007-06 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00149734

    Addition of Ondansetron to Ongoing Antipsychotic Treatment for Schizophrenia

    Not yet reported University of Colorado, Denver 8 participants Est. completion 2010-05 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00156637

    A Study of Strategies to Improve Schizophrenia Treatment

    Not yet reported US Department of Veterans Affairs 106 participants Est. completion 2008-03 4 sites
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT00156715

    Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder

    Not yet reported Dartmouth-Hitchcock Medical Center 23 participants Est. completion 2008-10 4 sites
    Other conditions: Schizophrenia, Schizoaffective Disorder, Psychotic Disorder, Substance Abuse, Alcohol Abuse
    View official trial listing →
  • Status unknown NCT NCT00157378

    Optimization of Acute Treatment in First Episode Schizophrenia

    Not yet reported Ludwig-Maximilians - University of Munich 300 participants Est. completion 2004-12 1 site
    Other conditions: Schizophrenia, First-Episode
    View official trial listing →
  • Completed NCT NCT00159081

    One Year Drug Treatment in First-Episode Schizophrenia

    Not yet reported Heinrich-Heine University, Duesseldorf 159 participants Est. completion 2005-06 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00159120

    Maintenance Treatment vs. Stepwise Drug Discontinuation in First-Episode Schizophrenia

    Not yet reported Heinrich-Heine University, Duesseldorf 71 participants Est. completion 2006-06 1 site
    Other conditions: Schizophrenia, Psychoses
    View official trial listing →
  • Completed NCT NCT00159133

    Prodrome-Based Early Intervention With Antipsychotics vs. Benzodiazepines in First-Episode Schizophrenia

    Not yet reported Heinrich-Heine University, Duesseldorf 71 participants Est. completion 2006-06 1 site
    Other conditions: Schizophrenia, Psychoses
    View official trial listing →
  • Terminated NCT NCT00159757

    12 Week Open, Non-Comparative Switch Study Of Oral Ziprazidone In Previously Treated Schizophrenic Patients

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 150 participants Est. completion 2005-02 8 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00159770

    Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 290 participants Est. completion 2004-09 43 sites
    Other conditions: Schizophrenia, Schizoaffective Disorder, Psychotic Disorders
    View official trial listing →
  • Completed NCT NCT00161018

    New Antipsychotic Strategies: Quetiapine and Risperidone vs. Fluphenazine in Treatment Resistant Schizophrenia

    Not yet reported University of Maryland, Baltimore 150 participants Est. completion 2004-11 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00161031

    Atomoxetine as an Adjunct to Novel Antipsychotic Medication in the Treatment of Cognitive Deficits of Schizophrenia

    Not yet reported University of Maryland, Baltimore 30 participants Est. completion 2006-12 2 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00167154

    Risperidone and Suicidality in Major Depressive Disorder

    Not yet reported University of Alabama at Birmingham 30 participants Est. completion 2008-08 1 site
    Other conditions: Depression
    View official trial listing →
  • Completed NCT NCT00167310

    Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid Supplementation

    Not yet reported University of Pittsburgh 57 participants Est. completion 2015-12 1 site
    Cardiovascular disease Other conditions: Schizophrenia, Schizoaffective Disorder, Major Depression, Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00167934

    Determining Metabolic Effects of Valproate and Antipsychotic Therapy

    Not yet reported Washington University School of Medicine 164 participants Est. completion 2008-12 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Terminated NCT NCT00169026

    Alcoholism and Schizophrenia: Effects of Clozapine

    Not yet reported Dartmouth-Hitchcock Medical Center 64 participants Est. completion 2004-01 1 site
    Other conditions: Schizophrenia, Dual Diagnosis, Schizoaffective Disorder, Psychotic Disorder, Substance Abuse, Alcohol Abuse
    View official trial listing →
  • Completed NCT NCT00169702

    The Effect of a Weight Management Program During Treatment With Olanzapine

    Not yet reported Heinrich-Heine University, Duesseldorf 100 participants Est. completion 2007-07 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00169988

    Antidepressant and Antipsychotic to Treat Attenuated Positive and Negative Symptoms

    Not yet reported Northwell Health 8 participants Est. completion 2007-04 1 site
    Other conditions: Prodromal Schizophrenia, Psychotic Disorders
    View official trial listing →
  • Completed NCT NCT00174200

    Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone

    Not yet reported Pfizer 20 participants Est. completion 2006-05 3 sites
    Other conditions: Schizophrenia, Psychotic Disorders
    View official trial listing →
  • Completed NCT NCT00175955

    Levetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia

    Not yet reported UCB Pharma 70 participants Est. completion 2005-12 7 sites
    Other conditions: Dyskinesia, Medication-induced
    View official trial listing →
  • Completed NCT NCT00176202

    Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar

    Not yet reported University of Illinois Chicago 65 participants Est. completion 2008-01 3 sites
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00177164

    Risperdal Consta for Bipolar Disorder

    Not yet reported University of Pittsburgh 50 participants Est. completion 2009-12 4 sites
    Other conditions: Bipolar I Disorder
    View official trial listing →
  • Completed NCT NCT00178932

    Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors

    Not yet reported Northwestern University 37 participants Est. completion 2024-05-16 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Bipolar Disorder, Major Depression
    View official trial listing →
  • Completed NCT NCT00178958

    Evaluation of QTc Interval by Continuous Holter ECG Recording in Antipsychotic Drug-treated Patients With Schizophrenia

    Not yet reported Northwestern University 70 participants Est. completion 2006-06
    Other conditions: Schizophrenia, Schizoaffective, Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00179062

    Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder

    Not yet reported Vanderbilt University 300 participants Est. completion 2007-06 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Depressive Disorder, Major, Bipolar Disorder
    View official trial listing →
  • Active, not recruiting NCT NCT00179465

    Treating Schizophrenia by Correcting Abnormal Brain Development

    Not yet reported Beth Israel Deaconess Medical Center 36 participants Est. completion 2026-09 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT00182494

    Diabetes Prevention Program in Schizophrenia [DPPS]

    Not yet reported Hamilton Health Sciences Corporation 200 participants Est. completion 2009-01 1 site
    Other conditions: Diabetes Mellitus, Schizophrenia
    View official trial listing →
  • Completed NCT NCT00183625

    Supported Employment and Skills Training in Conjunction With Pharmacotherapy in Schizophrenia Patients

    Not yet reported University of California, Los Angeles 107 participants Est. completion 2006-09 2 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00188942

    A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar Disorder

    Not yet reported University Health Network, Toronto 42 participants Est. completion 2009-06 2 sites
    Other conditions: Major Depressive Disorder
    View official trial listing →
  • Completed NCT NCT00191555

    Efficacy Study of Switching Stabilized Schizophrenic Patients From Conventional to Atypical Antipsychotic Treatment

    Not yet reported Eli Lilly and Company 360 participants Est. completion 2006-05 62 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00191828

    A Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational Programme

    Not yet reported Eli Lilly and Company 60 participants Est. completion 2005-08 1 site
    Other conditions: Weight Gain
    View official trial listing →
  • Completed NCT NCT00194038

    Aripiprazole in Late Life Bipolar Disorder

    Not yet reported University Hospitals Cleveland Medical Center 20 participants Est. completion 2006-06
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Status unknown NCT NCT00197834

    Study of Depakote for Behavioral and Psychological Symptoms in Dementia

    Not yet reported Hearthstone Alzheimer Care 20 participants 1 site
    Other conditions: Dementia
    View official trial listing →
  • Completed NCT NCT00198107

    Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With Autism

    Not yet reported Indiana University 81 participants Est. completion 2011-09 1 site
    Other conditions: Autistic Disorder
    View official trial listing →
  • Status unknown NCT NCT00201292

    Pharmacogenetic Profiling of Antipsychotics-Induced X-Syndrome and Diabetes (PAXD)

    National Health Research Institutes, Taiwan 1350 participants Est. completion 2008-10 3 sites
    Metabolic syndrome Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00202280

    Efficacy of Treating First Episode Psychosis With Folic Acid,B12 and B6 in Addition to Antipsychotic Medication

    Not yet reported, Not yet reported Melbourne Health 120 participants Est. completion 2009-06 1 site
    Other conditions: First Episode Psychosis
    View official trial listing →
  • Completed NCT NCT00202293

    Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Features

    Not yet reported Melbourne Health 83 participants Est. completion 2015-11-01 1 site
    Other conditions: Bipolar Disorder, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT00205660

    Changes in Adiposity, Metabolic Measures From Atypicals to Aripiprazole

    Not yet reported Washington University School of Medicine 51 participants Est. completion 2009-08 1 site
    Type 2 diabetes Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00205699

    Metabolic Effects of Antipsychotics in Children

    Not yet reported Washington University School of Medicine 144 participants Est. completion 2011-07 1 site
    Other conditions: Aggression, Attention Deficit-Hyperactivity, Oppositional Defiant Disorder, Pervasive Development Disorders, Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00206570

    Clinical Estradiol Trial in Women With Schizophrenia

    Not yet reported Bayside Health 100 participants Est. completion 2004-12 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder
    View official trial listing →
  • Completed NCT NCT00206960

    Dopaminergic, Functional, Structural, and Cognitive Disturbances in First-episode Schizophrenia

    Not yet reported Birte Glenthoj 56 participants Est. completion 2010-09 6 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00207064

    Neurobiological and Neurocognitive Disturbances in First-episode Schizophrenia

    Not yet reported Birte Glenthoj 46 participants Est. completion 2008-09 3 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00208533

    Aripiprazole in Children With Autism: A Pilot Study

    Not yet reported Drexel University College of Medicine 11 participants Est. completion 2011-11-16 1 site
    Other conditions: Autism
    View official trial listing →
  • Completed NCT NCT00210548

    A Study to Evaluate the Effectiveness and Safety of 3 Doses of Paliperidone Palmitate in Treating Subjects With Schizophrenia

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 366 participants Est. completion 2006-06
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00210717

    A Study to Compare the Effectiveness and Safety of Flexibly Varied Doses of Paliperidone Palmitate and Risperidone in Treating Patients With Schizophrenia

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 748 participants Est. completion 2007-04
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00210769

    A Study of the Long-term Safety and Tolerability and the Long-term Effectiveness of Extended-release Oral Paliperidone in Patients Diagnosed With Schizophrenia

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 203 participants Est. completion 2005-12
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00215150

    Geodon for the Treatment of Refractory Social Anxiety Disorder

    Not yet reported Duke University 51 participants Est. completion 2009-07 2 sites
    Other conditions: Social Anxiety Disorder
    View official trial listing →
  • Completed NCT NCT00215241

    Risperidone Augmentation for PTSD

    Not yet reported, Not yet reported Duke University 80 participants Est. completion 2006-07 2 sites
    Other conditions: Post-Traumatic Stress Disorder
    View official trial listing →
  • Completed NCT NCT00215254

    Quetiapine in Social Anxiety Disorder

    Not yet reported, Not yet reported Duke University 15 participants Est. completion 2006-02 1 site
    Other conditions: Social Anxiety Disorder
    View official trial listing →
  • Completed NCT NCT00216476

    A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder

    Not yet reported Janssen-Cilag International NV 753 participants Est. completion 2007-11 96 sites
    Other conditions: Schizophrenia, Psychotic Disorders
    View official trial listing →
  • Completed NCT NCT00216580

    A Pilot Study of the Use of Risperidone Long Acting Injectable in the Treatment of Patients With Recent Onset Psychosis

    Not yet reported Janssen Pharmaceutica N.V., Belgium 50 participants Est. completion 2006-12
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00216632

    A Study of Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™)

    Not yet reported Janssen Pharmaceutica N.V., Belgium 99 participants Est. completion 2007-07
    Other conditions: Schizophrenia, Psychotic Disorders
    View official trial listing →
  • Completed NCT NCT00216671

    Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute Episode

    Not yet reported Janssen Pharmaceutica N.V., Belgium 220 participants Est. completion 2009-12 31 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00222807

    Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus

    University of Pittsburgh 200 participants Est. completion 2016-03 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Delusional Disorder
    View official trial listing →
  • Completed NCT NCT00222833

    The Effect of Switching to Aripiprazole on Heart Health in Overweight and Obese Patients With Schizophrenia

    Not yet reported University of Pittsburgh 30 participants Est. completion 2005-12 1 site
    Cardiovascular disease Other conditions: Overweight, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT00223522

    Do Self-Report and Physician Impressions of Adherence to Oral Antipsychotic Medication Agree With Objective Data?

    The University of Texas Health Science Center at San Antonio 50 participants Est. completion 2005-03 1 site
    Other conditions: Schizophrenia, Schizoaffective
    View official trial listing →
  • Completed NCT NCT00224276

    Prevalence of Diabetes Mellitus Among Patients Treated With Atypical and Conventional Antipsychotics

    Yale University 100 participants
    Other conditions: Schizophrenia, Bipolar Disorder, Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00224822

    The Effects of Aripiprazole on Patients With Metabolic Syndrome

    Not yet reported New Mexico VA Healthcare System 27 participants Est. completion 2007-03 1 site
    Metabolic syndrome Other conditions: Schizophrenia, Schizoaffective Disorder, Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00230893

    Characterization of the Use of Antipsychotics in PTSD During the Past Seven Years

    Tuscaloosa Research & Education Advancement Corporation 99 participants Est. completion 2005-09 1 site
    Other conditions: PTSD, Post-Traumatic Stress Disorder
    View official trial listing →
  • Completed NCT NCT00231894

    Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia

    Not yet reported Nathan Kline Institute for Psychiatric Research 56 participants Est. completion 2010-01 1 site
    Other conditions: Diabetes, Schizophrenia, Insulin Resistance, Cognitive Impairment
    View official trial listing →
  • Completed NCT NCT00232336

    Quetiapine for Cocaine Use and Cravings

    Not yet reported Seattle Institute for Biomedical and Clinical Research 42 participants Est. completion 2006-01 1 site
    Substance use disorder Other conditions: Cocaine-Related Disorders
    View official trial listing →
  • Withdrawn NCT NCT00233467

    Characterization of the Use of Antipsychotics in Posttraumatic Stress Disorder During the Past Decade

    Tuscaloosa Research & Education Advancement Corporation Est. completion 2005-09-30 1 site
    Other conditions: PTSD, Posttraumatic Stress Disorder
    View official trial listing →
  • Completed NCT NCT00234377

    Seroquel Switching Study: Feasibility of Switching Any Antipsychotic Treatment to Seroquel in Patients With Schizophrenia

    Not yet reported AstraZeneca 550 participants Est. completion 2006-05 27 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00236457

    A Study Comparing the Efficacy of Long-acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 629 participants Est. completion 2002-12
    Other conditions: Schizophrenia, Psychotic Disorders
    View official trial listing →
  • Completed NCT NCT00236587

    A Long Term Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 100 participants Est. completion 2004-02
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00237861

    Effectiveness of Atypical Versus Conventional Antipsychotics in Treating Schizophrenia

    Not yet reported Yale University
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00240708

    A Study of the Efficacy and Safety of Long-acting Injectable Risperidone and Risperidone Tablets in Patients With Schizophrenia

    Not yet reported Janssen Pharmaceutical K.K. 205 participants Est. completion 2006-04
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00245206

    Side Effects of Newer Antipsychotics in Older Adults

    Not yet reported Veterans Medical Research Foundation 406 participants Est. completion 2010-10 1 site
    Other conditions: Schizophrenia, Alzheimer's Disease, Dementia
    View official trial listing →
  • Completed NCT NCT00246246

    A Randomized, Open-label Trial of Long-acting Injectable Risperidone Versus Oral Antipsychotic Medication in Patients With Bipolar Disorder

    Not yet reported Janssen-Ortho Inc., Canada 48 participants Est. completion 2006-04
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00246259

    A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis

    Not yet reported Janssen-Ortho Inc., Canada 77 participants Est. completion 2008-12 11 sites
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Psychotic Disorders
    View official trial listing →
  • Completed NCT NCT00246285

    A Study of the Effectiveness and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 381 participants Est. completion 2006-12
    Other conditions: Schizophrenia, Psychotic Disorders
    View official trial listing →
  • Completed NCT NCT00249119

    A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic Schizophrenia

    Not yet reported Janssen, LP 1579 participants Est. completion 1991-12
    Other conditions: Schizophrenia, Psychotic Disorder
    View official trial listing →
  • Completed NCT NCT00249132

    A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic Schizophrenia

    Not yet reported Janssen, LP 523 participants Est. completion 1991-07
    Other conditions: Schizophrenia, Psychotic Disorders
    View official trial listing →
  • Completed NCT NCT00249171

    A Study of Risperidone in Combination With Lorazepam Compared With Standard Therapy for Emergency Treatment of Schizophrenic Patients

    Not yet reported Janssen Pharmaceutica N.V., Belgium 226 participants Est. completion 2003-02
    Other conditions: Schizophrenia, Psychotic Disorders, Emergency Treatment
    View official trial listing →
  • Completed NCT NCT00249223

    A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic Schizophrenia

    Not yet reported Janssen Pharmaceutica N.V., Belgium 641 participants Est. completion 2000-12
    Other conditions: Schizophrenia, Psychotic Disorders
    View official trial listing →
  • Completed NCT NCT00249236

    A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 291 participants Est. completion 2001-12
    Other conditions: Bipolar Disorder, Manic Episode
    View official trial listing →
  • Completed NCT NCT00250367

    A Study of the Effectiveness and Safety of Risperidone Versus Placebo as add-on Therapy to Mood Stabilizers, in the Treatment of Manic Episodes Associated With Bipolar Disorder.

    Not yet reported Janssen Pharmaceutica N.V., Belgium 151 participants Est. completion 1999-11
    Other conditions: Bipolar Disorder, Manic Disorder
    View official trial listing →
  • Completed NCT NCT00253136

    A Study of the Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With Schizophrenia

    Not yet reported Janssen, LP 458 participants Est. completion 2000-12
    Other conditions: Schizophrenia, Psychotic Disorders
    View official trial listing →
  • Completed NCT NCT00253149

    A Study of the Effectiveness and Safety of Risperidone as add-on Therapy to Mood Stabilizers in the Treatment of Manic Episodes Associated With Bipolar Disorder

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 158 participants Est. completion 1999-04
    Other conditions: Bipolar Disorders, Manic Disorder
    View official trial listing →
  • Completed NCT NCT00253162

    A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With Haloperidol

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 439 participants Est. completion 2002-09
    Other conditions: Bipolar Disorders, Manic Disorder
    View official trial listing →
  • Completed NCT NCT00254202

    Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia

    Not yet reported Vanda Pharmaceuticals 593 participants Est. completion 2007-03-21 42 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00255879

    Movement Disorders Caused by Antipsychotic Drugs in Older Patients

    Not yet reported University of California, San Diego 250 participants Est. completion 2004-08 1 site
    Other conditions: Dyskinesia, Drug-Induced
    View official trial listing →
  • Terminated NCT NCT00256997

    A Study of Risperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Participants With a History of Being Poorly Compliant With Taking Their Medication

    Not yet reported Janssen-Ortho Inc., Canada 167 participants Est. completion 2009-04 44 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00257075

    A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 267 participants Est. completion 2002-05
    Other conditions: Bipolar Disorders, Manic Episode
    View official trial listing →
  • Completed NCT NCT00264069

    ADH.E.R.E.: Therapeutic ADHerence and Treatment Strategies: A Mental Health Registry

    Janssen-Cilag, S.A. 2622 participants Est. completion 2006-06
    Other conditions: Schizophrenia, Bipolar Disorder, Depression, Personality Disorder
    View official trial listing →
  • Terminated NCT NCT00272025

    Treatment Resistant Bipolar Depression

    Not yet reported Queen's University 1 participants Est. completion 2010-01 1 site
    Other conditions: Bipolar Depression
    View official trial listing →
  • Completed NCT NCT00272597

    Risperidone LA Heathcare Resource Study

    Not yet reported University of British Columbia 30 participants Est. completion 2010-10 1 site
    Other conditions: Psychosis, Schizophrenia
    View official trial listing →
  • Terminated NCT NCT00279409

    Treatment of Children With ADHD Who do Not Fully Respond to Stimulants

    Not yet reported New York State Psychiatric Institute 10 participants Est. completion 2009-02 1 site
    Other conditions: Attention Deficit Hyperactivity Disorder
    View official trial listing →
  • Completed NCT NCT00283517

    A Registry of Treatment Adherence for Patients With Schizophrenia

    Janssen-Cilag, S.A. 2046 participants Est. completion 2006-05
    Other conditions: Schizophrenia, Psychotic Disorders
    View official trial listing →
  • Terminated NCT NCT00287027

    Family Perspectives:Treatment of Psychiatric Illnesses With Atypical Long Acting Injectable Antipsychotic Medication

    National Alliance on Mental Illness New Hampshire 60 participants Est. completion 2006-12 1 site
    Other conditions: Psychotic Disorders
    View official trial listing →
  • Terminated NCT NCT00287742

    A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's Disease

    Not yet reported Janssen Pharmaceutical K.K. 33 participants Est. completion 2003-03
    Other conditions: Alzheimer's Disease, Dementia
    View official trial listing →
  • Terminated NCT NCT00288353

    Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic Changes

    Not yet reported Northwestern University 48 participants Est. completion 2008-12 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00288366

    Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome

    Not yet reported Northwestern University 49 participants Est. completion 2008-12 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00290121

    Appetite Increase in Schizophrenia Patients Treated With Atypical Antipsychotics

    Not yet reported Université de Montréal 25 participants Est. completion 2008-06 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00292370

    Quetiapine Augmentation for Treatment-resistant PTSD

    Not yet reported VA Office of Research and Development 124 participants Est. completion 2009-05 3 sites
    Other conditions: Combat Disorders, Stress Disorders, Post-Traumatic
    View official trial listing →
  • Completed NCT NCT00294008

    A Study to Evaluate Treatment Adherence in Schizophrenia With Long Acting Risperidone Microspheres (e-STAR)

    Janssen Korea, Ltd., Korea 230 participants Est. completion 2009-06
    Other conditions: Schizophrenia, Tranquilizing Agents, Mental Disorders, Therapeutic Uses, Physiological Effects of Drugs, Psychotropic Drugs, Antipsychotic Agents
    View official trial listing →
  • Completed NCT NCT00297388

    A Study of How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections in Patients With Schizophrenia or Schizoaffective Disorder

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 40 participants Est. completion 2004-09
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT00297739

    Risperidone Augmentation for Treatment-Resistant Aggression in ADHD

    Not yet reported Armenteros, Jorge L., M.D., P.A. 25 participants Est. completion 2005-04 1 site
    Other conditions: Aggression
    View official trial listing →
  • Completed NCT NCT00304616

    SWitching to Abilify Trial (SWAT)

    Not yet reported Korea Otsuka Pharmaceutical Co., Ltd. 500 participants Est. completion 2007-10 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00306475

    Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)?

    Not yet reported Northwestern University 60 participants Est. completion 2008-04 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT00309413

    A Clinical Trial on the Antipsychotic Properties of Cannabidiol

    Not yet reported University of Cologne 29 participants Est. completion 2008-07 1 site
    Other conditions: Schizophrenia, Psychotic Disorders
    View official trial listing →
  • Completed NCT NCT00309452

    Specialized Treatment Early in Psychosis (STEP)

    Not yet reported Yale University 120 participants Est. completion 2013-08 1 site
    Other conditions: Schizophrenia and Disorders With Psychotic Features
    View official trial listing →
  • Terminated NCT NCT00310661

    Sarizotan in the Treatment of Neuroleptic-induced Tardive Dyskinesia

    Not yet reported Centre for Addiction and Mental Health 60 participants Est. completion 2008-03 2 sites
    Other conditions: Neuroleptic-induced Tardive Dyskinesia
    View official trial listing →
  • Completed NCT NCT00312598

    Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine

    University of North Carolina, Chapel Hill 30 participants Est. completion 2010-04
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Mood Disorders
    View official trial listing →
  • Terminated NCT NCT00314613

    Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal

    Not yet reported Duke University 30 participants 2 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00314639

    Modafinil as an Adjunctive on Cognitive Functioning in Patients With Schizophrenia

    Not yet reported, Not yet reported Laval University 30 participants 1 site
    Other conditions: Schizophrenia and Schizophrenia Spectrum Psychosis
    View official trial listing →
  • Completed NCT NCT00328952

    Changes in Auditory Verbal Hallucination During Atypical Antipsychotic Treatment of Patients With Schizophrenia

    Seoul National University Hospital 40 participants Est. completion 2008-08 1 site
    Other conditions: Schizophrenia, Hallucinations
    View official trial listing →
  • Status unknown NCT NCT00330226

    Efficacy and Safety of Psychopharmacotherapy in Patients With Schizophrenia or Bipolar Disorders

    Seoul National University Hospital 500 participants Est. completion 2012-12 1 site
    Other conditions: Schizophrenia, Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00330551

    Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia

    Not yet reported University of California, Los Angeles 126 participants Est. completion 2012-11 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00330863

    Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy

    Not yet reported Northwell Health 357 participants Est. completion 2011-01 8 sites
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT00331825

    Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or Parkinsonism

    Not yet reported Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan 70 participants Est. completion 2003-07 1 site
    Other conditions: Schizophrenia, Extrapyramidal Syndrome
    View official trial listing →
  • Completed NCT NCT00332098

    Effectiveness of Family-Focused Treatment Plus Pharmacotherapy for Bipolar Disorder in Adolescents

    Not yet reported University of California, Los Angeles 145 participants Est. completion 2012-07 3 sites
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00333177

    Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset Schizophrenia

    Not yet reported University of California, Los Angeles 92 participants Est. completion 2013-01 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00334035

    Antipsychotic Therapy and First Episode

    Not yet reported The University of Hong Kong 169 participants Est. completion 2007-06 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00334126

    Evaluation of Effectiveness and Safety of Paliperidone ER (Extended-release) Compared With Quetiapine in Patients With Schizophrenia

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 399 participants Est. completion 2007-09
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00337662

    Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia

    Not yet reported Eli Lilly and Company 628 participants Est. completion 2007-12 34 sites
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder
    View official trial listing →
  • Completed NCT NCT00344500

    Healthy Lifestyles for Mentally Ill People Who Have Experienced Weight Gain From Their Antipsychotic Medications

    Not yet reported VA Office of Research and Development 122 participants Est. completion 2009-09 1 site
    Other conditions: Diabetes, Obesity, Weight Gain
    View official trial listing →
  • Completed NCT NCT00347425

    Switch Study of Existing Atypical Antipsychotics to Bifeprunox

    Not yet reported Solvay Pharmaceuticals 286 participants Est. completion 2008-02 122 sites
    Other conditions: Schizophrenia and Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT00357006

    A Definitive Estrogen Patch Study (ADEPT)

    Not yet reported The Alfred 180 participants Est. completion 2013-12 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder(Not in Manic Phase)
    View official trial listing →
  • Completed NCT NCT00361166

    Antipsychotic and Motor Effects of ACP-103 When Administered in Combination With Haloperidol and Risperidone

    Not yet reported ACADIA Pharmaceuticals Inc. 400 participants Est. completion 2007-03 17 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00362804

    Tetrabenazine for Partial Responders

    Not yet reported Centre for Addiction and Mental Health 41 participants Est. completion 2006-01 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT00363181

    Side Effects of Antipsychotic Medications

    Stanford University 76 participants Est. completion 2011-12 1 site
    Metabolic syndrome Other conditions: Insulin Resistance, Schizophrenia and Disorders With Psychotic Features, Mood Disorders, Psychotic Disorders
    View official trial listing →
  • Completed NCT NCT00373672

    Effects of Armodafinil on Cognition for Patients With Schizophrenia or Schizoaffective Disorder

    Not yet reported Northwestern University 58 participants Est. completion 2010-01 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Terminated NCT NCT00374543

    Ziprasidone for the Treatment of Generalized Anxiety in Patients With Bipolar Disorder

    Not yet reported Massachusetts General Hospital 3 participants Est. completion 2008-11 1 site
    Other conditions: Generalized Anxiety Disorder, Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00378092

    A Follow-Up Study of Schizophrenic Participants Following Treatment Discontinuation After Remission From a First Psychotic Episode

    Not yet reported Janssen Cilag N.V./S.A. 33 participants Est. completion 2010-03 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00378183

    A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine.

    Not yet reported Janssen, LP 120 participants Est. completion 2002-05
    Other conditions: Schizoaffective Disorder, Schizophrenia
    View official trial listing →
  • Completed NCT NCT00389493

    Risperidone or Cognitive-Behavioral Therapy for Improving Medication Treatment for Obsessive-compulsive Disorder

    Not yet reported New York State Psychiatric Institute 100 participants Est. completion 2012-12 2 sites
    Other conditions: Obsessive-Compulsive Disorder
    View official trial listing →
  • Completed NCT NCT00391261

    An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications.

    Not yet reported Cambridge Health Alliance 11 participants Est. completion 2007-10 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Bipolar Disorder, Autism Spectrum Disorders
    View official trial listing →
  • Completed NCT NCT00392743

    A Study to Compare Two Different Brain Imaging Techniques in Healthy Volunteers and in Schizophrenic Patients

    GlaxoSmithKline 60 participants Est. completion 2007-05 7 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT00395915

    Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of Schizophrenia

    Not yet reported Universita di Verona 106 participants Est. completion 2009-12 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00397033

    Evaluation of Effectiveness and Safety of Paliperidone Extended Release in Patients With Schizoaffective Disorder.

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 316 participants Est. completion 2008-02
    Other conditions: Schizoaffective Disorder, Psychotic Disorder
    View official trial listing →
  • Completed NCT NCT00399334

    PROFILe3: Epidemiologic Survey in Patients With Schizophrenia or Schizoaffective Disorders

    Janssen-Cilag, S.A. 1607 participants Est. completion 2005-12
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder
    View official trial listing →
  • Completed NCT NCT00399776

    Bone Mineral Content and Bone Metabolism in Adolescents on Antipsychotic Therapy

    Creighton University 60 participants Est. completion 2009-09 1 site
    Other conditions: Adolescent Depression
    View official trial listing →
  • Completed NCT NCT00401089

    Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in Schizophrenia

    Not yet reported, Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 60 participants Est. completion 2007-10 4 sites
    Other conditions: Schizophrenia, Schizoaffective Disorder, Tardive Dyskinesia, Insulin Resistance, Obesity
    View official trial listing →
  • Completed NCT NCT00406315

    Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 255 participants Est. completion 2009-03 40 sites
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT00406718

    Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia

    Not yet reported The University of Texas Health Science Center at San Antonio 197 participants Est. completion 2013-07 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT00412373

    Evaluation of Effectiveness and Safety of Flexible-dose Paliperidone Extended Release in Patients With Schizoaffective Disorder.

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 307 participants Est. completion 2008-06 44 sites
    Other conditions: Schizoaffective Disorder, Psychotic Disorder
    View official trial listing →
  • Completed NCT NCT00417482

    Antipsychotic Discontinuation in Alzheimer's Disease

    Not yet reported New York State Psychiatric Institute 180 participants Est. completion 2011-04 7 sites
    Other conditions: Alzheimer Disease, Psychotic Disorders, Agitation, Aggression
    View official trial listing →
  • Terminated NCT NCT00418873

    Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward

    Not yet reported Astellas Pharma Inc 39 participants Est. completion 2009-12 4 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00419146

    Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants

    Not yet reported, Not yet reported University Hospital, Aker 99 participants Est. completion 2004-04 1 site
    Other conditions: Schizophrenia, Schizophreniform Disorders, Schizoaffective Disorder, Psychotic Disorders
    View official trial listing →
  • Completed NCT NCT00420823

    A Study of Taurine in Patients With First-episode Psychosis Receiving Antipsychotic Treatment

    Not yet reported, Not yet reported Melbourne Health 121 participants Est. completion 2010-12 2 sites
    Other conditions: Psychotic Disorders
    View official trial listing →
  • Completed NCT NCT00423878

    Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder

    Not yet reported National Institute of Mental Health (NIMH) 215 participants Est. completion 2010-03 28 sites
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Withdrawn NCT NCT00425815

    Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia

    Not yet reported University of California, Los Angeles Est. completion 2009-04 8 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00431574

    Antipsychotic Medication Extended Dosing Study

    Not yet reported Centre for Addiction and Mental Health 120 participants Est. completion 2007-10 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00433121

    Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSD

    Not yet reported Sykehuset Innlandet HF 24 participants Est. completion 2007-08 1 site
    Other conditions: Dementia
    View official trial listing →
  • Completed NCT NCT00434876

    The Effects of Quetiapine (Seroquel XR) on Sleep During Alcohol Abstinence

    Not yet reported Subhajit Chakravorty 22 participants Est. completion 2009-12 1 site
    Other conditions: Alcoholism, Sleep Initiation and Maintenance Disorders
    View official trial listing →
  • Terminated NCT NCT00439634

    Efficacy and Safety of AVE1625 as a Co-treatment With Antipsychotic Therapy in Schizophrenia

    Not yet reported Sanofi 873 participants Est. completion 2009-09 2 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Withdrawn NCT NCT00440843

    Zyprexa and Task Engagement in Schizophrenia

    Not yet reported VA Connecticut Healthcare System Est. completion 2012-06 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT00448630

    An Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical Antipsychotics

    Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 328 participants Est. completion 2008-07-30 47 sites
    Metabolic syndrome Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00451399

    Efficacy of Lifestyle Interventions and Metformin for the Treatment of Antipsychotic-Induced Weight Gain

    Not yet reported Central South University 128 participants Est. completion 2006-12 1 site
    Other conditions: Weight Gain
    View official trial listing →
  • Completed NCT NCT00456976

    Efficacy of Selegiline in Negative Symptoms of Schizophrenia

    Not yet reported Tabriz University 70 participants Est. completion 2007-09 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00457197

    Quetiapine for Bipolar Disorder and Alcohol Dependence

    Not yet reported University of Texas Southwestern Medical Center 90 participants Est. completion 2011-07 1 site
    Alcohol use disorder Other conditions: Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00458211

    Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychotics

    Not yet reported Bronx Psychiatric Center 40 participants Est. completion 2008-04 2 sites
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT00460512

    An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended Release (ER) in Participants With Schizophrenia

    Not yet reported Janssen-Cilag International NV 1814 participants Est. completion 2020-03-04 231 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT00469664

    Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia

    Not yet reported Research Foundation for Mental Hygiene, Inc. 50 participants Est. completion 2008-12 3 sites
    Other conditions: Schizophrenia, Schizoaffective Disorder, Cognitive Impairment
    View official trial listing →
  • Completed NCT NCT00474227

    Proper Nutrition, Physical Exercise and Appropriate Weight in Individuals With Long Term Mental Illness

    Not yet reported Lev-Hasharon Mental Healtlh Center 50 participants Est. completion 2007-10 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00480168

    A Prospective Study to Assess Metabolic Changes in Children and Adolescents Treated With Atypical Antipsychotics

    London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 50 participants Est. completion 2012-08-31 2 sites
    Other conditions: Adverse Effects
    View official trial listing →
  • Completed NCT NCT00485498

    Managing Acute Schizophrenia, a Comparison Between Two Atypical Antipsychotics

    Not yet reported Eli Lilly and Company 122 participants Est. completion 2003-12 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00488319

    Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.

    Not yet reported Janssen Research & Development, LLC 400 participants Est. completion 2012-07 53 sites
    Other conditions: Schizophrenia, Schizophrenic Disorders, Psychotic Disorders, Dementia Praecox
    View official trial listing →
  • Terminated NCT NCT00488891

    The Paliperidone ER Observational Study of Economic, Functional, and Clinical Outcomes in Patients With Schizophrenia

    Ortho-McNeil Janssen Scientific Affairs, LLC 43 participants Est. completion 2007-10
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00493233

    Antipsychotic Polypharmacy in Schizophrenia

    Not yet reported Centre for Addiction and Mental Health 100 participants 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00495352

    The Pharmacogenetic Study , Readiness to Change, and Pharmacological Intervention for Smoking Cessation in Schizophrenia

    Not yet reported Yu-Li Hospital 360 participants Est. completion 2008-12 1 site
    Other conditions: Tobacco Dependence, Schizophrenia
    View official trial listing →
  • Completed NCT NCT00498550

    Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual

    Not yet reported Dartmouth-Hitchcock Medical Center 31 participants Est. completion 2009-03 4 sites
    Other conditions: Schizophrenia, Dual Diagnosis, Schizoaffective Disorder, Psychotic Disorder, Cannabis Abuse
    View official trial listing →
  • Terminated NCT NCT00506909

    Oxytocin Add on Study for Stable Schizophrenic Patients

    Not yet reported David Feifel 21 participants Est. completion 2014-03 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Terminated NCT NCT00508157

    A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 125 participants Est. completion 2009-03-01 30 sites
    Metabolic syndrome Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00514449

    Systematic Evaluation of Antiviral Medication in Schizophrenia

    Not yet reported Konasale Prasad 31 participants Est. completion 2016-09 2 sites
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT00515723

    Glucose and Lipid Metabolism on Antipsychotic Medication

    Not yet reported Washington University School of Medicine 96 participants Est. completion 2008-12 2 sites
    Type 2 diabetes Other conditions: Schizophrenia, Schizoaffective Disorder, Hyperglycemia
    View official trial listing →
  • Completed NCT NCT00517387

    The Effects of Quetiapine XR on Cognition, Mood and Anxiety Symptoms in SSRI-Resistant Unipolar Depression

    Not yet reported University of British Columbia 64 participants Est. completion 2010-09 1 site
    Other conditions: Unipolar Depression
    View official trial listing →
  • Completed NCT NCT00518323

    A Double-blind, Placebo-controlled Study of the Safety and Efficacy of Paliperidone Extended Release (ER) in the Treatment of Schizophrenia in Adolescent Patients

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 201 participants Est. completion 2009-03 34 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00523445

    The Effects of Varenicline on Cognitive Function in Patients With Schizophrenia

    Not yet reported Inje University 120 participants Est. completion 2009-07 5 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00526877

    An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care Treatment

    Not yet reported Johnson & Johnson Taiwan Ltd 31 participants Est. completion 2009-01-31 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorders
    View official trial listing →
  • Completed NCT NCT00528359

    β-Cell Function in Schizophrenic Subjects on Atypical Antipsychotic drugS

    Cliniques universitaires Saint-Luc- Université Catholique de Louvain 36 participants Est. completion 2007-02 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Terminated NCT NCT00533455

    Gabapentin for the Treatment of Neuroleptic-Induced Tremor

    Not yet reported Minneapolis Veterans Affairs Medical Center 40 participants Est. completion 2007-08 1 site
    Other conditions: Neuroleptic-Induced Tremor
    View official trial listing →
  • Completed NCT NCT00534222

    Unraveling the Relation of Patient's Profile and Therapeutical Effects of Atypicals, Including Quetiapine Effect

    AstraZeneca 387 participants Est. completion 2007-12 6 sites
    Other conditions: Mania, Schizophrenia
    View official trial listing →
  • Withdrawn NCT NCT00534898

    Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia Patients

    Not yet reported Beersheva Mental Health Center 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Cognition
    View official trial listing →
  • Completed NCT NCT00535145

    Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver Disease

    Not yet reported Ortho-McNeil Janssen Scientific Affairs, LLC 121 participants Est. completion 2009-02 21 sites
    Other conditions: Schizophrenia, Schizoaffective Disorder, Psychotic Disorders
    View official trial listing →
  • Completed NCT NCT00535574

    Bexarotene Augmentation of Antipsychotic Treatment for Chronic Schizophrenia

    Not yet reported Beersheva Mental Health Center 90 participants Est. completion 2011-05 3 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00536783

    Schizophrenia Sensory Gating Deficit With Quetiapine

    New Mexico VA Healthcare System 20 participants Est. completion 2006-03 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00538122

    Changes in Heart Rhythms Associated With Antipsychotic Drug Treatment

    Vanderbilt University 12 participants Est. completion 2008-09 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00538642

    Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone

    Not yet reported The University of Texas Health Science Center at San Antonio 24 participants Est. completion 2011-11 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00541398

    Antipsychotic Polypharmacy: Prevalence, Background and Consequences

    Not yet reported Glostrup University Hospital, Copenhagen 222 participants Est. completion 2009-10 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT00541554

    Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia

    Not yet reported Genovate Biotechnology Co., Ltd., Est. completion 2009-02
    Other conditions: Hyperprolactinemia, Weight Gain, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00543088

    Effectiveness of Anti-Psychotic in GPs Setting

    AstraZeneca 250 participants Est. completion 2008-06 57 sites
    Other conditions: Schizophrenia, Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00545467

    Evaluation of the Strategies of Switching Schizophrenia Patients to Aripiprazole From Other Antipsychotic Agents

    Not yet reported National Taiwan University Hospital 79 participants Est. completion 2009-07 1 site
    Other conditions: DSM-IV Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT00552500

    Effects of Atypical Antipsychotic and Valproate Combination Therapy on Glucose and Lipid Metabolism in Schizophrenia

    Not yet reported Washington University School of Medicine 120 participants Est. completion 2005-12 1 site
    Other conditions: Insulin Resistance, Body Composition
    View official trial listing →
  • Completed NCT NCT00555412

    Staccato Loxapine Multidose PK

    Not yet reported Alexza Pharmaceuticals, Inc. 40 participants Est. completion 2007-12 1 site
    Other conditions: Volunteers on Chronic, Stable Antipsychotic Regimens
    View official trial listing →
  • Completed NCT NCT00556140

    The Combination of Aripiprazole and Antidepressants in Psychotic Major Depression

    Not yet reported Massachusetts General Hospital 16 participants Est. completion 2008-01 1 site
    Other conditions: Psychotic Depression
    View official trial listing →
  • Completed NCT NCT00561587

    Quetiapine vs. Placebo in Alcohol Relapse Prevention - a Pilot Study

    Not yet reported Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH 40 participants Est. completion 2010-02 1 site
    Alcohol use disorder Other conditions: Alcohol Relapse Prevention, Alcoholism, Alcohol Consumption, Alcohol Abuse
    View official trial listing →
  • Status unknown NCT NCT00563017

    Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone

    Not yet reported Hospital Authority, Hong Kong 30 participants Est. completion 2005-11 1 site
    Other conditions: Schizophrenia, Catatonic, Schizophrenia, Disorganized, Schizophrenia, Paranoid, Schizophrenia, Psychotic Disorders
    View official trial listing →
  • Status unknown NCT NCT00567099

    Remediation of Schizophrenia Sensory Gating Deficit With Aripiprazole

    Not yet reported New Mexico VA Healthcare System 20 participants Est. completion 2008-09 1 site
    Other conditions: Schizophrenia, Sensory Gating
    View official trial listing →
  • Withdrawn NCT NCT00568672

    Optimal Duration of Olanzapine Add-on Therapy in Major Depression

    Not yet reported Charite University, Berlin, Germany Est. completion 2008-04 1 site
    Other conditions: Relapse Rate of a Major Depressive Episode, Safety of Olanzapine in Subjects With Major Depression
    View official trial listing →
  • Status unknown NCT NCT00569504

    Prevalence of the Metabolic Syndrome in SPR Taking Antipsychotics

    Seoul National Hospital 1000 participants Est. completion 2009-09 1 site
    Metabolic syndrome Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00569517

    Cognitive Behavioral Therapy for Obesity

    Not yet reported US Department of Veterans Affairs 32 participants Est. completion 2009-03 1 site
    Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT00569764

    Effect on Metabolic Parameters of Abilify in SPR

    Seoul National Hospital 100 participants Est. completion 2009-10 2 sites
    Metabolic syndrome Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00576732

    A Study of the Effectiveness and Safety of Two Doses of Risperidone in the Treatment of Children and Adolescents With Autistic Disorder

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 96 participants Est. completion 2010-03 20 sites
    Other conditions: Autistic Disorder, Autism
    View official trial listing →
  • Completed NCT NCT00585273

    Antipsychotics and Blood Vessel Function

    Jess G. Fiedorowicz 44 participants Est. completion 2014-12 1 site
    Other conditions: Bipolar Disorder, Schizophrenia
    View official trial listing →
  • Completed NCT NCT00589914

    Comparison of Paliperidone Palmitate and RISPERDAL CONSTA in Patients With Schizophrenia

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1221 participants Est. completion 2009-06 82 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00590577

    Effectiveness and Safety of 3 Fixed Doses (25 mg eq., 100 mg eq., and 150 mg eq.) of Paliperidone Palmitate in Patients With Schizophrenia

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 652 participants Est. completion 2008-03 66 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00594269

    Dementia Antipsychotics And Antidepressants Discontinuation Study

    Not yet reported Sykehuset Innlandet HF 149 participants Est. completion 2010-12 8 sites
    Other conditions: Dementia
    View official trial listing →
  • Completed NCT NCT00595504

    Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia

    Not yet reported Massachusetts General Hospital 25 participants Est. completion 2010-03 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorders
    View official trial listing →
  • Completed NCT NCT00597168

    Quality of Life in Schizophrenic Patients

    AstraZeneca 124 participants Est. completion 2009-10 45 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT00604760

    Study to Evaluate the Safety and Efficacy of MEM 3454 as Adjunctive Treatment in Combination With a Preexisting Antipsychotic in Patients With Cognitive Impairment Associated With Schizophrenia

    Not yet reported Memory Pharmaceuticals 160 participants 44 sites
    Other conditions: Cognitive Impairment Associated With Schizophrenia
    View official trial listing →
  • Completed NCT NCT00616798

    A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.

    Not yet reported Hoffmann-La Roche 323 participants Est. completion 2010-02 73 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Terminated NCT NCT00617058

    Improving Metabolic Parameters of Antipsychotic Child Treatment With Ziprasidone, Aripiprazole, and Clozapine

    Not yet reported University of North Carolina, Chapel Hill 1 participants Est. completion 2010-09 1 site
    Other conditions: Weight Gain
    View official trial listing →
  • Completed NCT NCT00617240

    Strategies to Reduce Antipsychotic-Associated Weight Gain in Youth

    Not yet reported University of North Carolina, Chapel Hill 9 participants Est. completion 2012-10 1 site
    Other conditions: Weight Gain
    View official trial listing →
  • Completed NCT NCT00621998

    Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia

    Not yet reported Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan 60 participants Est. completion 2004-06 1 site
    Other conditions: Neuroleptic-Induced Tardive Dyskinesia
    View official trial listing →
  • Completed NCT NCT00625170

    Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Antipsychotic Drugs in Healthy Humans

    Not yet reported Leiden University Medical Center 11 participants Est. completion 2004-12 1 site
    Other conditions: Insulin Resistance, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00627510

    Routine Plasma Level Determination to Compare Actual vs Expected Plasma Levels at Psychiatric Inpatient Admission

    Medical University Innsbruck 161 participants Est. completion 2007-12 1 site
    Other conditions: Depression, Affective Disorders, Psychotic
    View official trial listing →
  • Status unknown NCT NCT00627757

    Antipsychotic Medicine and Metabolic Syndrome

    Glostrup University Hospital, Copenhagen 100 participants Est. completion 2010-12 2 sites
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT00628290

    Evaluation of the Antipsychotic Efficacy of Cannabidiol in Acute Schizophrenic Psychosis

    Not yet reported University of Cologne 42 participants Est. completion 2008-03 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00632645

    Neuroleptic and Huntington Disease Comparison of : Olanzapine, la Tetrabenazine and Tiapride

    Not yet reported Assistance Publique - Hôpitaux de Paris 180 participants Est. completion 2017-04-28 1 site
    Other conditions: Huntington Disease
    View official trial listing →
  • Suspended NCT NCT00636753

    Antipsychotics and Metabolic Syndrome

    Glostrup University Hospital, Copenhagen 60 participants 2 sites
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT00636896

    Effects of Modafinil on Olanzapine Weight Gain

    Not yet reported Neuropsychiatric Research Institute, Fargo, North Dakota 50 participants Est. completion 2007-08 1 site
    Other conditions: Weight Gain
    View official trial listing →
  • Completed NCT NCT00637234

    Oxcarbazepine as an Adjunct of Antipsychotic Therapy in Acute Schizophrenia

    Not yet reported, Not yet reported University of Cologne 54 participants Est. completion 2008-07 2 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00640562

    Quetiapine Extended Release Depression Symptoms

    Not yet reported AstraZeneca 216 participants Est. completion 2010-02 21 sites
    Other conditions: Schizophrenia, Depression
    View official trial listing →
  • Completed NCT NCT00643123

    Allopurinol Add-on Treatment for Refractory Mania

    Not yet reported Cedars-Sinai Medical Center 40 participants Est. completion 2010-06 1 site
    Other conditions: Bipolar Disorder, Mixed Mania, Treatment-Resistant Mania
    View official trial listing →
  • Status unknown NCT NCT00645580

    Genetic Expression in Schizophrenics Treated With SSRI Augmentation: Relationship to Clinical and Cognitive Function

    Not yet reported Sha'ar Menashe Mental Health Center 15 participants Est. completion 2009-04 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00649064

    A Study of the Effects of Ziprasidone for the Treatment of Schizophrenia or Schizoaffective Disorder in Patients Who Were Switched From Other Antipsychotic Drugs

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 46 participants Est. completion 2004-09 3 sites
    Other conditions: Schizoaffective Disorder, Schizophrenia
    View official trial listing →
  • Terminated NCT NCT00649220

    Memantine and Antipsychotics Use

    Not yet reported Merz Pharmaceuticals GmbH 19 participants Est. completion 2009-06 1 site
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT00649844

    A Study Comparing the Efficacy and Tolerability of Ziprasidone vs. Clozapine for the Treatment of Schizophrenia in Patients Who Continue to Have Symptoms on or Cannot Tolerate Other Antipsychotic Drugs

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 147 participants Est. completion 2004-09 22 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00654576

    Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With Schizophrenia

    Not yet reported Central South University 1400 participants Est. completion 2007-12 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Terminated NCT NCT00658645

    Efficacy of Bifeprunox in Patients With Schizophrenia

    Not yet reported H. Lundbeck A/S 227 participants Est. completion 2009-11 38 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00659919

    Treatment of Neuroleptic Induced Acute Akathisia With Trazodone

    Not yet reported BeerYaakov Mental Health Center 13 participants Est. completion 2003-12 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Terminated NCT NCT00665444

    Study of Aripiprazole to Reduce Medical Risks in Bipolar Disorder

    Not yet reported University of Pittsburgh 3 participants Est. completion 2009-08 1 site
    Metabolic syndrome Other conditions: Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00677898

    A Patient-Centered Approach to Improve Screening for Side Effects of Second Generation Antipsychotics (SGAs)

    Not yet reported US Department of Veterans Affairs 239 participants Est. completion 2013-06 1 site
    Other conditions: Schizophrenia, Psychotic Disorders
    View official trial listing →
  • Terminated NCT NCT00681668

    Quetiapine in Postpartum Depression

    Not yet reported AstraZeneca 5 participants Est. completion 2008-10 1 site
    Other conditions: Postpartum Depressive Disorder
    View official trial listing →
  • Completed NCT NCT00682448

    Metformin for the Prevention of the Metabolic Side-effects of Zyprexa

    Not yet reported Rush University Medical Center 25 participants Est. completion 2011-08 1 site
    Other conditions: Metabolic Complications
    View official trial listing →
  • Completed NCT NCT00685334

    Effectiveness of Atypical Antipsychotic Medication for Outpatients With Anorexia Nervosa

    Not yet reported New York State Psychiatric Institute 22 participants Est. completion 2006-09 2 sites
    Other conditions: Eating Disorders
    View official trial listing →
  • Terminated NCT NCT00686699

    Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628)

    Not yet reported Merck Sharp & Dohme LLC 11 participants Est. completion 2008-03-06
    Other conditions: Akathisia, Drug-Induced, Dyskinesia, Drug-Induced, Parkinsonian Disorders
    View official trial listing →
  • Status unknown NCT NCT00686946

    The National Register of Antipsychotic Medication in Pregnancy (NRAMP)

    The Alfred 500 participants Est. completion 2025-12 1 site
    Other conditions: Pregnancy, Mental Disorders
    View official trial listing →
  • Completed NCT NCT00689325

    Evaluating Subjective Well-being in Schizophrenic Patients Treated With quetiapineXR® and Other Atypical Antipsychotics

    AstraZeneca 158 participants Est. completion 2010-01 37 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00690274

    Study to Demonstrate Cognitive Enhancing Effects of BF2.649

    Not yet reported University of Texas Southwestern Medical Center 52 participants Est. completion 2011-10 2 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00690365

    Safety and Efficacy of Switching to Quetiapine in Outpatients With Schizophrenia

    AstraZeneca 576 participants Est. completion 2008-04
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00691353

    Subjective Well Being of Patients Receiving Atypical Antipsychotics as Monotherapy or Cotherapy With Mood Stabilizers

    AstraZeneca 540 participants Est. completion 2008-07 20 sites
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00692133

    Spanish Validation of Tool Questionnaire to Assess Patients´Perception About Antipsychotic Treatment

    AstraZeneca 250 participants Est. completion 2008-08 32 sites
    Other conditions: Schizophrenia, Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00692185

    Effectiveness of Olanzapine Versus Placebo in Treating Outpatients With Anorexia Nervosa

    Not yet reported New York State Psychiatric Institute 23 participants Est. completion 2010-09 1 site
    Other conditions: Eating Disorders
    View official trial listing →
  • Terminated NCT NCT00693472

    Study of Preladenant for the Treatment of Neuroleptic Induced Akathisia (Study P05145)

    Not yet reported Merck Sharp & Dohme LLC 46 participants Est. completion 2009-01-09
    Other conditions: Akathisia, Drug-Induced, Antipsychotic Agents, Movement Disorders
    View official trial listing →
  • Completed NCT NCT00696813

    Observational Study to Assess Outcomes During Antipsychotic Treatment With Paliperidone ER or Other Oral Antipsychotics

    Janssen-Cilag International NV 3064 participants Est. completion 2011-01 84 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT00698295

    Linear and Non-linear Analysis of EEG Changes in Schizophrenia After Atypical Antipsychotics Medication

    Seoul National University Hospital 60 participants Est. completion 2010-09 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00699946

    Prophylactic Olanzapine Versus Placebo for Prevention of Postoperative Delirium After Joint Replacement Surgery

    Not yet reported The New England Baptist Hospital 495 participants Est. completion 2007-10 1 site
    Other conditions: Delirium
    View official trial listing →
  • Terminated NCT NCT00701753

    A Pharmacogenetic Investigation of Antipsychotics in Schizophrenia and Schizophrenia-Like Psychoses

    TheraGenetics Limited 24 participants Est. completion 2009-03 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Terminated NCT NCT00704509

    Efficacy of Bifeprunox in Patients With Schizophrenia

    Not yet reported H. Lundbeck A/S 346 participants Est. completion 2009-11 45 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00707382

    Effect of Genotyping for CYP450 Polymorphisms Versus Intense Clinical Monitoring on Antipsychotic Drug Treatment

    Not yet reported Gesche Jurgens 311 participants Est. completion 2011-12 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00709202

    Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain

    Not yet reported Nathan Kline Institute for Psychiatric Research 48 participants Est. completion 2016-12 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Bipolar I Disorder, Bipolar II, Bipolar NOS(Not Otherwise Specified), Psychotic Disorder Not Otherwise Specified, Autism Spectrum Disorder
    View official trial listing →
  • Completed NCT NCT00709345

    Behavioral Intervention to Reduce Novel Antipsychotic Medication Health Risks

    Not yet reported, Not yet reported Medical College of Wisconsin 333 participants Est. completion 2011-07
    Other conditions: Mental Illness
    View official trial listing →
  • Terminated NCT NCT00712270

    Best Event Schizophrenia Trial--A Randomized Double-Blind Trial of Aripiprazole and Risperidone in Schizophrenia

    Not yet reported Kettering Health Network 21 participants Est. completion 2010-11 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00712660

    Study With Information Technology (IT) - Aided Preventive Program in Schizophrenia

    Not yet reported Prague Psychiatric Center 146 participants Est. completion 2012-03 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Terminated NCT NCT00715377

    Anticholinergic Burden in Schizophrenia

    Not yet reported Centre for Addiction and Mental Health 2 participants Est. completion 2011-12 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Delusional Disorder, Psychotic Disorders
    View official trial listing →
  • Completed NCT NCT00716755

    Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.

    Not yet reported Centre for Addiction and Mental Health 45 participants Est. completion 2015-08 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Delusional Disorder, Psychotic Disorder
    View official trial listing →
  • Completed NCT NCT00725075

    Adjuvant Treatment With a Glycine Uptake Inhibitor in Participants With Negative Symptoms of Schizophrenia (P05695) (MK-8435-001)

    Not yet reported Merck Sharp & Dohme LLC 215 participants Est. completion 2008-10-24
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00733668

    Efficacy of SEROQUEL in Selective Serotonin Reuptake Inhibitors (SSRI)-Resistant Major Depressive Disorder

    Not yet reported AstraZeneca Est. completion 2007-11 4 sites
    Other conditions: Major Depressive Disorder
    View official trial listing →
  • Completed NCT NCT00740259

    Efficacy and Tolerability of Flunarizine for the Treatment of Schizophrenia: Comparison With Haloperidol

    Not yet reported Ambulatório de Bipolaridade 70 participants Est. completion 2007-05 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00741026

    A Crossover Study of the Acute Effects of Olanzapine in Healthy Volunteers

    Not yet reported Milton S. Hershey Medical Center 15 participants Est. completion 2011-05 1 site
    Other conditions: Insulin Resistance, Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00745966

    Atypical Antipsychotics in Improvement of Quality of Life in Bipolar Disorder

    AstraZeneca 1000 participants 2 sites
    Other conditions: Naturalistic, Observational
    View official trial listing →
  • Terminated NCT NCT00746252

    Side Effect Study of Antipsychotic Medicines to Treat Childhood Bipolar Disorder

    Not yet reported University of Maryland, Baltimore 5 participants Est. completion 2010-10 1 site
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00749970

    Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia

    AstraZeneca 100 participants Est. completion 2009-01 14 sites
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder
    View official trial listing →
  • Terminated NCT NCT00750776

    KvaliMed - a Quality Project With Focus on Patients in Antipsychotic Treatment

    Psychiatric Centre Rigshospitalet 212 participants Est. completion 2012-08 10 sites
    Other conditions: Antipsychotic Treatment, Quality Assurance, Medical Treatment
    View official trial listing →
  • Status unknown NCT NCT00752960

    DNA Diagnostics for Minimizing Metabolic Side-Effects of Antipsychotics

    Genomas, Inc 1000 participants Est. completion 2009-12 2 sites
    Other conditions: Psychoses
    View official trial listing →
  • Completed NCT NCT00757705

    An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended-Release (ER) in Participants With Schizophrenia

    Not yet reported Johnson & Johnson Taiwan Ltd 299 participants Est. completion 2009-05
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00761579

    Paliperidone Extended Release(ER) Effectiveness Study to Evaluate the Objective Symptom Change and Symptomatic Remission

    Not yet reported Janssen Korea, Ltd., Korea 190 participants Est. completion 2010-12 8 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00761605

    Phase 4 Study to Evaluate Efficacy of Paliperidone Extended-Release(ER) in Schizophrenic Participants

    Not yet reported Janssen Korea, Ltd., Korea 387 participants Est. completion 2010-10 8 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Terminated NCT NCT00762814

    The Use of Sensory or Motor Cues Using Electrical Stimulation to Reduce Gait Freezing in Patients With Parkinson Disease

    Not yet reported Washington University School of Medicine 4 participants Est. completion 2009-06 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT00763438

    Safety Study of an Antipsychotic, Sertindole, to Treat Schizophrenia

    Not yet reported H. Lundbeck A/S 18 participants Est. completion 2010-10 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Terminated NCT NCT00767715

    A Study in the Treatment of Acute Mania

    Not yet reported Eli Lilly and Company 11 participants Est. completion 2005-04 1 site
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00768326

    Efficacy of Lu 31-130 in Patients With Schizophrenia

    Not yet reported H. Lundbeck A/S 280 participants Est. completion 2009-11 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00770744

    Efficacy of Lu 31-130 in Patients With Schizophrenia

    Not yet reported H. Lundbeck A/S 93 participants Est. completion 2009-11 21 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Withdrawn NCT NCT00786318

    Ziprasidone vs Standard Therapy for Agitated Patients in the ED

    Not yet reported George Washington University Est. completion 2011-07 1 site
    Other conditions: Psychosis, Agitation, Delirium
    View official trial listing →
  • Status unknown NCT NCT00789022

    Glutamatergic Amino Acids and Oxytocin Levels in the Plasma of Patients in First Psychotic Episode (FPE)- Before and After Neuroleptic Treatment

    Shalvata Mental Health Center 80 participants 1 site
    Other conditions: Schizophrenia, Schizophreniform, Schizoaffective Disorder, Brief Psychotic Episode
    View official trial listing →
  • Status unknown NCT NCT00789906

    Development of Population Norms of the Computerized Neuropsychological Assessment for Effectiveness of the Antipsychotic Treatment in Schizophrenia

    BeerYaakov Mental Health Center 700 participants 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00790517

    Reducing Weight and Diabetes Risk in an Underserved Population (STRIDE)

    Not yet reported Kaiser Permanente 200 participants Est. completion 2014-12 3 sites
    Type 2 diabetes Other conditions: Weight Loss, Psychotic Disorders
    View official trial listing →
  • Completed NCT NCT00790777

    A Study of the Bioequivalence of 12 mg Paliperidone Extended Release Tablets Manufactured at Gurabo and Vacaville

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 72 participants Est. completion 2007-05
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00791167

    A Study of the Dose Proportionality of Extended Release Paliperidone

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 58 participants Est. completion 2006-08
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00791193

    A Pharmacokinetic Study of the Relative Bioavailability of Paliperidone ER Formulations With Different Release Profiles and a Comparison to Paliperidone IR

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 80 participants Est. completion 2007-05
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00791232

    A Study of Extended Release Extended-release (ER) OROS Paliperidone Tolerability, as Compared to Immediate-release (IR)Risperidone, in Patients With Schizophrenia

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 113 participants Est. completion 2003-06
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00791284

    A Study of the Pharmacokinetics of Paliperidone in Volunteers With Normal or Impaired Liver Function

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 20 participants Est. completion 2004-12
    Other conditions: Schizophrenia, Hepatic Impairment
    View official trial listing →
  • Completed NCT NCT00791349

    A Study of QT and QTc Intervals in Patients Administered Immediate Release Paliperidone

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 141 participants Est. completion 2005-05
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT00791401

    A Study of the Pharmacokinetics of ER OROS Paliperidone in Volunteers With Normal or Impaired Renal Function

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 47 participants Est. completion 2005-02
    Other conditions: Schizophrenia, Renal Impairment
    View official trial listing →
  • Completed NCT NCT00791622

    A Study of QT and QTc Intervals in Patients Administered Extended Release Paliperidone or Quetiapine

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 110 participants Est. completion 2006-06
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT00791713

    A Study of the Effects of Paroxetine on the Pharmacokinetics of Paliperidone ER

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 60 participants Est. completion 2006-07
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00796029

    A Study of Plasma Concentrations, Metabolism and Excretion of 14C-paliperidone After a Single Oral Dose

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 5 participants Est. completion 2003-07
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00796185

    As Study of the Pharmacokinetics of Paliperidone Extended-release and Risperidone Immediate-release Formulations

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 62 participants Est. completion 2004-01
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT00796276

    A Study of Paliperidone Enantiomer Disposition With Different Formulations and the Bioavailability of Immediate- and Extended-release Paliperidone

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 20 participants Est. completion 2004-08
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00796432

    A Study of Dopamine Type 2 (D2) Receptor Occupancy Following a Single Oral Dose of OROS Paliperidone

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 4 participants Est. completion 2003-06
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00796471

    A Pharmacokinetics and Pharmacodynamics Study Under Fasting and Fed Conditions With Paliperidone Extended-release and Immediate-release Formulations

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 35 participants Est. completion 2003-08
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00796640

    A Pharmacokinetics and Pharmacodynamics Study Under Fasting and Fed Conditions With Paliperidone Extended-release and Immediate-release Formulations

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 35 participants Est. completion 2003-11
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00796835

    A Dose-proportionality Study of Five Tablet Strengths of ER OROS Paliperidone

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 50 participants Est. completion 2004-10
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00797927

    Quetiapine Related Neurochemical Changes as Measured by Magnetic Resonance Spectroscopy in Schizophrenia

    Not yet reported National Taiwan University Hospital 30 participants Est. completion 2009-04 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00799383

    Calcium and Vitamin D to Optimize Bone Mass in Boys With Risperidone-induced Hyperprolactinemia

    Not yet reported Chadi A. Calarge 47 participants Est. completion 2014-03 1 site
    Other conditions: Risperidone-induced Hyperprolactinemia
    View official trial listing →
  • Completed NCT NCT00802100

    Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia

    Not yet reported National Institute of Mental Health (NIMH) 21 participants Est. completion 2009-10 13 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00806234

    Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics

    Not yet reported Johns Hopkins University 127 participants Est. completion 2014-03 4 sites
    Other conditions: Psychotic Disorders
    View official trial listing →
  • Completed NCT NCT00809731

    Observational Study to Evaluate Efficacy and Remission Status for Schizophrenia Patients Under Atypical Treatment

    AstraZeneca 490 participants Est. completion 2010-09 17 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00815854

    Examining Risk Factors for Atypical Antipsychotic Metabolic Side Effects

    Not yet reported University of Michigan 88 participants Est. completion 2019-05 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00816894

    D-serine Monotherapy for Schizophrenia

    Not yet reported Herzog Hospital 18 participants Est. completion 2013-02 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00816907

    The Use of Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (The METS Study)

    Not yet reported National Institute of Mental Health (NIMH) 146 participants Est. completion 2010-03 16 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Withdrawn NCT NCT00817323

    What is the Antidepressant Mechanism of Action of Quetiapine in Bipolar Depression?

    Not yet reported University of British Columbia Est. completion 2013-12
    Other conditions: Bipolar Depression
    View official trial listing →
  • Completed NCT NCT00817648

    A Study to Evaluate the Efficacy and Safety of Seroquel in Chinese Han Patients With Schizophrenia

    Not yet reported Shanghai Mental Health Center 120 participants Est. completion 2010-05 4 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00818298

    24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study

    Not yet reported Centre for Addiction and Mental Health 12 participants Est. completion 2011-06 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT00821600

    Characterization of Intramuscular Injections of Risperidone 4 Week Long-acting Injectable (LAI) Formulation in the Buttock of Patients With Schizophrenia

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 24 participants Est. completion 2009-06 3 sites
    Other conditions: Psychotic Disorders, Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT00825045

    Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia

    Not yet reported Centre for Addiction and Mental Health 14 participants Est. completion 2020-12 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder
    View official trial listing →
  • Completed NCT NCT00827840

    Paliperidone Extended-Release (ER) Versus Risperidone for Neurocognitive Function in Patients With Schizophrenia

    Not yet reported Chonnam National University Hospital 58 participants Est. completion 2011-02 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00828490

    Electronic Pharmacotherapy Risk Management

    University of Utah 174000 participants Est. completion 2010-03 1 site
    Other conditions: Asthma, Mental Health, Pain
    View official trial listing →
  • Terminated NCT NCT00833300

    Haloperidol vs Olanzapine for the Management of ICU Delirium

    Not yet reported Richard Hall 200 participants Est. completion 2011-11 2 sites
    Other conditions: Delirium, Agitation
    View official trial listing →
  • Completed NCT NCT00833456

    NIS to Observe Improvement in Global Assessment of Functioning in Patients With Schizophrenia

    AstraZeneca 106 participants Est. completion 2010-11 14 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00833976

    Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia

    Not yet reported Massachusetts General Hospital 65 participants Est. completion 2013-03 1 site
    Other conditions: High Triglycerides, Hypercholesterolemia, Schizophrenia, Schizoaffective Disorder, Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00835107

    An Investigation of Sleep Architecture in Ziprasidone-Treated Bipolar Depression

    Not yet reported Queen's University 14 participants Est. completion 2011-06 1 site
    Other conditions: Depression, Bipolar
    View official trial listing →
  • Completed NCT NCT00836251

    Effects of Antipsychotic Medications on Energy Intake and Expenditure

    Washington University School of Medicine 15 participants Est. completion 2008-06 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Weight Gain
    View official trial listing →
  • Status unknown NCT NCT00837707

    Aripiprazole for Neuroleptic-Induced Tardive Dyskinesia

    Not yet reported Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan 25 participants Est. completion 2010-02 1 site
    Other conditions: Dyskinesia, Drug-Induced
    View official trial listing →
  • Withdrawn NCT NCT00838227

    Modafinil Augmentation in Chronic Schizophrenia and Schizoaffective Disorder

    Not yet reported Manhattan Psychiatric Center Est. completion 2012-06
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00838669

    A Study of the Effect of Food and Posture on the Pharmacokinetics of a Single Dose of ER OROS Paliperidone

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 74 participants Est. completion 2005-12
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00842608

    Pharmacological Management of Delirium

    Not yet reported Indiana University 551 participants Est. completion 2015-07 3 sites
    Other conditions: Delirium, Cognitive Impairment
    View official trial listing →
  • Completed NCT NCT00845026

    A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients

    Not yet reported Denovo Biopharma LLC 261 participants Est. completion 2010-12 23 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00845572

    The Consta Club: A Demonstration Project for Setting up a Consta Club in a Community Mental Health Center

    Not yet reported The University of Texas Health Science Center at San Antonio 30 participants Est. completion 2010-06 1 site
    Other conditions: Schizophrenia, Schizoaffective
    View official trial listing →
  • Status unknown NCT NCT00845936

    Metformin for Weight Control in Adolescents Taking Atypical Antipsychotics

    Not yet reported BeerYaakov Mental Health Center 30 participants Est. completion 2010-05 1 site
    Other conditions: Drug Induced Weight Gain
    View official trial listing →
  • Completed NCT NCT00845988

    Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders

    Not yet reported Seoul National University Hospital 28 participants Est. completion 2012-03 1 site
    Other conditions: Bipolar Disorders, Metabolic Complication
    View official trial listing →
  • Completed NCT NCT00854919

    Effectiveness and Safety of Atypical Antipsychotic Agents in Augmenting SSRI-Refractory Obsessive-Compulsive Disorder

    Not yet reported Osaka City University Est. completion 2007-12 1 site
    Other conditions: SSRI-Refractory Obsessive-Compulsive Disorder
    View official trial listing →
  • Completed NCT NCT00857064

    Subjective Well Being of Schizophrenic Patients in Greece

    AstraZeneca 600 participants Est. completion 2009-10 24 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT00859664

    Use of Pharmacogenetics in the Treatment of Children With Autistic Spectrum Disorders

    Assaf-Harofeh Medical Center 500 participants Est. completion 2011-07 1 site
    Other conditions: Autism, Neuroleptic Treatment
    View official trial listing →
  • Status unknown NCT NCT00861003

    An Adherence Study of Antipsychotic Medication in Outpatients With Schizophrenia or Schizoaffective Disorder

    Korea University Guro Hospital 57 participants Est. completion 2010-08 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT00862992

    Safety, Pharmacokinetics and Efficacy Study of MP-214 in Patients With Schizophrenia

    Not yet reported Tanabe Pharma Corporation 34 participants Est. completion 2009-09 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00864825

    Allopurinol in Schizophrenia: A Randomized Trial Administering Allopurinol vs Placebo as add-on Antipsychotics in Patients With Schizophrenia

    Not yet reported Sheba Medical Center 248 participants Est. completion 2010-01 33 sites
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT00873249

    Effect of Daily Short Message System (SMS) Reminders on Medication Adherence to Oral Antipsychotics in Patients With Schizophrenia

    AstraZeneca 339 participants Est. completion 2010-03 25 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Terminated NCT NCT00885690

    Comparing the Effects of Sertindole and Olanzapine on Cognition (SEROLA)

    Not yet reported University of Aarhus 11 participants Est. completion 2012-11 2 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00888264

    A NIS Evaluating the Treatment Patterns of Atypical Antipsychotics in Patients Diagnosed With Bipolar I or II Disorder

    AstraZeneca 152 participants Est. completion 2010-08 45 sites
    Other conditions: Bipolar Disorders
    View official trial listing →
  • Completed NCT NCT00888953

    Nursing Homes Study of Fall Risk Assessment Oriented to Intervention

    Not yet reported Fundacio Salut i Envelliment UAB 331 participants Est. completion 2012-04 1 site
    Other conditions: Accidental Falls, Activities of Daily Living, Quality of Life, Self-Efficacy
    View official trial listing →
  • Completed NCT NCT00892125

    A Study of the Effect of Carbamazepine on the Pharmacokinetics of Paliperidone Extended Release (ER) in Patients With Schizophrenia or Bipolar I Disorder

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 64 participants Est. completion 2007-03
    Other conditions: Schizophrenia, Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT00892320

    A Study of the Effect of Food on the Pharmacokinetics of ER OROS Paliperidone in Healthy Japanese Volunteers

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 20 participants Est. completion 2004-05
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00892489

    A Bioequivalence Study of 15 mg ER OROS Paliperidone

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 80 participants Est. completion 2004-12
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00892541

    A Study of the Potential Effects of Trimethoprim on the Pharmacokinetics of ER OROS Paliperidone

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 30 participants Est. completion 2004-11
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00894738

    Measurement of Cardiometabolic Risk in Antipsychotic-Treated Children

    Washington University School of Medicine 44 participants Est. completion 2016-06-01 1 site
    Other conditions: Mental Disorders
    View official trial listing →
  • Completed NCT NCT00895921

    Examining the Effects of Antipsychotic Medications on Insulin Sensitivity

    Not yet reported Veterans Medical Research Foundation 30 participants Est. completion 2010-06 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00903916

    Effect of Antipsychotics on Appetite Regulation

    University of North Carolina, Chapel Hill 45 participants Est. completion 2012-03 1 site
    Other conditions: Psychotic Disorders
    View official trial listing →
  • Withdrawn NCT NCT00910780

    Metabolic Effects of Antipsychotic Substitution in Children

    Not yet reported, Not yet reported Washington University School of Medicine Est. completion 2009-11
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00910988

    Healthy Volunteers Study of the Effects of Olanzapine and Ziprasidone

    Not yet reported Washington University School of Medicine 46 participants Est. completion 2012-06 1 site
    Other conditions: Hyperglycemia, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT00922272

    Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms

    Not yet reported Shire 92 participants Est. completion 2011-01-20 27 sites
    Other conditions: Schizophrenia and Predominant Negative Symptoms
    View official trial listing →
  • Completed NCT NCT00926965

    Tardive Dyskinesia and Cognitive Function

    Not yet reported Taipei Veterans General Hospital, Taiwan 80 participants Est. completion 2007-12 1 site
    Other conditions: Tardive Dyskinesia, Neurocognitive Function
    View official trial listing →
  • Terminated NCT NCT00931996

    Oculomotor and Spatial Cognition Deficits in Schizophrenia

    Not yet reported University of Illinois Chicago 12 participants Est. completion 2011-11 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00932529

    Use, Effects and Side-effects of Second-generation Antipsychotics in a Naturalistic Setting

    Not yet reported University of Bergen 226 participants Est. completion 2010-01 1 site
    Other conditions: Psychotic Disorders
    View official trial listing →
  • Terminated NCT NCT00934635

    A Positron-Emission-Tomography (PET) Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Areas of the Brain in Relation to the Plasma Concentrations of Paliperidone Extended Release (ER) and Oral Risperidone in Schizophrenia Patients and Healthy Controls

    Not yet reported Janssen-Cilag G.m.b.H 2 participants Est. completion 2009-12 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00937716

    Treatment Response in Schizophrenia: Bridging Imaging and Postmortem Studies

    University of Alabama at Birmingham 75 participants Est. completion 2021-06-30 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00937755

    The Study of Atypical Antipsychotics-induced Metabolic Disturbances

    Taipei Medical University Hospital 80 participants Est. completion 2009-05 1 site
    Other conditions: Schizophrenia, Antipsychotics
    View official trial listing →
  • Completed NCT NCT00946491

    To Demonstrate the Relative Bioequivalency of Generic Haloperidol Tablets Versus Haldol in Normal Volunteers

    Not yet reported Sandoz 30 participants Est. completion 1987-05
    Other conditions: Psychosis
    View official trial listing →
  • Completed NCT NCT00952757

    Changes in Hyperprolactinemia Secondary to Antipsychotics After Switching to Quetiapine

    Investigaciones Médicas Montejo S.L. 35 participants Est. completion 2008-08 6 sites
    Other conditions: APS-related Hyperprolactinaemia, Schizophrenia, Bipolar Disorder
    View official trial listing →
  • Terminated NCT NCT00954603

    A Double-blind, Randomized, Controlled Trial of Quetiapine Versus Haloperidol for the Treatment of Delirium

    Not yet reported Chiang Mai University 52 participants Est. completion 2012-07 1 site
    Other conditions: Delirium
    View official trial listing →
  • Completed NCT NCT00956189

    Identification and Treatment Response Prediction of Antipsychotic-Related Metabolic Syndrome

    Not yet reported National Taiwan University Hospital 132 participants Est. completion 2012-10 3 sites
    Metabolic syndrome
    View official trial listing →
  • Status unknown NCT NCT00973297

    A Targeted Falls Prevention Program in Rehabilitation In-Patients

    Not yet reported Hadassah Medical Organization 100 participants Est. completion 2010-11 1 site
    Other conditions: Accidental Falls
    View official trial listing →
  • Completed NCT NCT00977301

    Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA)

    Not yet reported Radboud University Medical Center 24 participants Est. completion 2010-08 1 site
    Other conditions: HIV Infections
    View official trial listing →
  • Terminated NCT NCT00977522

    A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia

    Not yet reported Pfizer 207 participants Est. completion 2010-09 37 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00981526

    Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia

    Not yet reported University of Massachusetts, Worcester 66 participants Est. completion 2012-05 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT00992407

    An Efficacy and Safety Study of Long Acting Injectable Risperidone and Oral Risperidone in Participants With Schizophrenia or Schizoaffective Disorder

    Not yet reported Janssen Korea, Ltd., Korea 75 participants Est. completion 2010-12 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT00999505

    Amantadine as Adjunctive Therapy to Antipsychotics in Schizophrenia

    Not yet reported Hospital de Clinicas de Porto Alegre 40 participants Est. completion 2011-09 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT00999895

    A Study Evaluating the Treatment Selection and Outcome When Changing Antipsychotic Treatment in Schizophrenic Patients

    AstraZeneca 574 participants Est. completion 2010-09 43 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01004354

    Vitamin D Supplementation in Psychiatric Illnesses

    Not yet reported University of Massachusetts, Worcester 12 participants Est. completion 2010-06 1 site
    Other conditions: Obesity, Vitamin D Deficiency, Psychosis, Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Status unknown NCT NCT01016145

    Identifying Predictors of Response to Antipsychotics Using a Treatment Algorithm

    Not yet reported University of Sao Paulo 126 participants Est. completion 2010-07 1 site
    Other conditions: Schizophrenia or Schizoaffective Disorder
    View official trial listing →
  • Status unknown NCT NCT01022450

    Study of the Causes of the Breakdown of Muscle Fibers in Hospitalized Patients

    National Taiwan University Hospital 2500 participants 1 site
    Other conditions: Rhabdomyolysis, Myopathy, Acute Renal Failure, Neuroleptic Malignant Syndrome
    View official trial listing →
  • Completed NCT NCT01026285

    InORS - International Observational Registry on Schizophrenia With Injectable Risperidone and Oral Antipsychotics

    Janssen-Cilag International NV 1085 participants Est. completion 2012-03 98 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01029769

    Efficacy of an Early Antipsychotic Switch in Case of Poor Initial Response to the Treatment of Schizophrenia

    Not yet reported Technical University of Munich 350 participants Est. completion 2015-03 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder
    View official trial listing →
  • Completed NCT NCT01030874

    Orthostatic Hypotension Treatment on Rehab Unit

    Not yet reported VA Office of Research and Development 356 participants Est. completion 2016-05 1 site
    Other conditions: Orthostatic Hypotension, Falls
    View official trial listing →
  • Completed NCT NCT01043250

    Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients

    Samsung Medical Center 81 participants Est. completion 2010-12 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT01050582

    A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 244 participants Est. completion 2011-07 28 sites Stand-alone
    Other conditions: Schizophrenia, Bipolar Disorder, Autistic Disorder, Conduct and Other Disruptive Behavior Disorders
    View official trial listing →
  • Completed NCT NCT01051531

    A Safety, Tolerability, and Treatment Response Study of Paliperidone Palmitate Administered to Patients With Schizophrenia

    Not yet reported Janssen Research & Development, LLC 546 participants Est. completion 2013-05-17 41 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01052103

    A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms

    Not yet reported Denovo Biopharma LLC 167 participants Est. completion 2012-06 9 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01052714

    Healthy Lifestyles for Mentally Ill People Who Have Experienced Weight Gain From Their Antipsychotic Medications - 2

    Not yet reported VA Office of Research and Development 121 participants Est. completion 2015-05-28 3 sites
    Other conditions: Diabetes, Obesity, Weight Gain
    View official trial listing →
  • Status unknown NCT NCT01057849

    Standard Comprehensive Intervention to Treat First-episode Schizophrenia

    Not yet reported Peking University 600 participants 6 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01066403

    Adjuvant Therapy With Pergolide in Treating Cognitive Deficits in Schizophrenia

    Not yet reported Heidelberg University 28 participants Est. completion 2008-03 4 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Terminated NCT NCT01071135

    Quetiapine XR in Schizophrenic Patients

    Not yet reported Hannover Medical School 5 participants Est. completion 2010-08 3 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01075295

    Prevention of Weight Gain in Early Psychoses

    Not yet reported Centre for Addiction and Mental Health 70 participants Est. completion 2012-12 1 site
    Other conditions: Schizophreniform Disorder, Bipolar I Disorder, Bipolar II Disorder, Major Depressive Disorder, Substance-Induced Psychoses, Psychosis Not Otherwise Specified, Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT01081769

    Prevention of Relapse With Injectable Paliperidone Palmitate Versus Oral Antipsychotics

    Not yet reported Janssen-Cilag International NV 769 participants Est. completion 2013-02 94 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01082588

    Effects of Pravastatin on Cholesterol, Inflammation and Cognition in Schizophrenia

    Not yet reported Massachusetts General Hospital 60 participants Est. completion 2012-09 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorders, Schizophreniform Disorders
    View official trial listing →
  • Completed NCT NCT01085383

    Aripiprazole and Prolactin Study

    Not yet reported University of Oxford 15 participants Est. completion 2014-12 1 site
    Other conditions: Hyperprolactinemia
    View official trial listing →
  • Completed NCT NCT01092221

    Allopurinol for Mania: A Randomized Trial Administering Allopurinol vs. Placebo as add-on to Mood Stabilizers and/or Antipsychotics in Patients in a Bipolar Manic Episode

    Not yet reported Sheba Medical Center 180 participants Est. completion 2011-04 24 sites
    Other conditions: Mania
    View official trial listing →
  • Completed NCT NCT01104766

    Safety and Efficacy of Cariprazine in Patients With Schizophrenia

    Not yet reported Forest Laboratories 617 participants Est. completion 2011-12-20 58 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01104779

    Safety and Efficacy of Cariprazine in Schizophrenia

    Not yet reported Forest Laboratories 446 participants Est. completion 2011-12-15 41 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01104792

    Long-term Study of Cariprazine in Patients With Schizophrenia

    Not yet reported Forest Laboratories 752 participants Est. completion 2013-01-31 86 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01116830

    A Study of the Effect of RO4917838 on Biomarker Measures of Cognitive Dysfunction in Participants With Schizophrenia and Schizoaffective Disorder

    Not yet reported Hoffmann-La Roche 29 participants Est. completion 2014-02 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01119014

    Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis

    Not yet reported Anne Katrine Pagsberg 300 participants Est. completion 2015-07 9 sites
    Other conditions: Psychosis
    View official trial listing →
  • Completed NCT NCT01125267

    Promoting Adherence to Treatment in Schizophrenia

    Not yet reported University of California, Los Angeles 174 participants Est. completion 2008-10 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Terminated NCT NCT01129674

    A Long-Term, Open-Label, Study on Schizophrenia

    Not yet reported, Not yet reported Denovo Biopharma LLC 560 participants Est. completion 2012-10 81 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01139463

    Study of Blood Lactate Levels in Patients Treated With Antipsychotics

    University of Split 60 participants Est. completion 2009-10 1 site
    Other conditions: Movement Disorders, Lactic Acidosis
    View official trial listing →
  • Completed NCT NCT01143077

    A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents

    Not yet reported Sumitomo Pharma America, Inc. 244 participants Est. completion 2011-05 27 sites
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT01145313

    Impact of Atypical Antipsychotic Therapy on Health Outcomes and Costs Among Patients With Major Depressive Disorder

    Otsuka Pharmaceutical Development & Commercialization, Inc. 501 participants Est. completion 2010-06
    Other conditions: Depressive Disorder, Major
    View official trial listing →
  • Completed NCT NCT01152697

    Customized Adherence Enhancement Plus Long-acting Injectable Antipsychotic

    Not yet reported University Hospitals Cleveland Medical Center 30 participants Est. completion 2012-08 1 site
    Other conditions: Patient Noncompliance
    View official trial listing →
  • Completed NCT NCT01154829

    Pan European Collaboration on Antipsychotic Naive Schizophrenia (PECANS)

    Not yet reported University of Copenhagen 136 participants Est. completion 2016-05 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01157351

    15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated

    Not yet reported Janssen Scientific Affairs, LLC 450 participants Est. completion 2013-12 56 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01160679

    Effectiveness of Atypical Antipsychotics on Anhedonic Features in Patients With Schizophrenia

    AstraZeneca 231 participants Est. completion 2011-08 12 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01160991

    Effect of Atypical Antipsychotic Drugs Olanzapine and Amisulpride on Glucose Metabolism

    Not yet reported Central Institute of Mental Health, Mannheim 10 participants Est. completion 2006-10 1 site
    Other conditions: Schizophrenia, Diabetes, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT01164059

    Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in Schizophrenia

    Not yet reported University of Bremen 149 participants Est. completion 2014-03 18 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01174290

    Preventing ICU Subsyndromal Delirium Conversion to Delirium With Haloperidol

    Not yet reported Northeastern University 68 participants Est. completion 2014-03 2 sites
    Other conditions: Subsyndromal Delirium
    View official trial listing →
  • Completed NCT NCT01176721

    Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia

    Not yet reported cerbomed GmbH 20 participants Est. completion 2012-02 2 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Terminated NCT NCT01177709

    Metformin for Weight Loss in Schizophrenia

    Not yet reported Nathan Kline Institute for Psychiatric Research 12 participants Est. completion 2011-04 1 site
    Other conditions: Schizophrenia, Obesity
    View official trial listing →
  • Completed NCT NCT01181960

    Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations

    Janssen Scientific Affairs, LLC 1066 participants Est. completion 2013-11 34 sites
    Other conditions: Schizophrenia, Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT01184235

    Multidimensional Measurement of Psychopharmacological Treatment Response

    Child Psychopharmacology Institute 44 participants Est. completion 2011-08 1 site
    Other conditions: Autism Spectrum Disorders, Mood Disorders, Sleep Disorders, Attention Deficit Disorders
    View official trial listing →
  • Completed NCT NCT01185418

    Evaluation of Negative Symptoms and Cognitive Function After Administration of Antipsychotics in Healthy Volunteer

    Chonbuk National University Hospital 80 participants Est. completion 2009-07 1 site
    Other conditions: Normal Volunteers
    View official trial listing →
  • Completed NCT NCT01185743

    Antipsychotics and Gene Expression in Soft Tissues

    Not yet reported Medical University of Vienna 16 participants Est. completion 2017-01-01 1 site
    Other conditions: Schizophrenia, Diabetes
    View official trial listing →
  • Completed NCT NCT01189006

    Add-On Therapy to Risperidonein Schizophrenia

    Not yet reported, Not yet reported National Cheng-Kung University Hospital 161 participants Est. completion 2008-12 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01192867

    A Study of RO4917838 in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia (NN25310)

    Not yet reported Hoffmann-La Roche 629 participants Est. completion 2014-05-26 122 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01192880

    A Study to Evaluate Efficacy and Safety of Bitopertin in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia

    Not yet reported Hoffmann-La Roche 625 participants Est. completion 2014-07 103 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01192906

    A Study of RO4917838 (Bitopertin) in Patients With Persistent, Predominant Negative Symptoms of Schizophrenia (WN25309)

    Not yet reported Hoffmann-La Roche 624 participants Est. completion 2014-07 113 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Withdrawn NCT NCT01193166

    Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital

    Not yet reported Ortho-McNeil Janssen Scientific Affairs, LLC Est. completion 2012-09
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01198353

    Effectiveness of Ziprasidone for Patients With Schizophrenia

    Not yet reported Soonchunhyang University Hospital 67 participants Est. completion 2013-12 6 sites
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT01206153

    Metformin for Treatment Antipsychotic Induced Amenorrhea in Female Schizophrenic Patients

    Not yet reported Central South University 84 participants Est. completion 2010-03 1 site
    Other conditions: Amenorrhea
    View official trial listing →
  • Completed NCT NCT01207414

    Switching to Iloperidone From Other Antipsychotics in Schizophrenia

    Not yet reported Novartis 501 participants Est. completion 2012-01 59 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01211522

    The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study

    Not yet reported Vanderbilt University Medical Center 566 participants Est. completion 2018-07-19 16 sites
    Other conditions: Delirium, Impaired Cognition, Long Term Psychologic Disorders
    View official trial listing →
  • Completed NCT NCT01212575

    A Retrospective NIS to Evaluate the Use of Seroquel XR and IR in the Clinical Practice of Outpatients With Schizophrenia

    AstraZeneca 186 participants Est. completion 2011-02 13 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01214135

    A Retrospective Non-interventional Study to Evaluate the Use of Seroquel Extended Release (XR) and Immediate Release (IR) in the Clinical Practice of Inpatients With Schizophrenia

    AstraZeneca 300 participants Est. completion 2010-12 14 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT01215383

    The Antiatherogenic Properties of HDL in Psychiatric Patients With and Without Antipsychotic Therapy

    Ziv Hospital 20 participants 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT01222494

    Healthy Bodies, Healthy Kids

    Not yet reported Washington University School of Medicine 47 participants Est. completion 2017-03 1 site
    Metabolic syndrome Other conditions: Child Mental Disorders, Obesity
    View official trial listing →
  • Completed NCT NCT01222793

    Effects of Antipsychotics on Eating and Food Craving in People With Schizophrenia

    National Institute on Drug Abuse (NIDA) 60 participants Est. completion 2012-05-03 1 site
    Other conditions: Schizophrenia, Obesity
    View official trial listing →
  • Completed NCT NCT01231074

    Reducing Antipsychotic-Induced Weight Gain in Children With Metformin

    Not yet reported Nationwide Children's Hospital 96 participants Est. completion 2013-05 1 site
    Other conditions: Obesity, Weight Gain, Psychotropic Induced Weight Gain
    View official trial listing →
  • Withdrawn NCT NCT01234298

    SPD489 as Adjunctive Treatment in Adults With Negative Symptoms of Schizophrenia

    Not yet reported Shire Est. completion 2014-02-24
    Other conditions: Negative Symptoms of Schizophrenia
    View official trial listing →
  • Completed NCT NCT01234454

    Atypical Antipsychotic Treatment Effect On Brain Function In Schizophrenia Measured By FMRI

    Not yet reported University of North Carolina, Chapel Hill 34 participants Est. completion 2007-12 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01235520

    A Study of RO4917838 in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (NN25307)

    Not yet reported Hoffmann-La Roche 595 participants Est. completion 2014-07 121 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01235559

    A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25305)

    Not yet reported Hoffmann-La Roche 604 participants Est. completion 2015-03 90 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01235585

    A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25306)

    Not yet reported Hoffmann-La Roche 597 participants Est. completion 2014-09 120 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT01236274

    The Risk of Myocardial Infarction in Users of Antipsychotic Agents

    London School of Hygiene and Tropical Medicine 90000 participants Est. completion 2014-12 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01244815

    Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder (P06107 Has an Extension [P05898; NCT01349907])(P06107)

    Not yet reported Organon and Co 404 participants Est. completion 2013-09-17
    Other conditions: Bipolar Disorder, Pediatric
    View official trial listing →
  • Completed NCT NCT01245348

    Relative Effectiveness of Schizophrenia Therapy Study

    Medco Health Solutions, Inc. 1110 participants Est. completion 2012-12 1 site
    Other conditions: Schizophrenia, Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT01246232

    Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia

    Not yet reported Imperial College London 69 participants Est. completion 2015-03 3 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT01259973

    Typical Versus Atypical Antipsychotics; Occupation of Striatal Receptors and the Appearance of Extrapyramidal Symptomatology, in Healthy Volunteers

    Not yet reported Hospital Clinic of Barcelona 24 participants Est. completion 2011-12 2 sites
    Other conditions: Pharmacogenetics, Healthy
    View official trial listing →
  • Completed NCT NCT01269710

    Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study

    University of North Carolina, Chapel Hill 4 participants Est. completion 2011-03 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Psychotic Disorder, Not Otherwise Specified, Prodromal Schizophrenia, Mood Disorder, Bipolar Disorder, Major Depressive Disorder, Depressive Disorder, Not Otherwise Specified, Mood Disorder, Not Otherwise Specified, Autism Spectrum Disorder
    View official trial listing →
  • Completed NCT NCT01272531

    Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD)

    University of California, San Diego 560 participants Est. completion 2016-04 10 sites
    Other conditions: Bipolar Affective Disorder
    View official trial listing →
  • Status unknown NCT NCT01280305

    Raloxifene in Treatment of Schizophrenia and Schizoaffective Disorder

    Not yet reported Sheba Medical Center 200 participants Est. completion 2013-03 13 sites
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT01280396

    Metabolic Side-effects for Second-generation Antipsychotics

    The University of Hong Kong 241 participants Est. completion 2014-12 1 site
    Other conditions: Mental Disorders
    View official trial listing →
  • Completed NCT NCT01281527

    Paliperidone Palmitate Flexible Dosing in Schizophrenia

    Not yet reported Janssen-Cilag International NV 1044 participants Est. completion 2013-11 127 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01284959

    Different Safety Profile of Risperidone and Paliperidone Extended-release

    Not yet reported Chonbuk National University Hospital 34 participants Est. completion 2010-12 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01291368

    Sedation Influence on Delirium and Post-traumatic Stress-disorder as a Result of Hospitalization in Intensive Care

    University of Aarhus 248 participants Est. completion 2012-02 2 sites
    Other conditions: Delirium, Stress Disorders, Post-Traumatic
    View official trial listing →
  • Completed NCT NCT01291511

    Relapse Prevention Study in Patients With Schizophrenia

    Not yet reported Vanda Pharmaceuticals 635 participants Est. completion 2015-03 63 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01295372

    Safety and Efficacy of Zicronapine in Patients With Schizophrenia

    Not yet reported H. Lundbeck A/S 160 participants 24 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT01300364

    Reboxetine and Citalopram as an Adjunct Treatment to Second Generation Antipsychotics in the Treatment of Negative Symptoms of Schizophrenia

    Not yet reported Fundació Sant Joan de Déu 249 participants 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01303367

    Medication Management and Care of Demented Patients With Behavioral and Psychological Symptoms of Dementia in Taiwan: A Retrospective Pilot Study

    Taipei Medical University WanFang Hospital 200 participants Est. completion 2010-12 1 site
    Other conditions: Dementia
    View official trial listing →
  • Terminated NCT NCT01305707

    Continuation Electroconvulsive Therapy (C-ECT) for Relapse Prevention in Major Depression

    Not yet reported Hospital Universitari de Bellvitge 104 participants Est. completion 2014-07 3 sites
    Other conditions: Depression
    View official trial listing →
  • Status unknown NCT NCT01320982

    Minocycline, Acetylsalicylic Acid or Pramipexole vs Placebo in Patients With Schizophrenia or Schizoaffective Disorder

    Not yet reported Sheba Medical Center 400 participants Est. completion 2012-07 14 sites
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT01323205

    Investigation of the Safety, Tolerability and Potential Therapeutic Effects of JNJ-40411813 in Patients With Schizophrenia

    Not yet reported Janssen Research & Development, LLC 100 participants Est. completion 2012-12 20 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01331304

    Comparative Effectiveness Study for Bipolar Disorder

    Not yet reported Massachusetts General Hospital 482 participants Est. completion 2013-09 11 sites
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT01333072

    Biomarkers in Autism of Aripiprazole and Risperidone Treatment (BAART)

    Not yet reported Medical University of South Carolina 80 participants Est. completion 2015-08 1 site
    Other conditions: Autistic Disorder
    View official trial listing →
  • Completed NCT NCT01342120

    PHARMO Institute Seroquel Safety Study

    AstraZeneca 18325 participants Est. completion 2010-11
    Other conditions: Schizophrenia, Major Depressive Disorder, Bipolar Disorder, Generalized Anxiety Disorder
    View official trial listing →
  • Completed NCT NCT01347619

    iADAPT: Off Label Use of Antipsychotics in the Nursing Home

    Not yet reported University of Massachusetts, Worcester 42 participants Est. completion 2013-09 1 site
    Other conditions: Off-label Use of Atypical Antipsychotic Drugs
    View official trial listing →
  • Terminated NCT NCT01368458

    Conversion to Antipsychotic Monotherapy

    Not yet reported Nathan Kline Institute for Psychiatric Research 24 participants Est. completion 2008-07
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT01376492

    FYS Study: Epidemiological, Multicentre, Cross-sectional Study in a Clinical Practice Environment, About the Relationship Between Functioning Status and the Quality of Sleep Perceived by Schizophrenic Outpatients in Spain

    Janssen-Cilag, S.A. 709 participants Est. completion 2011-07
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01377233

    Study of the Safety, Tolerability, and Pharmacokinetics of Once Weekly Zicronapine in Patients With Schizophrenia

    Not yet reported H. Lundbeck A/S 46 participants 4 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01384279

    The Therapeutic Effects of Topiramate and Metformin on Second Generation Antipsychotics-induced Obesity

    Not yet reported Beitou Armed Forces Hospital, Taipei, Taiwan 25 participants Est. completion 2012-01 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT01392482

    IBIS: Italian Burden of Illness on Schizophrenia & Bipolar Disorder

    AstraZeneca 751725 participants Est. completion 2012-09 16 sites
    Other conditions: Schizophrenia, Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT01394601

    A Study to Observe Real-life Allocation of Antipsychotics in Acute Inpatient Management of Schizophrenia

    AstraZeneca 600 participants Est. completion 2011-12 8 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01409590

    Exercise and Diet Program for Schizophrenia Patients Who Are Taking Atypical Antipsychotic Medications

    Not yet reported Sheba Medical Center 100 participants Est. completion 2009-08 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01411930

    Acute Impact of Intramuscular (IM) Aripiprazole and Olanzapine on Insulin Resistance in High Risk Prediabetics

    Not yet reported Veterans Medical Research Foundation 15 participants Est. completion 2011-08 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Terminated NCT NCT01420575

    Decision Aid to Facilitate Shared Decision Making During Treatment in Schizophrenia

    Not yet reported VA Nebraska Western Iowa Health Care System 8 participants Est. completion 2012-08 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT01421342

    VA Augmentation and Switching Treatments for Improving Depression Outcomes

    Not yet reported VA Office of Research and Development 1522 participants Est. completion 2016-06 35 sites
    Other conditions: Major Depressive Disorder
    View official trial listing →
  • Completed NCT NCT01432444

    Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 493 participants Est. completion 2013-12 124 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01446328

    Bergen Psychosis Project 2 - The Best Intro Study

    Not yet reported Haukeland University Hospital 151 participants Est. completion 2017-12 4 sites
    Other conditions: Schizophrenia, Psychotic Disorders
    View official trial listing →
  • Completed NCT NCT01447082

    General Practice Research Database Seroquel XR Safety Study

    AstraZeneca 37372 participants Est. completion 2012-12 1 site
    Other conditions: Schizophrenia, Major Depressive Disorder, Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT01448720

    Treatment of Patients With Recently Exacerbated Schizophrenia With Paliperidone Palmitate

    Not yet reported Janssen-Cilag Farmaceutica Ltda. 142 participants Est. completion 2013-12 12 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Terminated NCT NCT01454453

    Optimisation of Antipsychotic Drug Use in Older People

    Not yet reported Institute of Psychiatry, London 64 participants Est. completion 2015-07 1 site
    Other conditions: Alzheimer's Disease, Schizophrenia
    View official trial listing →
  • Completed NCT NCT01467089

    The Assessment of Movement Disorders Utilizing Live Two-Way Video

    Northwell Health 37 participants Est. completion 2016-06 1 site
    Other conditions: Tardive Dyskinesia
    View official trial listing →
  • Completed NCT NCT01479400

    Effects of Exposed to Antipsychotics Throughout Pregnancy on Infants Development: A Prospective Study

    Central South University 152 participants Est. completion 2011-05 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01479413

    Mitochondria and Schizophrenia: Effects of Antipsychotic Drugs

    Chang Gung Memorial Hospital 77 participants Est. completion 2013-09 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01481883

    Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?

    Not yet reported The Alfred 13 participants Est. completion 2019-02 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder
    View official trial listing →
  • Completed NCT NCT01491412

    Non-interventional Study: Real-life Use of Atypical Antipsychotics in Acute Inpatient Management of Schizophrenia

    AstraZeneca 503 participants Est. completion 2012-05 14 sites
    Other conditions: Acute Psychotic Episode, Schizophrenia
    View official trial listing →
  • Withdrawn NCT NCT01495156

    Study of the Efficacy of Adjunctive Lithium Treatment for the Treatment of Psychotic Mania

    Not yet reported Northwell Health Est. completion 2015-09 1 site
    Other conditions: Bipolar I Disorder
    View official trial listing →
  • Completed NCT NCT01495169

    Tolerability and Pharmacokinetics of Iloperidone in Adolescent Patients

    Not yet reported Vanda Pharmaceuticals 33 participants Est. completion 2015-02 10 sites
    Other conditions: Safety and Tolerability of Iloperidone
    View official trial listing →
  • Completed NCT NCT01499563

    Study of a Novel Antipsychotic ITI-007 in Schizophrenia

    Not yet reported Intra-Cellular Therapies, Inc. 335 participants Est. completion 2013-11 8 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Terminated NCT NCT01509053

    Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 30 participants Est. completion 2012-10 10 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01516424

    Efficiency Study to Investigate Blonanserin in Treatment of Schizophrenia When Compared With Risperidone

    Not yet reported Marubeni Pharmaceuticals (Suzhou) Co., Ltd. 267 participants Est. completion 2013-02 16 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01527305

    A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Subjects With Acute Schizophrenia

    Not yet reported Janssen Research & Development, LLC 212 participants Est. completion 2013-12-31 21 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01527448

    Quetiapine in the Treatment of Postpartum Depression (PPD) in Bipolar Disorder (BD), Type II

    Not yet reported BC Women's Hospital & Health Centre 26 participants Est. completion 2010-07 1 site
    Other conditions: Postpartum Depression
    View official trial listing →
  • Completed NCT NCT01530308

    Haloperidol Prophylaxis in Older Emergency Department Patients

    Not yet reported Amsterdam UMC, location VUmc 242 participants Est. completion 2015-10 6 sites
    Other conditions: Delirium
    View official trial listing →
  • Completed NCT NCT01534936

    Atypical Antipsychotics in the Treatment of Affective Symptoms of Schizophrenia in Hungary

    AstraZeneca 2153 participants Est. completion 2012-12 53 sites
    Other conditions: Schizophrenia, Affective Symptoms
    View official trial listing →
  • Completed NCT NCT01543321

    Xenazine in Late Dyskinetic Syndrome With Neuroleptics

    Not yet reported Centre Hospitalier Universitaire, Amiens 54 participants Est. completion 2017-08 19 sites
    Other conditions: Tardive Dyskinesia
    View official trial listing →
  • Completed NCT NCT01544608

    Observe Real-life Allocation of Atypical Antipsychotics in the Acute Inpatient Management of Schizophrenia

    AstraZeneca 1076 participants Est. completion 2012-12 7 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01552772

    Safety and Tolerability Trial of Aripiprazole IM Depot Treatment in Adult Subjects With Schizophrenia Stabilized on Oral Antipsychotics Other Than Aripiprazole

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 60 participants Est. completion 2012-04 12 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01556763

    Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Schizophrenia

    Not yet reported FORUM Pharmaceuticals Inc 21 participants Est. completion 2008-08 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Central Nervous System Diseases
    View official trial listing →
  • Withdrawn NCT NCT01567124

    Alleviating the Metabolic Side Effects of Antipsychotic Medications

    Not yet reported Baker Heart and Diabetes Institute 4 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01578486

    Salsalate as an Adjunctive Treatment for Patients With Schizophrenia

    Not yet reported University of Massachusetts, Worcester 17 participants Est. completion 2015-07 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Withdrawn NCT NCT01584466

    Long Acting Paliperidone in Dually Diagnosed People With Schizophrenia: An Open-label Pilot Study

    Not yet reported University of Maryland, Baltimore Est. completion 2014-01 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01587118

    An Open Label Pilot Study of Adjunctive Asenapine for the Treatment of Posttraumatic Stress Disorder

    Not yet reported Lori Davis, MD 18 participants Est. completion 2016-07 1 site
    Other conditions: Posttraumatic Stress Disorder
    View official trial listing →
  • Completed NCT NCT01587521

    Prevalence of and Factors Associated With Metabolic Syndrome in Schizophrenia

    Chiang Mai University 80 participants Est. completion 2016-06 1 site
    Metabolic syndrome Other conditions: Quality of Life, Depression
    View official trial listing →
  • Terminated NCT NCT01592201

    A Comparative Study of Patient Satisfaction Between Continued Administration of Previous Antipsychotics Versus Switched Administration to Paliperidone ER in Non-satisfied Patients With Previous Antipsychotic Drug

    Not yet reported Janssen Korea, Ltd., Korea 13 participants Est. completion 2013-06 9 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT01598623

    Administrating Oxytocin to Treat Treatment Schizophrenia and Schizo-affective Patients

    Not yet reported Sheba Medical Center 48 participants Est. completion 2014-09 1 site
    Other conditions: Oxytocin + Non Specific Counselling, Oxytocin + Social Skills Training, Placebo + Non Specific Counselling, Placebo + Social Skills Training
    View official trial listing →
  • Completed NCT NCT01607762

    A Study to Compare Capillary and Venous Whole Blood and Plasma Concentrations of Five Antipsychotics

    Not yet reported Janssen Research & Development, LLC 31 participants Est. completion 2012-10 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01609153

    Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to Monotherapy

    Not yet reported Heinrich-Heine University, Duesseldorf 328 participants Est. completion 2019-04 21 sites
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Terminated NCT NCT01615185

    A Randomized, Double-blind, Comparison of the Efficacy and Safety of Amisulpride Versus Low-dose Amisulpride Plus Low-dose Sulpiride in the Treatment of Schizophrenia

    Not yet reported Kaohsiung Kai-Suan Psychiatric Hospital 96 participants Est. completion 2011-12 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Terminated NCT NCT01621737

    Antipsychotic Effects of Oxytocin

    Not yet reported University of California, San Diego 42 participants Est. completion 2018-12 2 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01625000

    Safety and Efficacy of MP-214 in Patients With Schizophrenia

    Not yet reported, Not yet reported Tanabe Pharma Corporation 512 participants Est. completion 2015-10 3 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01625897

    A Long-Term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia

    Not yet reported, Not yet reported Tanabe Pharma Corporation 125 participants Est. completion 2015-03 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01626859

    A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia

    Not yet reported, Not yet reported Tanabe Pharma Corporation 38 participants Est. completion 2013-08 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01626872

    Long-Term Study of MP-214 in Patients With Schizophrenia

    Not yet reported, Not yet reported Tanabe Pharma Corporation 254 participants Est. completion 2016-10 3 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01626885

    A Long-Term Study of MP-214 in Patients With Receiving Multiple Drugs Schizophrenia

    Not yet reported, Not yet reported Tanabe Pharma Corporation 42 participants Est. completion 2014-06 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01636037

    Antipsychotic Augmentation With L-Dopa

    Not yet reported Centre for Addiction and Mental Health 13 participants Est. completion 2016-01 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01639872

    Clozapine for Cannabis Use in Schizophrenia

    Not yet reported Dartmouth-Hitchcock Medical Center 49 participants Est. completion 2017-03-29 9 sites
    Other conditions: Schizophrenia, Cannabis Abuse, Cannabis Dependence, Dual Diagnosis
    View official trial listing →
  • Completed NCT NCT01646827

    An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 37 participants Est. completion 2013-04 6 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01662648

    Safety, Efficacy and Tolerability Study of Paliperidone Extended-Release (ER) in Participants With Schizophrenia

    Not yet reported Janssen Pharmaceutica 1117 participants Est. completion 2009-04
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01670019

    Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression

    Not yet reported Duke University 46 participants Est. completion 2014-06 5 sites
    Other conditions: Major Depressive Disorder Without Psychotic Features
    View official trial listing →
  • Status unknown NCT NCT01672554

    Clinical Benefits of Seroquel XR in Anxiety Disorder

    Not yet reported Corporation de Recherche en Neuropsycho Pharmacologie de Quebec 40 participants Est. completion 2013-10 1 site
    Other conditions: Schizophrenia, Anxiety
    View official trial listing →
  • Completed NCT NCT01682161

    A Comparative Study to Evaluate the Evolution of Medication Satisfaction and Adherence in Patients Unsatisfied With Current Oral Atypical Antipsychotics by Switching Medication to Paliperidone Palmitate

    Not yet reported Janssen Korea, Ltd., Korea 154 participants Est. completion 2013-09 9 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Suspended NCT NCT01684657

    A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering

    Not yet reported University of California, Irvine 32 participants Est. completion 2014-05 1 site
    Other conditions: Stuttering
    View official trial listing →
  • Completed NCT NCT01685931

    A Study of Paliperidone Palmitate in Patients With Schizophrenia Previously Unsuccessfully Treated by Oral Antipsychotics

    Not yet reported Xian-Janssen Pharmaceutical Ltd. 617 participants Est. completion 2014-12 17 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01686815

    Cross-Sectional Iloperidone IVGTT

    Massachusetts General Hospital 37 participants Est. completion 2016-05 1 site
    Metabolic syndrome Other conditions: Schizophrenia, Serious Mental Illness, Insulin Resistance, Glucose Metabolism
    View official trial listing →
  • Completed NCT NCT01689389

    Description of the Use of Quetiapine Extended Release (XR) in Real-life Practice in France. An Observational Study

    AstraZeneca 2292 participants Est. completion 2014-12 19 sites
    Other conditions: Schizophrenia, Bipolar Episodes
    View official trial listing →
  • Status unknown NCT NCT01710163

    Potentiation of Quetiapine Treatment With Lithium or Aripiprazole in Bipolar 1 Nonresponders Patients

    Not yet reported University of Sao Paulo 50 participants Est. completion 2015-06 2 sites
    Other conditions: Bipolar I Disorder
    View official trial listing →
  • Completed NCT NCT01714661

    Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy

    Not yet reported FORUM Pharmaceuticals Inc 753 participants Est. completion 2015-12 94 sites
    Other conditions: Schizophrenia, Impaired Cognition
    View official trial listing →
  • Completed NCT NCT01714713

    A 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy

    Not yet reported FORUM Pharmaceuticals Inc 830 participants Est. completion 2015-10 128 sites
    Other conditions: Schizophrenia, Impaired Cognition
    View official trial listing →
  • Completed NCT NCT01716975

    Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy

    Not yet reported FORUM Pharmaceuticals Inc 767 participants Est. completion 2016-02 106 sites
    Other conditions: Schizophrenia, Impaired Cognition
    View official trial listing →
  • Completed NCT NCT01720095

    Niapsan as Add -on Therapy to Antipsychotic Treatment in First Episode Psychosis

    Not yet reported Nova Scotia Health Authority 22 participants Est. completion 2014-12 1 site
    Other conditions: Psychosis
    View official trial listing →
  • Completed NCT NCT01724359

    Tolerability, Safety and Efficacy of Flexibly Dosed Paliperidone ER in Patients With Schizophrenia

    Not yet reported Janssen-Cilag, S.A. 95 participants Est. completion 2009-11 5 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Withdrawn NCT NCT01724372

    The Role of Antidepressants or Antipsychotics in Preventing Psychosis

    Not yet reported St. Luke's-Roosevelt Hospital Center Est. completion 2014-05
    Other conditions: Psychotic Disorder
    View official trial listing →
  • Completed NCT NCT01726335

    Switching From Oral Antipsychotics to Long-Acting Risperidone in Participants With Schizophrenia

    Not yet reported Janssen-Cilag Ltd. 53 participants Est. completion 2008-03 5 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01731119

    Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents

    Not yet reported University of North Carolina, Chapel Hill 9 participants Est. completion 2014-08 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Psychosis NOS, Autistic Disorder, Asperger Syndrome, Child Development Disorders, Pervasive, Bipolar I Disorder, Bipolar II Disorder, Mood Disorder NOS, Severe Major Depression With Psychotic Features, Single Episode Major Depression Without Psychotic Symptoms, Severe Mood Disorder With Psychotic Features
    View official trial listing →
  • Terminated NCT NCT01738698

    Adjunctive SPD489 to Antipsychotic Medication in Clinically Stable Adults With Persistent Predominant Negative Symptoms of Schizophrenia

    Not yet reported Shire 4 participants Est. completion 2013-04-01 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01739127

    Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI

    University of British Columbia 83 participants Est. completion 2016-02 1 site
    Metabolic syndrome Other conditions: Psychotic Disorders, Bipolar Disorder
    View official trial listing →
  • Status unknown NCT NCT01752465

    Is Health Coaching Effective for Improving Metabolic Health in People With Psychosis Disorders?

    Not yet reported University of British Columbia 40 participants Est. completion 2016-09 1 site
    Metabolic syndrome Other conditions: Psychotic Disorders
    View official trial listing →
  • Withdrawn NCT NCT01758887

    Antipsychotic Discontinuation in High-risk Subjects

    Seoul National University Hospital Est. completion 2016-09 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Terminated NCT NCT01760889

    SPD489 Low Dose and High Dose Ranges When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia

    Not yet reported Shire 1 participants Est. completion 2013-04-01 4 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Terminated NCT NCT01760993

    Long-term Safety of SPD489 When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia

    Not yet reported Shire 2 participants Est. completion 2013-04-01 2 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT01765829

    Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis

    Not yet reported Fundación Pública Andaluza Progreso y Salud 104 participants Est. completion 2015-11 17 sites
    Other conditions: Psychosis Nos/Other
    View official trial listing →
  • Completed NCT NCT01778244

    Metformin for Treatment of Antipsychotic-induced Dyslipidemia

    Not yet reported Central South University 162 participants Est. completion 2012-06 1 site
    Other conditions: Dyslipidemia
    View official trial listing →
  • Completed NCT NCT01779700

    Fingolimod in Schizophrenia Patients

    Not yet reported Indiana University 40 participants Est. completion 2016-08 3 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01786239

    Omega-3 Dietary Supplements in Schizophrenia

    Not yet reported Delbert Robinson 50 participants Est. completion 2015-09 1 site
    Other conditions: Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, Bipolar Disorder, Psychosis NOS
    View official trial listing →
  • Completed NCT NCT01786369

    Adherence in Patients Admitted to a Psychiatric Unit for Acute Psychosis: an Analysis of Serum Levels of Antipsychotics.

    Northwell Health 106 participants Est. completion 2015-04 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT01794429

    Treatment of Antipsychotic-associated Obesity With a GLP-1 Analogue

    Not yet reported Bjorn H. Ebdrup 45 participants Est. completion 2015-06 1 site
    Metabolic syndrome Other conditions: Obesity, Drug-induced Obesity, Schizophrenia
    View official trial listing →
  • Completed NCT NCT01797575

    N-Acetyl Cysteine and Aspirin as an Adjunctive Treatment for Bipolar Disorder

    Not yet reported The University of Texas Health Science Center, Houston 38 participants Est. completion 2017-02-01 1 site
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT01804582

    The Family VOICE Study

    Not yet reported University of Maryland, Baltimore 350 participants Est. completion 2016-03-31 1 site
    Other conditions: Autism, Aggression, Bipolar Disorder, Psychotic Disorders
    View official trial listing →
  • Completed NCT NCT01811160

    Metabolic Effects of Melatonin in Patients Treated With Second Generation Antipsychotics

    Not yet reported Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente 50 participants Est. completion 2011-11 1 site
    Other conditions: Second Generation Antipsychotic Induced Metabolic Adverse Effects
    View official trial listing →
  • Completed NCT NCT01811459

    Trial Comparing Haloperidol, Quetiapine and Placebo in the Pharmacological Treatment of Delirium

    Not yet reported Centre hospitalier de l'Université de Montréal (CHUM) 107 participants Est. completion 2016-09 1 site
    Other conditions: Delirium
    View official trial listing →
  • Completed NCT NCT01822418

    Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH)

    Not yet reported Central Institute of Mental Health, Mannheim 27 participants Est. completion 2015-12 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Delusional Disorder
    View official trial listing →
  • Completed NCT NCT01825798

    Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)

    Not yet reported Holland Bloorview Kids Rehabilitation Hospital 60 participants Est. completion 2015-10 4 sites
    Other conditions: Overweight, Autism Spectrum Disorder
    View official trial listing →
  • Status unknown NCT NCT01831986

    Pregnenolone and L-theanine Augmentation in the Treatment for Schizophrenia and Schizoaffective Disorders

    Not yet reported Sha'ar Menashe Mental Health Center 60 participants Est. completion 2013-12
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Terminated NCT NCT01844700

    1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain

    Not yet reported Northwell Health 14 participants Est. completion 2014-04 1 site
    Other conditions: High Risk MC4R Genotype, Low Risk MC4R Genotype, One Week or Less Antipsychotic Lifetime Exposure
    View official trial listing →
  • Status unknown NCT NCT01845259

    Does a GLP-1 Receptor Agonist Change Glucose Tolerance in Antipsychotic-treated Patients?

    Not yet reported Psychiatric Centre Rigshospitalet 103 participants Est. completion 2017-03 1 site
    Prediabetes
    View official trial listing →
  • Completed NCT NCT01851863

    Compliance With Antidepressant Medication in Treatment of Functional Dyspepsia

    Not yet reported RenJi Hospital 262 participants Est. completion 2014-06 1 site
    Other conditions: Dyspepsia, Compliance, Depression
    View official trial listing →
  • Completed NCT NCT01852331

    Peony-Glycyrrhiza Decoction (PGD) for Antipsychotic-induced Hyperprolactinemia in Patients With Schizophrenia

    Not yet reported The University of Hong Kong 103 participants Est. completion 2014-11 4 sites
    Other conditions: Schizophrenia, Schizophrenic Disorder, Hyperprolactinemia, Hyperprolactinaemia
    View official trial listing →
  • Completed NCT NCT01855074

    An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective Disorders

    Not yet reported Janssen-Cilag Ltd. 80 participants Est. completion 2009-02
    Other conditions: Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder
    View official trial listing →
  • Status unknown NCT NCT01855152

    Improving Well-being and Health for People With Dementia

    Not yet reported professor Clive Ballard 1000 participants Est. completion 2015-03 1 site
    Other conditions: Dementia
    View official trial listing →
  • Completed NCT NCT01858948

    SGA-induced Metabolic Syndrome in Bipolar Youth

    Not yet reported University of Cincinnati 19 participants Est. completion 2018-04 1 site
    Other conditions: Bipolar Youth Treated With Second-generation Antipsychotics
    View official trial listing →
  • Completed NCT NCT01866098

    Naltrexone for Antipsychotic-Induced Weight Gain

    Not yet reported Yale University 144 participants Est. completion 2019-04-07 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Bipolar Disorder, Severe Major Depression With Psychotic Features
    View official trial listing →
  • Terminated NCT NCT01867398

    Effects of Atypical Antipsychotics on Brain Function in Children and Teens With Conduct Disorders

    National Institute of Mental Health (NIMH) 12 participants Est. completion 2015-05-18 1 site
    Other conditions: Conduct Disorder, fMRI
    View official trial listing →
  • Completed NCT NCT01871974

    Study to Evaluate Safety and Tolerability of FK949E in Patients With Major Depressive Disorder

    Not yet reported Astellas Pharma Inc 16 participants Est. completion 2010-03 2 sites
    Other conditions: Major Depressive Disorder Patients
    View official trial listing →
  • Completed NCT NCT01871987

    Study to Evaluate the Effect of Food Intake on the Plasma Concentration Changes of Quetiapine After Oral Administration of FK949E in Healthy Volunteers

    Not yet reported Astellas Pharma Inc 24 participants Est. completion 2009-08 1 site
    Other conditions: Healthy, Plasma Concentration Change of Quetiapine
    View official trial listing →
  • Completed NCT NCT01875822

    Open-label Study of Curcumin C-3 Complex in Schizophrenia

    Not yet reported, Not yet reported Woodbury, Michel, M.D. 17 participants Est. completion 2012-05 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Depression
    View official trial listing →
  • Completed NCT NCT01875861

    Monitoring and Management for Metabolic Side Effects of Antipsychotics

    Not yet reported VA Office of Research and Development 12 participants Est. completion 2017-04 1 site
    Other conditions: Mental Health, Psychotic Disorders
    View official trial listing →
  • Status unknown NCT NCT01885923

    A RCT Study in Schizophrenia Relapse Prevention

    Not yet reported Prague Psychiatric Center 150 participants Est. completion 2015-12 1 site
    Other conditions: Relapse Schizophrenia
    View official trial listing →
  • Completed NCT NCT01888107

    Maintenance of Efficacy With Risperidone Long Acting Injectable (R-LAI) in Patients With Schizophrenia or Schizoaffective Disorder

    Not yet reported Janssen-Cilag S.p.A. 347 participants Est. completion 2007-04
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Terminated NCT NCT01894984

    An Observational Study to Evaluate Efficacy and Safety of Risperidone Long-Acting Injection for Treatment of Schizophrenia

    Xian-Janssen Pharmaceutical Ltd. 640 participants Est. completion 2009-12
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01903200

    Study to Evaluate Safety and Tolerability of FK949E in Elderly Patients With Major Depressive Disorder

    Not yet reported Astellas Pharma Inc 16 participants Est. completion 2011-09 2 sites
    Other conditions: Major Depressive Disorder Patients
    View official trial listing →
  • Terminated NCT NCT01908192

    Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen®

    Not yet reported, Not yet reported SyneuRx International (Taiwan) Corp 60 participants Est. completion 2023-10-26 23 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01908296

    Study to Evaluate the Effect of Multiple-dose of Fluvoxamine on the Plasma Concentration of Quetiapine (FK949E) in Healthy Male Volunteers

    Not yet reported Astellas Pharma Inc 24 participants Est. completion 2011-08 1 site
    Other conditions: Healthy, Pharmacokinetics of Quetiapine
    View official trial listing →
  • Terminated NCT NCT01913327

    Antipsychotic Effects on Brain Function in Schizophrenia

    Not yet reported University of California, San Francisco 4 participants Est. completion 2017-01 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder
    View official trial listing →
  • Completed NCT NCT01920802

    Assessment and Comparison of Metabolic Changes in Non-psychotic Adults Taking Iloperidone or Olanzapine or Placebo

    Not yet reported New York State Psychiatric Institute 31 participants Est. completion 2014-09 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01924520

    Oral Multiple-dose Study in Patients With Major Depressive Disorder

    Not yet reported Astellas Pharma Inc 32 participants Est. completion 2011-05 2 sites
    Other conditions: Major Depressive Disorder
    View official trial listing →
  • Terminated NCT NCT01929889

    Assessing the Effects of Fanapt® on Social Cognition in Schizophrenia

    Not yet reported Northwestern University 19 participants Est. completion 2014-10 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT01931059

    Acute D2 Receptor Blockade Induced Neuronal Network Changes in Human Volunteers

    Not yet reported Northwell Health 11 participants Est. completion 2016-07 1 site
    Other conditions: Imaging of the Brain and Antipsychotics, Neuronal Network Changes
    View official trial listing →
  • Status unknown NCT NCT01936220

    Relapse Prevention in First Episode Schizophrenia: a 5 Year Trial

    Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 200 participants Est. completion 2016-02 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT01938859

    Algorithm Guided Treatment Strategies for Bipolar Depression

    Not yet reported Shanghai Mental Health Center 360 participants Est. completion 2018-12 1 site
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT01947803

    A Safety and Effectiveness Study of Paliperidone Palmitate in Chinese Patients With Schizophrenia

    Not yet reported Xian-Janssen Pharmaceutical Ltd. 353 participants Est. completion 2015-03 12 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01953237

    MedActive: A Smartphone Intervention to Improve Adherence to Antipsychotic Medications

    Not yet reported University of Maryland, Baltimore 31 participants Est. completion 2015-12 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT01962402

    Lorcaserin for Weight Loss Management in Patients on Antipsychotics: A Pilot Study

    Not yet reported Southern California Institute for Research and Education 15 participants 1 site
    Other conditions: Weight Gain
    View official trial listing →
  • Status unknown NCT NCT01966588

    Adverse Events and Genomics in Schizophrenia

    University of British Columbia 100 participants Est. completion 2017-03 1 site
    Other conditions: Adverse Effect of Other Antipsychotics and Neuroleptics
    View official trial listing →
  • Completed NCT NCT01976793

    Retrospective Observational Study DIANA Study

    AstraZeneca 450 participants Est. completion 2013-12 8 sites
    Other conditions: Major Depressive Episode
    View official trial listing →
  • Completed NCT NCT01977300

    Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic Episode

    Not yet reported University of British Columbia 159 participants Est. completion 2011-08 1 site
    Other conditions: Bipolar I Disorder
    View official trial listing →
  • Completed NCT NCT01990755

    Neurobiology of Eating Disorders Treatments

    Not yet reported University of Turin, Italy 112 participants Est. completion 2013-05 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT01994109

    Efficacy and Safety Study of MYOBLOC® in the Treatment of Sialorrhea in Adult Subjects

    Not yet reported Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC 187 participants Est. completion 2017-01 34 sites
    Other conditions: Sialorrhea
    View official trial listing →
  • Completed NCT NCT01999309

    Simvastatin Addition for Patients With Recent-onset Schizophrenia

    Not yet reported Iris Sommer 121 participants Est. completion 2019-12-19 2 sites
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Psychosis NOS
    View official trial listing →
  • Completed NCT NCT02007928

    Assessment of Adverse Events in a Naive Pediatric Population Treated With an Antipsychotic

    Not yet reported Centre Hospitalier Universitaire de Nice 200 participants Est. completion 2017-07 14 sites
    Other conditions: Dissociative Disorders, Schizophrenia
    View official trial listing →
  • Completed NCT NCT02009371

    A Clinical Study of Light Therapy on Depressive Episodes of Bipolar Disorder

    Not yet reported Peking University 80 participants Est. completion 2015-07 1 site
    Other conditions: Depressive Episodes of Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT02013531

    Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 37 participants Est. completion 2014-06 21 sites
    Other conditions: Major Depressive Disorder, Anxiety
    View official trial listing →
  • Completed NCT NCT02013609

    Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work Environment

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 48 participants Est. completion 2014-10 24 sites
    Other conditions: MDD
    View official trial listing →
  • Completed NCT NCT02013622

    Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 49 participants Est. completion 2014-10 22 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02019329

    A Study of the Safety, Tolerability and Pharmacokientics of RO5545965 in Patients With Schizophrenia on Risperidone

    Not yet reported Hoffmann-La Roche 32 participants Est. completion 2014-08 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Terminated NCT NCT02020356

    Music Therapy in Alzheimer's Disease

    Not yet reported University Hospital, Toulouse 35 participants Est. completion 2015-06 7 sites
    Other conditions: Alzheimer's Type Dementia
    View official trial listing →
  • Completed NCT NCT02029989

    Point-of-Care Testing (POCT) Detection and Management of Metabolic Syndrome in Patients With Mental Illness

    Not yet reported University of Minnesota 121 participants Est. completion 2012-02 1 site
    Other conditions: Hyperlipidemia, Diabetes, Hypertension
    View official trial listing →
  • Completed NCT NCT02034253

    Glutamate, Brain Connectivity and Duration of Untreated Psychosis

    University of Alabama at Birmingham 134 participants Est. completion 2018-11 1 site
    Other conditions: Schizophrenia, Psychosis, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT02037074

    Study to Assess the Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Effects of EVP-6308 and the Potential of EVP-6308 to Affect the PK Properties of the Antipsychotic Regimen in Subjects With Schizophrenia Currently Receiving Stable Treatment With up to 2 Atypical Antipsychotics

    Not yet reported FORUM Pharmaceuticals Inc 40 participants 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT02040883

    Tandospirone Combined With Atypical Antipsychotic Drugs in Schizophrenia

    Not yet reported Qingyun Yin 100 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02051387

    Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study

    Not yet reported Central Institute of Mental Health, Mannheim 74 participants Est. completion 2017-08 2 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02054702

    Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Acute Schizophrenia

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 97 participants Est. completion 2014-07
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT02070211

    Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome.

    Not yet reported, Not yet reported Bambino Gesù Hospital and Research Institute 80 participants Est. completion 2016-06 1 site
    Other conditions: 22q11 Deletion Syndrome
    View official trial listing →
  • Completed NCT NCT02079844

    Roflumilast Plus Antipsychotics Proof of Mechanism Study in Schizophrenia

    Not yet reported Takeda 20 participants Est. completion 2015-06 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02085447

    A Concierge Model of CAE Plus LAI in Individuals With Schizophrenia at Risk for Treatment Non-adherence and Homelessness

    Not yet reported University Hospitals Cleveland Medical Center 30 participants Est. completion 2016-12 1 site
    Other conditions: Psychotic Disorders, Schizophrenia, Schizoaffective Disorder, Medication Adherence, Medication Non-Adherence
    View official trial listing →
  • Completed NCT NCT02087579

    Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants

    Not yet reported Janssen Research & Development, LLC 305 participants Est. completion 2014-12 24 sites
    Other conditions: Psychotic Disorders, Schizophrenia, Bipolar Disorder, Depressive Disorder
    View official trial listing →
  • Status unknown NCT NCT02093858

    The Mechanism of TCF7L2 and SLC30A8 on Antipsychotic-induced Metabolic Syndrome

    Central South University 212 participants Est. completion 2017-12 1 site
    Metabolic syndrome Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02109939

    Genomics Used to Improve DEpression Decisions

    Not yet reported Assurex Health Inc. 1398 participants Est. completion 2017-07-31 61 sites
    Other conditions: Major Depressive Disorder (MDD)
    View official trial listing →
  • Completed NCT NCT02137278

    Stop Vasodepressor Drugs in Reflex Syncope

    Not yet reported Gruppo Italiano Multidisciplinare per lo Studio della Sincope 58 participants Est. completion 2015-12 1 site
    Other conditions: Hypotensive Syncope
    View official trial listing →
  • Status unknown NCT NCT02137616

    Antipsychotic to Treat Psychosis Syndrome

    Not yet reported Central South University 300 participants Est. completion 2014-12 1 site
    Other conditions: Psychotic Disorders
    View official trial listing →
  • Completed NCT NCT02142556

    The Efficacy and Safety of Quetiapine XR in Patients With Schizophrenia Switched From Other Antipsychotics

    Not yet reported Tri-Service General Hospital (TSGH) 61 participants Est. completion 2012-03 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02146547

    European Long-acting Antipsychotics in Schizophrenia Trial

    Not yet reported UMC Utrecht 536 participants Est. completion 2020-08-26 49 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02151656

    F17464 in Acute Schizophrenia Trial

    Not yet reported Pierre Fabre Medicament 158 participants Est. completion 2015-12 27 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02181803

    Elpipodect (MK-8189) Multiple Dose Study in Healthy Volunteers and Schizophrenia Participants (MK-8189-003)

    Not yet reported Merck Sharp & Dohme LLC 55 participants Est. completion 2015-04-23
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02184767

    Study to Assess the Safety and Pharmacokinetics of ADASUVE® at Doses of 2.5, 5, or 10 mg in Children and Adolescents (10 Through 17 Years of Age) With Any Condition Warranting Chronic Use of an Antipsychotic Medication

    Not yet reported Teva Branded Pharmaceutical Products R&D, Inc. 30 participants Est. completion 2015-05 2 sites
    Other conditions: BiPolar
    View official trial listing →
  • Completed NCT NCT02192723

    A Randomized Double-blind Trial With 6 Antipsychotic Drugs for Schizophrenia

    Not yet reported Beijing HuiLongGuan Hospital 550 participants Est. completion 2014-06 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02194933

    Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Schizophrenia With Impulsivity

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 38 participants Est. completion 2016-04 1 site
    Other conditions: Schizophrenia With Impulsivity
    View official trial listing →
  • Status unknown NCT NCT02205437

    Novel Candidate Genes for Treatment Response to Antipsychotics in Schizophrenia

    Fundación Marques de Valdecilla 200 participants Est. completion 2020-12 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Withdrawn NCT NCT02212613

    Brexpiprazole (OPC 34712) Trial in the Treatment of Adults With Major Depressive Disorder and Irritability

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. Est. completion 2015-11 1 site
    Other conditions: Major Depressive Disorder and Irritability
    View official trial listing →
  • Withdrawn NCT NCT02213887

    Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric Medications

    Not yet reported University of British Columbia Est. completion 2020-11-02 1 site
    Other conditions: Psychotic Disorders, Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT02220504

    3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals

    Not yet reported Fundación Marques de Valdecilla 68 participants Est. completion 2014-07 1 site
    Other conditions: Schizophrenia, Schizophrenia Relapse, Schizophrenia Spectrum and Other Psychotic Disorders
    View official trial listing →
  • Completed NCT NCT02237417

    Impact of Aripiprazole Once Monthly Medications on Changes in Brain Structure and Metabolism

    Not yet reported University of Utah 47 participants Est. completion 2020-07-30 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02239094

    Biosignatures of Latuda for Bipolar Depression

    Not yet reported New York State Psychiatric Institute 20 participants Est. completion 2016-09 1 site
    Other conditions: Bipolar Depression
    View official trial listing →
  • Status unknown NCT NCT02240173

    Antipsychotic Effects of Sorghum Bicolor (JOBELYN) in the Treatment of Schizophrenia

    Not yet reported, Not yet reported Federal Neuro-Psychiatric Hospital, Yaba 100 participants Est. completion 2017-12 1 site
    Other conditions: Schizophrenia and Disorders With Psychotic Features
    View official trial listing →
  • Completed NCT NCT02248987

    Study on Abnormal Dopamine Synthesis and Connectivity According to the Antipsychotic Treatment Response in Schizophrenia

    Seoul National University Hospital 36 participants Est. completion 2016-05 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02281162

    The Influence of Vitamin D on Atypical Antipsychotic-induced Weight Gain

    Creighton University 20 participants Est. completion 2015-09 1 site
    Metabolic syndrome Other conditions: Schizophrenia, Vitamin D Deficiency
    View official trial listing →
  • Completed NCT NCT02281773

    A Study to Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia on Stable Antipsychotic Treatment.

    Not yet reported Boehringer Ingelheim 518 participants Est. completion 2016-06-13 43 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT02282085

    Treatment Study Comparing Aripiprazole Once Monthly With Standard of Care Medication in Outpatients With Schizophrenia

    Not yet reported Matt Byerly 200 participants 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02282761

    A Trial to Assess the Antipsychotic Efficacy of ITI-007

    Not yet reported Intra-Cellular Therapies, Inc. 450 participants Est. completion 2015-09 11 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Withdrawn NCT NCT02286206

    Study of the Effect of Dosing on Clozapine Levels

    Not yet reported University of British Columbia Est. completion 2017-12 1 site
    Other conditions: Psychotic Disorders, Schizophrenia
    View official trial listing →
  • Completed NCT NCT02295462

    Effect of Person-Centred-Care on Antipsychotic Drug Use in Nursing Homes: a Cluster-randomised Trial

    Not yet reported Martin-Luther-Universität Halle-Wittenberg 1158 participants Est. completion 2017-02 3 sites
    Other conditions: Dementia
    View official trial listing →
  • Completed NCT NCT02298985

    Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients

    Not yet reported Beersheva Mental Health Center 38 participants Est. completion 2017-05 2 sites
    Other conditions: Chronic Schizophrenia
    View official trial listing →
  • Completed NCT NCT02305823

    Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in the Treatment of First Episode Nonaffective Psychosis

    Not yet reported Fundación Marques de Valdecilla 203 participants Est. completion 2014-05 1 site
    Other conditions: Schizophrenia, Psychotic Disorders
    View official trial listing →
  • Completed NCT NCT02307396

    Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients

    Not yet reported Technical University of Munich 21 participants Est. completion 2016-06-22 1 site
    Other conditions: Schizophrenia, Schizophrenia and Disorders With Psychotic Features, Schizoaffective Disorders
    View official trial listing →
  • Status unknown NCT NCT02334904

    Comparison of Aripiprazole Versus Risperidone on Brain Morphology Using MRI

    University of British Columbia 60 participants Est. completion 2016-06 1 site
    Other conditions: First-Episode Psychosis, Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT02339844

    Pan European Collaboration on Antipsychotic Naïve Schizophrenia II

    Not yet reported University of Copenhagen 130 participants Est. completion 2021-01 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Terminated NCT NCT02357849

    Fluoxetine vs Aripiprazole Comparative Trial (FACT)

    Not yet reported Northwell Health 9 participants Est. completion 2022-04-04 1 site
    Other conditions: Attenuated Psychosis Syndrome
    View official trial listing →
  • Completed NCT NCT02360319

    Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics

    Not yet reported Vanguard Research Group 489 participants Est. completion 2019-03-31 39 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT02361255

    Degenerative Nigrostriatal Dysfunction in Drug-induced Parkinsonism

    Corporal Michael J. Crescenz VA Medical Center 40 participants Est. completion 2019-04 1 site
    Other conditions: Secondary Parkinsonism, Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02363738

    12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II Depression

    Not yet reported University Health Network, Toronto 60 participants Est. completion 2017-04 2 sites
    Other conditions: Bipolar Depression
    View official trial listing →
  • Withdrawn NCT NCT02363816

    Beta-carotene and Oxidative Stress in Pediatric Second Generation Antipsychotic Use

    Wayne State University
    Other conditions: Pediatric Population on Second Generation Antipsychotics
    View official trial listing →
  • Completed NCT NCT02366897

    Extrapyramidal Side-Effects in Antipsychotic Drug Therapeutics

    Not yet reported University of Edinburgh 21 participants Est. completion 2018-06-30 1 site
    Other conditions: Drug-induced Extrapyramidal Side Effects
    View official trial listing →
  • Completed NCT NCT02374996

    Pharmacoepigenetics of Bipolar Disorder Treatment

    Wayne State University 40 participants Est. completion 2017-09 1 site
    Other conditions: Antipsychotic Agents, Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT02409823

    Clinical Registry of Patients Under Treatment With Atypical Antipsychotics

    Pontifical Catholic University of Argentina 665 participants Est. completion 2015-08
    Other conditions: Schizophrenia, Major Depressive Disorder, Bipolar Depressive Disorder, Parkinson's Disease With Hallucinations
    View official trial listing →
  • Status unknown NCT NCT02423096

    Neuroendocrine and Metabolite Substrates in Schizophrenia

    Chang Gung Memorial Hospital 200 participants Est. completion 2016-12 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02423824

    Cognitive Dysfunction and Glucagon-like Peptide-1 Agonists

    Not yet reported University Health Network, Toronto 21 participants Est. completion 2016-05 1 site
    Other conditions: Bipolar Disorder, Major Depressive Disorder
    View official trial listing →
  • Completed NCT NCT02431702

    A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform

    Not yet reported Janssen Scientific Affairs, LLC 337 participants Est. completion 2019-11-12 38 sites
    Other conditions: Schizophrenia, Psychotic Disorders
    View official trial listing →
  • Terminated NCT NCT02435095

    Antipsychotic Induced Structural and Functional Brain Changes

    Not yet reported RWTH Aachen University 174 participants Est. completion 2020-08 11 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02435654

    5-HTR2A, DRD2,and COMT Genes Polymorphisms and Olanzapine Plasma Concentration in Treatment of Early-onset Schizophrenia

    Not yet reported Kunming Medical University 128 participants Est. completion 2018-12 1 site
    Other conditions: Early-onset Schizophrenia
    View official trial listing →
  • Completed NCT NCT02440594

    The PACE/PACENET Behavioral Health Laboratory Project

    Not yet reported University of Pennsylvania 2432 participants Est. completion 2015-06 1 site
    Other conditions: Depression
    View official trial listing →
  • Completed NCT NCT02442817

    Linagliptin and Mesenchymal Stem Cells: A Pilot Study

    Not yet reported University of Nevada, Reno 10 participants Est. completion 2018-03-02 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02447835

    Effect of Short Term Atypical Antipsychotic Administration Compared to Placebo on Hepatic Insulin Extraction

    Not yet reported Michael Rickels 15 participants Est. completion 2014-12 1 site
    Other conditions: Normal Non-fluency
    View official trial listing →
  • Terminated NCT NCT02462473

    A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry

    Not yet reported Janssen Research & Development, LLC 9 participants Est. completion 2016-01 3 sites
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT02466477

    Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment of Major Depressive Disorder

    Not yet reported Assurex Health Inc. 542 participants Est. completion 2019-09 14 sites
    Other conditions: Depressive Disorder, Major, Depression, Depressive Disorder
    View official trial listing →
  • Completed NCT NCT02469155

    A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment

    Not yet reported Intra-Cellular Therapies, Inc. 696 participants Est. completion 2016-08 11 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02496650

    Dexmedetomidine Addition to Benzodiazepines for Patients With Alcohol Withdrawal State in the ICU

    Not yet reported Bogomolets National Medical University 70 participants Est. completion 2015-06
    Other conditions: Alcohol Withdrawal State
    View official trial listing →
  • Completed NCT NCT02500628

    Heart Rate Variability in Response to Metformin Challenge

    Not yet reported Woodinville Psychiatric Associates 61 participants Est. completion 2016-02 1 site
    Type 2 diabetes Other conditions: Fibromyalgia, Mitochondrial Diseases, Movement Disorders
    View official trial listing →
  • Terminated NCT NCT02503124

    Effect of a Single Nights' Wake Followed by Bright Light Therapy for Severe Depression

    Not yet reported Sahlgrenska University Hospital 32 participants Est. completion 2020-03-15 1 site
    Other conditions: Depression
    View official trial listing →
  • Completed NCT NCT02504450

    Outcomes of Antipsychotic Medication Used in the Emergency Department

    Wake Forest University Health Sciences 93 participants Est. completion 2016-03
    Other conditions: Agitation,Psychomotor
    View official trial listing →
  • Completed NCT NCT02504476

    Multiple Ascending Dose Study on Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or Schizoaffective

    Not yet reported Amgen 52 participants Est. completion 2016-02 2 sites
    Other conditions: Schizophrenia or Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT02515773

    Metformin for Overweight & OBese ChILdren and Adolescents With BDS Treated With SGAs

    Not yet reported Melissa Delbello 1565 participants Est. completion 2023-06 29 sites
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT02526030

    Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in Treatment of First Episode Psychosis: 3-year Follow-up

    Not yet reported Fundación Marques de Valdecilla 203 participants Est. completion 2015-06 1 site
    Other conditions: Schizophrenia, Psychotic Disorders
    View official trial listing →
  • Status unknown NCT NCT02532491

    Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 1-year Follow-up

    Not yet reported Fundación Marques de Valdecilla 200 participants Est. completion 2020-12 1 site
    Other conditions: Schizophrenia, Psychotic Disorders
    View official trial listing →
  • Completed NCT NCT02534363

    Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-up

    Not yet reported Fundación Marques de Valdecilla 136 participants Est. completion 2013-01 1 site
    Other conditions: Schizophrenia, Psychotic Disorders
    View official trial listing →
  • Completed NCT NCT02536846

    The Effects of Antipsychotic Drugs on Brain Metabolism in Healthy Individuals

    Not yet reported Dost Ongur 35 participants Est. completion 2019-11-08 1 site
    Other conditions: Healthy
    View official trial listing →
  • Withdrawn NCT NCT02546336

    Ultrasound-Guided Hip Joint Cooled Radiofrequency Denervation

    Not yet reported Women's College Hospital Est. completion 2019-02-01 1 site
    Osteoarthritis Other conditions: Chronic Pain
    View official trial listing →
  • Status unknown NCT NCT02562287

    Clozapine Versus Other Atypical Antipsychotics for Bipolar Disorder

    Not yet reported Hospital de Clinicas de Porto Alegre 54 participants Est. completion 2020-12 1 site
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT02573168

    Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment With Antipsychotics

    Not yet reported St. Joseph's Healthcare Hamilton 103 participants Est. completion 2020-09 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT02573701

    Guideline vs Usual Treatment in Schizophrenic Adolescents

    Not yet reported Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, Mexico 91 participants Est. completion 2015-07
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02582736

    Antipsychotics and Risk of Hyperglycemic Emergencies

    Canadian Network for Observational Drug Effect Studies, CNODES 725489 participants Est. completion 2012-12 1 site
    Type 2 diabetes Other conditions: Psychotic Disorders, Schizophrenia, Schizoaffective Disorder, Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT02593058

    Positive Emotions Program for Schizophrenia (PEPS)

    Not yet reported Institut et Haute Ecole de la Santé la Source 80 participants Est. completion 2018-12-31 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT02593734

    Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in Ghana

    Not yet reported University of Ghana Medical School 139 participants Est. completion 2015-07 1 site
    Other conditions: Schizophrenia, Mood Disorders,, Anxiety Disorder
    View official trial listing →
  • Completed NCT NCT02600741

    Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)

    Janssen Scientific Affairs, LLC 296 participants Est. completion 2018-07-05 34 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02604056

    Pragmatic Cluster Trial for Nursing Home Antipsychotic Prescribing

    Not yet reported Women's College Hospital 60 participants Est. completion 2017-04
    Other conditions: Adverse Effect of Other Antipsychotics and Neuroleptics
    View official trial listing →
  • Completed NCT NCT02610868

    Open-Label and Single-Arm Study of MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adults

    Not yet reported Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC 187 participants Est. completion 2017-06 35 sites
    Other conditions: Sialorrhea
    View official trial listing →
  • Completed NCT NCT02634346

    A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)

    Not yet reported Alkermes, Inc. 403 participants Est. completion 2017-06-07 31 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02634463

    Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or Risperidone

    Not yet reported Janssen Research & Development, LLC 81 participants Est. completion 2016-11-09 1 site
    Other conditions: Immunoassay, Antipsychotic
    View official trial listing →
  • Completed NCT NCT02640300

    Switching Antipsychotics: Abrupt Discontinuation Versus Overlap

    Not yet reported Centre for Addiction and Mental Health 33 participants Est. completion 2004-07 1 site Stand-alone
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT02644577

    Metformin for Treatment Antipsychotic-induced Metabolic Syndrome in Bipolar Disorder Patients

    Not yet reported China Medical University, China 110 participants Est. completion 2015-09 1 site
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Status unknown NCT NCT02650102

    The Role of miR-30 Family Dysregulation in Response to Antipsychotic Treatment

    Not yet reported, Not yet reported Shanxi Medical University 200 participants Est. completion 2016-12 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT02653339

    Effectiveness of Qufeng Shengshi Fang on Treatment of Allergic Rhinitis.

    Not yet reported Peking Union Medical College Hospital 180 participants Est. completion 2018-08 1 site
    Other conditions: Rhinitis, Allergic, Perennial
    View official trial listing →
  • Completed NCT NCT02654964

    Cancer Stem Cell High-Throughput Drug Screening Study

    Not yet reported Swedish Medical Center 9 participants Est. completion 2023-06 1 site
    Other conditions: Glioblastoma Multiforme
    View official trial listing →
  • Completed NCT NCT02697045

    Effects of Aripiprazole (LAI) on Phychosocial/Cognitive Functioning, pt Reported AcceptabilityofTreatment in Sch

    Not yet reported Abdi İbrahim Otsuka 23 participants Est. completion 2018-03-31 15 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02704962

    Olanzapine vs. Low-dose Olanzapine Plus Trifluoperazine

    Not yet reported Kaohsiung Kai-Suan Psychiatric Hospital 94 participants Est. completion 2016-02 2 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02708394

    Molecular Mechanisms of Antipsychotic-induced Insulin Resistance

    Not yet reported Wayne State University 31 participants Est. completion 2023-10-01 1 site
    Other conditions: Adverse Effect of Other Antipsychotics and Neuroleptics, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT02712463

    A Study to Assess the Rate of Hospitalization in Participants With Schizophrenia Treated With Antipsychotics

    Janssen-Cilag Ltd. 310 participants Est. completion 2016-04 11 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02713672

    Cost-effectiveness of CYP2D6 and CYP2C19 Genotyping in Psychiatric Patients in Curacao

    Not yet reported GGZ Centraal 86 participants Est. completion 2015-06 1 site
    Other conditions: CYP2D6, Psychiatric Patients
    View official trial listing →
  • Terminated NCT NCT02717130

    Aripiprazole, Abilify Maintena Collaborative Clinical Protocol

    Not yet reported Florida Atlantic University 9 participants Est. completion 2017-05-25 4 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02731612

    Study of the Efficacy of Lurasidone in Cognitive Functioning in Bipolar Patients

    Not yet reported Lakshmi N Yatham 100 participants Est. completion 2024-12-31 9 sites
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT02744313

    MR Imaging of Fat Deposition in Adolescents With First Time Antipsychotic Use

    Centre for Addiction and Mental Health 17 participants Est. completion 2018-04 1 site
    Other conditions: Adiposity
    View official trial listing →
  • Completed NCT NCT02775864

    Comparative Effectiveness of Adaptive Treatment Strategies for Schizophrenia

    New York State Psychiatric Institute 81921 participants Est. completion 2018-06
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT02787122

    Pilot-trial of Emotion-focused Cognitive Behavior Therapy for Patients With Schizophrenia

    Not yet reported Philipps University Marburg 64 participants Est. completion 2017-12-31 2 sites
    Other conditions: Schizophrenia, Delusional Disorder, Schizoaffective Disorder, Brief Psychotic Disorder, Schizophreniform Disorder
    View official trial listing →
  • Completed NCT NCT02787135

    Efficacy and Mechanisms of Change of an Emotion-oriented Version of Cognitive-behavioral Therapy for Psychosis

    Not yet reported Philipps University Marburg 94 participants Est. completion 2019-12-31 2 sites
    Other conditions: Schizophrenia, Psychotic Disorders, Delusions, Emotions, Self-esteem, Sleep
    View official trial listing →
  • Completed NCT NCT02818777

    A Study of Tolerability and Efficacy of Cannabidiol on Tremor in Parkinson's Disease

    Not yet reported University of Colorado, Denver 13 participants Est. completion 2017-11 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Terminated NCT NCT02820519

    Tolerability and Analgesic Efficacy of Loxapine in Patients With Refractory, Chemotherapy-induced Neuropathic Pain

    Not yet reported University of Witten/Herdecke 4 participants Est. completion 2017-05-04 1 site
    Other conditions: Neuropathic Pain
    View official trial listing →
  • Completed NCT NCT02824055

    A Study to Evaluate The Effects of RO5545965 in Participants With Negative Symptoms of Schizophrenia Treated With Antipsychotics

    Not yet reported Hoffmann-La Roche 33 participants Est. completion 2017-04-24 3 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02827331

    Taking Account of Inobservable Periods in Longitudinal Drug Treatment Follow-up

    University Hospital, Toulouse 171861 participants Est. completion 2016-04
    Other conditions: Drug Exposition
    View official trial listing →
  • Status unknown NCT NCT02850445

    Trial and Follow-up of the Efficacy of Two-stage Integrated Treatment for Chinese Schizophrenia Inpatients

    Not yet reported Guangzhou Psychiatric Hospital 170 participants 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02874560

    Evaluation of the Functional Remission Occurrence and Predictive Factors in Schizophrenia

    Janssen-Cilag Ltd. 364 participants Est. completion 2017-07-12 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02877823

    Improving Cardiometabolic Health of Youth on Antipsychotic Medication

    Not yet reported University of Maryland, Baltimore 302 participants Est. completion 2021-12-31
    Other conditions: Childhood Obesity
    View official trial listing →
  • Status unknown NCT NCT02880995

    [18 Fluorine(F)]DOPA Determinants and Predictors of Treatment Response in Psychosis

    Not yet reported Seoul National University Hospital 62 participants Est. completion 2019-12 2 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT02884518

    Predicting Antipsychotic Discontinuation in Psychosis

    Not yet reported Seoul National University Hospital 35 participants Est. completion 2019-12 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02897167

    Study of the Activation of Proinflammatory Pathways of Toll-like Receptors in Schizophrenia Patients

    Fundación Marques de Valdecilla 150 participants Est. completion 2019-03 1 site
    Other conditions: Schizophrenia, Mental Disorders, Psychotic Disorders
    View official trial listing →
  • Status unknown NCT NCT02906501

    Effect of Risperidone on Cognitive Functions in Adolescents With ADHD and Behavioral Disturbances

    Shalvata Mental Health Center 45 participants Est. completion 2018-03 1 site
    Other conditions: ADHD
    View official trial listing →
  • Status unknown NCT NCT02907437

    Minocycline add-on to Antipsychotics for the Treatment of Negative and Cognitive Symptoms in Schizophrenia

    Not yet reported Beer Yaakov - Ness Ziona Mental Health Center 40 participants Est. completion 2018-01 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02909491

    Ionized Calcium and Behavioural Disorders in Older Adults (CALICO Study)

    University Hospital, Angers 90 participants Est. completion 2017-04-27 1 site
    Other conditions: Geriatric Disorders
    View official trial listing →
  • Completed NCT NCT02918370

    Aripiprazole for Bipolar Disorder and Alcohol Use Disorder

    Not yet reported University of Texas Southwestern Medical Center 75 participants Est. completion 2023-06-30 1 site
    Other conditions: Bipolar Disorder, Alcoholism, Alcohol Abuse
    View official trial listing →
  • Active, not recruiting NCT NCT02926859

    Enhancing Recovery in Early Schizophrenia

    Not yet reported Central Institute of Mental Health, Mannheim 180 participants Est. completion 2027-12 6 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02928965

    The Benefit of Minocycline on Negative Symptoms in Schizophrenia: Extent and Mechanisms

    Not yet reported University of Manchester 207 participants Est. completion 2016-05
    Other conditions: Schizophrenia and Disorders With Psychotic Features
    View official trial listing →
  • Status unknown NCT NCT02935998

    The Efficacy And Safety Of Intramuscular Ziprasidone For Three Days In Patients With Psychotic Agitation

    Not yet reported Yang Fude 1000 participants Est. completion 2017-12 1 site Stand-alone
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02949752

    Aripiprazole as an Adjunct to Atypical Antipsychotics for Weight Reduction and Improvement in Metabolic Profile

    Not yet reported Institute of Mental Health, Singapore 67 participants Est. completion 2020-01-01 1 site
    Other conditions: Antipsychotics Weight Gain
    View official trial listing →
  • Completed NCT NCT02953639

    A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics

    Not yet reported Hoffmann-La Roche 214 participants Est. completion 2019-12-12 37 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02958800

    Deprescribing Antipsychotics in Long-Term Care

    Not yet reported McMaster University 6 participants Est. completion 2019-08 1 site
    Other conditions: Dementia, Behavior
    View official trial listing →
  • Status unknown NCT NCT02964923

    Genes Polymorphisms and Metabolic Effects of the Second Generation Antipsychotic Drugs in Patients With Schizophrenia

    Xijing Hospital 300 participants Est. completion 2017-12 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02970292

    Efficacy and Safety of Adjunctive Pimavanserin for the Treatment of Schizophrenia (ENHANCE-1)

    Not yet reported ACADIA Pharmaceuticals Inc. 396 participants Est. completion 2019-06-25 105 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02970305

    Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE)

    Not yet reported ACADIA Pharmaceuticals Inc. 403 participants Est. completion 2019-10-28 101 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT02970721

    Use of Psychotropic Medications Among Pregnant Women With Bipolar Disorder

    Western University, Canada 3357 participants Est. completion 2018-05
    Other conditions: Bipolar Disorder, Pregnancy Complications
    View official trial listing →
  • Completed NCT NCT02983188

    Berberine as Adjuvant Treatment for Schizophrenia Patients

    Not yet reported, Not yet reported The University of Hong Kong 113 participants Est. completion 2021-01-04 1 site
    Metabolic syndrome Other conditions: Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
    View official trial listing →
  • Status unknown NCT NCT02986490

    Magnesium Variations and Cardiometabolic Risk in Patients With Antipsychotic Drugs

    Not yet reported University Hospital, Montpellier 100 participants Est. completion 2017-12 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT03005769

    Demographic and Clinical Predictors of Persistence in Patients Treated With Aripiprazole Once-monthly in Italy

    Otsuka Pharmaceutical Europe Ltd 262 participants Est. completion 2017-07 20 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT03007303

    The Relevance Between the microRNA-30e in Plasma and the Prognosis of Schizophrenia Patients

    Dalian Seventh People's Hospital 30 participants Est. completion 2020-07 1 site
    Other conditions: Schizophrenia, Micrognathia
    View official trial listing →
  • Completed NCT NCT03019887

    Correlation Between Cognitive Function and Relapse of Schizophrenia Regarding Dose Reduction

    Not yet reported Juntendo University 139 participants Est. completion 2017-01
    Other conditions: Schizophrenia Relapse
    View official trial listing →
  • Status unknown NCT NCT03062033

    Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents

    Neurocrine Biosciences 70 participants Est. completion 2018-08 34 sites
    Other conditions: Tardive Dyskinesia
    View official trial listing →
  • Status unknown NCT NCT03080194

    The Effect of a Community-based LAI-treated Management Model on the Violence Risk of Patients With Schizophrenia

    Not yet reported Maosheng Fang 150 participants Est. completion 2018-04
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT03090490

    10-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals

    Not yet reported Fundación Marques de Valdecilla 68 participants Est. completion 2020-12 1 site
    Other conditions: Schizophrenia, Schizophrenia Relapse, Schizophrenia Spectrum and Other Psychotic Disorders
    View official trial listing →
  • Status unknown NCT NCT03090503

    Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 3-year Follow-up

    Not yet reported Fundación Marques de Valdecilla 200 participants Est. completion 2021-06 1 site
    Other conditions: Schizophrenia, Psychotic Disorders, Psychosis
    View official trial listing →
  • Completed NCT NCT03093467

    Effectiveness of an Internet-based Intervention for the Treatment of Depression

    Not yet reported Instituto Milenio para Investigación en Depresión y Personalidad 167 participants Est. completion 2019-11-13 1 site
    Other conditions: Depression
    View official trial listing →
  • Completed NCT NCT03101319

    Role of Vitamin D Supplementation in Schizophrenia

    Not yet reported Central Institute of Psychiatry, Ranchi, India 73 participants Est. completion 2021-06-22 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT03110471

    Nurse-led Medicines' Monitoring in Care Homes: a Process Evaluation

    Swansea University 60 participants Est. completion 2018-03-30 10 sites
    Other conditions: Dementia
    View official trial listing →
  • Completed NCT NCT03116100

    Clinical Situations Leading to the Prescription of Neuroleptics by General Practitioner in the Elderly. Practice Survey

    Centre Hospitalier Universitaire, Amiens 30 participants Est. completion 2017-10-15 1 site
    Other conditions: Behavior Disorders, Neuroleptic
    View official trial listing →
  • Terminated NCT NCT03121586

    Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia

    Not yet reported ACADIA Pharmaceuticals Inc. 995 participants Est. completion 2024-05-30 161 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT03125252

    Impact of Non-pharmacological Prevention Measures on the Incidence of Delirium in Adult Intensive Care Units

    Not yet reported University Hospital, Toulouse 379 participants Est. completion 2020-11 14 sites
    Other conditions: Delirium
    View official trial listing →
  • Status unknown NCT NCT03130465

    Aripiprazole Once-monthly Versus Daily Oral Atypical Antipsychotic Treatment in Patients With Recent-onset Schizophrenia

    Otsuka Pharmaceutical Europe Ltd 636 participants Est. completion 2020-01-31 67 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT03130478

    Predictors of Persistence in Patients With Schizophrenia Treated With Once-monthly Aripiprazole in Spain

    Otsuka Pharmaceutical Europe Ltd 119 participants Est. completion 2018-07-30 15 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT03147521

    Accidental Falls Care Bundle

    Not yet reported IRCCS Azienda Ospedaliero-Universitaria di Bologna 10000 participants Est. completion 2017-01-31
    Other conditions: Accidental Falls
    View official trial listing →
  • Completed NCT NCT03148639

    Virtual Reality Therapy for Treatment-resistant Auditory Hallucinations in Schizophrenia

    Not yet reported Ciusss de L'Est de l'Île de Montréal 19 participants Est. completion 2017-12-02 1 site
    Alcohol use disorder Other conditions: Treatment-resistant Schizophrenia
    View official trial listing →
  • Terminated NCT NCT03152292

    The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice) Study

    ACADIA Pharmaceuticals Inc. 764 participants Est. completion 2021-03-08 69 sites
    Other conditions: Parkinson Disease Psychosis
    View official trial listing →
  • Status unknown NCT NCT03155685

    Use of Antipsychotics in Palliative Care (NEUROPAL)

    University Hospital, Caen 100 participants Est. completion 2018-05
    Other conditions: Antipsychotics in Palliative Care
    View official trial listing →
  • Status unknown NCT NCT03192631

    Financial Incentives to Improve Acceptance of Antipsychotic Injections

    Not yet reported Focus Community Mental Health Team 20 participants Est. completion 2021-12-31
    Other conditions: Schizophrenia, Schizo Affective Disorder, Bipolar I Disorder
    View official trial listing →
  • Status unknown NCT NCT03237052

    Validating and Optimizing Model of Antipsychotics Selection

    Not yet reported Shanghai Mental Health Center 2000 participants Est. completion 2020-12 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT03248180

    Guided Dose Reduction of Antipsychotic in Patients With Psychosis in Remitted States

    National Taiwan University Hospital 160 participants Est. completion 2020-12-31 1 site
    Other conditions: Psychosis, Remission
    View official trial listing →
  • Status unknown NCT NCT03284294

    Influence of Vitamin D Supplementation on Serum BDNF Level and Cognitive Function in Schizophrenia

    Not yet reported Universitas Padjadjaran 40 participants Est. completion 2020-12
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT03319953

    A Randomized, Double-Blind, Placebo Controlled, Two-Period Cross-Over, Proof of Activity Study to Evaluate the Effects of TAK-041 on Motivational Anhedonia as Add-On to Antipsychotics in Participants With Stable Schizophrenia

    Not yet reported Neurocrine Biosciences 23 participants Est. completion 2019-11-06 1 site
    Other conditions: Stable Schizophrenia
    View official trial listing →
  • Terminated NCT NCT03351244

    This Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months

    Not yet reported Boehringer Ingelheim 264 participants Est. completion 2021-03-31 59 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Withdrawn NCT NCT03360474

    Implementation of a Delirium Screening

    Not yet reported University of Miami Est. completion 2018-12
    Other conditions: Delirium, Cancer, Bone Marrow Ablation
    View official trial listing →
  • Status unknown NCT NCT03369795

    Add-on Methotrexate for the Treatment of Schizophrenia

    Not yet reported Sheba Medical Center 100 participants Est. completion 2020-01-01
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT03376763

    MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical Antipsychotics

    Not yet reported Korea Otsuka Pharmaceutical Co., Ltd. 201 participants Est. completion 2021-11-19 27 sites
    Other conditions: Schizophrenia, Antipsychotics, Long-Acting Injection, LAI, Aripiprazole
    View official trial listing →
  • Completed NCT NCT03388554

    The Effects of tDCS on Auditory Hallucination, Insight, Neurocognitive Function and HRV in Patients With Schizophrenia

    Not yet reported Tri-Service General Hospital (TSGH) 60 participants Est. completion 2018-03-02 1 site
    Alcohol use disorder Other conditions: Schizophrenia, Schizoaffective Disorder, Neurocognitive Dysfunction, Autonomic Imbalance, Psychosocial Impairment, Quality of Life
    View official trial listing →
  • Completed NCT NCT03389425

    Application of the SIMPLE Program for Weight Loss at Pathways to Housing: A Feasibility Study

    Not yet reported University of Calgary 9 participants Est. completion 2015-10-08
    Other conditions: Obesity, Abdominal Obesity
    View official trial listing →
  • Status unknown NCT NCT03390712

    Mirror-image Study of Paliperidone Palmitate and Risperidone Long-acting Injection

    Réseau de Santé Vitalité Health Network 328 participants Est. completion 2018-12 4 sites
    Other conditions: Schizophrenia Spectrum and Other Psychotic Disorders
    View official trial listing →
  • Completed NCT NCT03408873

    CAE Plus LAI in Individuals With Bipolar Disorder at Risk for Treatment Non-adherence (BD-CAEL)

    Not yet reported Martha Sajatovic 30 participants Est. completion 2020-05-06 1 site
    Other conditions: Bipolar Disorder, Medication Adherence, Medication Non Adherence
    View official trial listing →
  • Active, not recruiting NCT NCT03414151

    Gut Microbiome in AP Naive

    Centre for Addiction and Mental Health 25 participants Est. completion 2026-08 1 site
    Other conditions: Psychotic Disorder, Schizophrenia
    View official trial listing →
  • Completed NCT NCT03418675

    Brexpiprazole in Borderline Personality Disorder

    Not yet reported University of Chicago 80 participants Est. completion 2021-04-14 1 site
    Other conditions: Borderline Personality Disorder
    View official trial listing →
  • Completed NCT NCT03427892

    Brexpiprazole for Bipolar Depression

    Not yet reported University of Texas Southwestern Medical Center 21 participants Est. completion 2018-03-15 1 site
    Other conditions: Bipolar Depression
    View official trial listing →
  • Completed NCT NCT03430596

    a Pilot Study of Pramipexole to Treat Extrapyramidal Symptoms Induced by Antipsychotics

    Not yet reported Shanghai Mental Health Center 50 participants Est. completion 2021-12-30 1 site
    Other conditions: Extrapyramidal Syndrome
    View official trial listing →
  • Status unknown NCT NCT03434210

    The Effect of a Community-based LAT-treated Management Model on the Violence Risk of Patients With Schizophrenia

    Not yet reported Yi Li MD, PhD 110 participants Est. completion 2020-10 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Active, not recruiting NCT NCT03442101

    Trajectories of Treatment Response as Window Into the Heterogeneity of Psychosis: a Longitudinal Multimodal Imaging Study

    University of Alabama at Birmingham 156 participants Est. completion 2026-12-31 1 site
    Other conditions: Psychosis
    View official trial listing →
  • Completed NCT NCT03448575

    Safer Use of Antipsychotics in Youth

    Not yet reported Kaiser Permanente 733 participants Est. completion 2021-12-24 4 sites
    Other conditions: Child Behavior Disorders
    View official trial listing →
  • Completed NCT NCT03451734

    Optimizing and Individualizing the Pharmacological Treatment of First-episode Schizophrenic Patients

    Central South University 2000 participants Est. completion 2021-06-30 1 site
    Metabolic syndrome Other conditions: Schizophrenia
    View official trial listing →
  • Terminated NCT NCT03471013

    Impact of Caregiver Beliefs on Adherence to Antipsychotic Medications in Patients With Schizophrenia

    University Hospital, Clermont-Ferrand 50 participants Est. completion 2026-02-02 1 site
    Other conditions: DSM-5 Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT03481192

    Voluntary Drug Poisoning by Psychoactive Molecules: Identify Cognitive Markers

    Not yet reported University Hospital, Toulouse 103 participants Est. completion 2019-01 1 site
    Other conditions: Suicide, Drug Poisoning
    View official trial listing →
  • Status unknown NCT NCT03481465

    Searching for Early Biomarkers of Long-term Hepatic, Metabolic and Endothelial Dysfunction in Non-affective Psychosis

    Fundación Marques de Valdecilla 200 participants Est. completion 2020-12 1 site
    Metabolic syndrome Other conditions: Schizophrenia, Psychosis
    View official trial listing →
  • Completed NCT NCT03510325

    Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments(SMART-CAT)

    Not yet reported Shanghai Mental Health Center 762 participants Est. completion 2023-09-27 7 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT03522168

    Long-term Antipsychotic Pediatric Safety Trial

    Duke University 509 participants Est. completion 2023-11-21 37 sites
    Other conditions: Weight, Body
    View official trial listing →
  • Completed NCT NCT03526354

    Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder

    Not yet reported University of Massachusetts, Worcester 50 participants Est. completion 2024-02-29 4 sites
    Substance use disorder Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT03535636

    Sleep Impairments in Refugees Diagnosed With PTSD

    Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital 40 participants Est. completion 2023-02-07 1 site
    Other conditions: PTSD, Sleep Disorder
    View official trial listing →
  • Completed NCT NCT03537040

    Piloting MOL Intervention for Neuroleptic Decision Making

    Not yet reported University of Manchester 5 participants Est. completion 2019-05-10 2 sites
    Other conditions: Psychosis, Medication Adherence
    View official trial listing →
  • Terminated NCT NCT03537547

    Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive Disorder

    Not yet reported Washington University School of Medicine 6 participants Est. completion 2019-08-19 1 site
    Other conditions: Major Depressive Disorder, Depression, Depressive Disorder, Depressive Episode, Depression, Unipolar
    View official trial listing →
  • Completed NCT NCT03548155

    Berberine Effects on Clinical Symptoms and Metabolic Disturbance in Patients With Schizophrenia

    Not yet reported Tianjin Anding Hospital 65 participants Est. completion 2017-05-08
    Other conditions: Schizophrenia, Therapeutics
    View official trial listing →
  • Completed NCT NCT03557593

    Optimizing Prescribing of Antipsychotics in Long-Term Care

    Not yet reported Queen's University Est. completion 2017-12
    Other conditions: Dementia
    View official trial listing →
  • Completed NCT NCT03557931

    A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication

    Not yet reported Astellas Pharma Global Development, Inc. 233 participants Est. completion 2019-10-21 27 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT03559426

    Research Into Antipsychotic Discontinuation and Reduction Trial

    Not yet reported University College, London 253 participants Est. completion 2022-03-10 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Delusional Disorder, Schizophreniform Disorders
    View official trial listing →
  • Completed NCT NCT03565068

    A Safety, Tolerability, and Pharmacokinetics Study of MK-8189 in Participants With Schizophrenia and in Healthy Participants (MK-8189-007)

    Not yet reported Merck Sharp & Dohme LLC 75 participants Est. completion 2020-04-03 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT03568500

    A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 44 participants Est. completion 2019-09-06 5 sites
    Other conditions: Schizophrenia, Schizoaffective Disorder, First Episode Psychosis
    View official trial listing →
  • Terminated NCT NCT03628391

    Haloperidol for Delirium in Adult Critically Ill Patients

    Not yet reported Erasmus Medical Center 142 participants Est. completion 2021-01-23 8 sites
    Other conditions: Delirium, Critical Illness, Intensive Care Psychosis, Cognitive Impairment, Cognitive Decline
    View official trial listing →
  • Completed NCT NCT03629951

    A Study for Schizophrenia Relapse Prediction

    Janssen Research & Development, LLC 333 participants Est. completion 2021-12-31 10 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT03639558

    TREC-Lebanon: A Trial for Rapid Tranquilisation for Agitated Patients in the Emergency Setting

    Not yet reported Joseph Dib 100 participants Est. completion 2019-07-07 2 sites
    Other conditions: Psychiatric Emergency, Aggression, Agitation
    View official trial listing →
  • Terminated NCT NCT03643159

    A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 2 participants Est. completion 2018-10-17 5 sites
    Other conditions: Schizophrenia, Bipolar 1 Disorder, Major Depressive Disorder
    View official trial listing →
  • Status unknown NCT NCT03651674

    Longitudinal Effect of Electroconvulsive Therapy on Schizophrenia and Bipolar Disorder: a MRI Study

    Not yet reported Xidian University 200 participants Est. completion 2020-04-01
    Other conditions: Schizophrenia, Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT03663465

    The Effect of Hawthorn on Lipoprotein Cholesterol Ratio in Schizophrenics With Antipsychotics

    Not yet reported Calo Psychiatric Center 135 participants Est. completion 2014-07-31
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT03666715

    A Study to Analyze the Impact of Treatment With Paliperidone Palmitate on Clinical Outcomes and Hospital Resource Utilization in Adult Participants With Schizophrenia in Portugal

    Janssen-Cilag Farmaceutica Ltda. 55 participants Est. completion 2021-05-31 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT03675750

    Effects of Hyperprolactinemia Induced by Antipsychotic Drugs on Bone Metabolism

    Shanghai Mental Health Center 120 participants Est. completion 2020-10-31 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT03692182

    The Use of Antipsychotics in the Program of All-inclusive Care for the Elderly (PACE)

    Tabula Rasa HealthCare 10000 participants Est. completion 2019-03 1 site
    Other conditions: Behavioral and Psychiatric Symptoms of Dementia
    View official trial listing →
  • Status unknown NCT NCT03693794

    A Study in Italy About Evidence Based Psychosocial/Rehabilitative Interventions in Patients With Early Schizophrenia Treated Continuously With Antipsychotics

    Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 270 participants Est. completion 2020-12-01 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT03695289

    Interactive Obesity Treatment Approach (iOTA) for Obesity Prevention in Serious Mental Illness

    Not yet reported Washington University School of Medicine 30 participants Est. completion 2020-06-25 1 site
    Other conditions: Obesity, Mentally Ill Persons
    View official trial listing →
  • Completed NCT NCT03701100

    The Effects of Bimodal tDCS on Illness Severity, Insight, Functional Outcomes, Neurocognition and HRV in Schizophrenia

    Not yet reported Tri-Service General Hospital (TSGH) 60 participants Est. completion 2018-09-21 1 site
    Other conditions: Schizophrenia, Insight Impaired, Psychotic Symptoms, Schizoaffective Disorder, Neurocognitive Dysfunction, Autonomic Imbalance, Psychosocial Impairment, Quality of Life
    View official trial listing →
  • Status unknown NCT NCT03708549

    Comparison of Berberine and Metformin for the Treatment for MS in Schizophrenia Patients

    Not yet reported Tianjin Anding Hospital 100 participants Est. completion 2023-12-01 1 site
    Metabolic syndrome Other conditions: Schizophrenia, Berberine, Metformin
    View official trial listing →
  • Status unknown NCT NCT03708614

    A Study Looking at How Well Children With Autism Spectrum Disorder on Medications Like Having More Protein

    Not yet reported Holland Bloorview Kids Rehabilitation Hospital 10 participants Est. completion 2020-06 1 site
    Other conditions: Autism Spectrum Disorder
    View official trial listing →
  • Suspended NCT NCT03718156

    The Prevention Program for Alzheimer's Related Delirium (PREPARED) Trial

    Not yet reported McGill University 800 participants Est. completion 2026-06 6 sites
    Other conditions: Delirium, Dementia
    View official trial listing →
  • Completed NCT NCT03730857

    Early Predictors of Poor Treatment Response in Patients With Schizophrenia Treated With Atypical Antipsychotics

    Not yet reported Calo Psychiatric Center 111 participants Est. completion 2008-12
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT03741478

    Intranasal Insulin and Olanzapine Study in Healthy Volunteers

    Not yet reported Centre for Addiction and Mental Health 46 participants Est. completion 2026-06-01 2 sites
    Other conditions: Healthy Controls
    View official trial listing →
  • Completed NCT NCT03749629

    Comparative Effectiveness of Pharmacogenomics for Treatment of Depression

    Not yet reported Massachusetts General Hospital 201 participants Est. completion 2022-03-15 1 site
    Other conditions: Major Depressive Disorder
    View official trial listing →
  • Completed NCT NCT03772951

    The Efficacy of Computerized Cognitive Remediation Therapy for Chronic Schizophrenia

    Not yet reported Shanghai Mental Health Center 154 participants Est. completion 2021-03-31 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT03788759

    Alpha-lipoic Acid Adjunctive Therapy in Schizophrenia

    Not yet reported, Not yet reported Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara 48 participants Est. completion 2021-12-01 1 site
    Other conditions: Schizophrenia, Oxidative Stress
    View official trial listing →
  • Status unknown NCT NCT03790345

    Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics

    Not yet reported, Not yet reported Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara 45 participants Est. completion 2021-11-03 1 site
    Other conditions: Schizophrenia, Drug Induced Movement Disorder, Unspecified, Oxidative Stress
    View official trial listing →
  • Completed NCT NCT03818256

    A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Miricorilant (CORT118335) in Obese Adults With Schizophrenia or Bipolar Disorder Treated With Antipsychotic Medications

    Not yet reported Corcept Therapeutics 71 participants Est. completion 2022-07-06 27 sites
    Other conditions: Antipsychotic-induced Weight Gain (AIWG)
    View official trial listing →
  • Completed NCT NCT03822910

    Hippocampal Memory Circuits in Delusions

    NYU Langone Health 212 participants Est. completion 2023-08-12 3 sites
    Other conditions: Psychosis
    View official trial listing →
  • Completed NCT NCT03848234

    Estradiol Patch as add-on to Antipsychotics in Patients With Schizophrenia, Schizoaffective or Schizophreniform Disorder

    Not yet reported Tangent Data 209 participants Est. completion 2016-07-29 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorders
    View official trial listing →
  • Terminated NCT NCT03852706

    EEG-based Neurofeedback for Auditory Verbal Hallucinations (HALFEED)

    Not yet reported University of Dublin, Trinity College 4 participants Est. completion 2022-03-25 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT03863691

    Influence of Dopaminergic Blockade on Stress Responses, Motivation and Emotional Reactivity in Humans.

    Not yet reported Philipps University Marburg 85 participants Est. completion 2020-07-15 1 site
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT03865719

    Weight Management Intervention for Youth and Young Adults With Autism Spectrum Disorder

    Not yet reported University of Pittsburgh 10 participants Est. completion 2021-12-01 1 site
    Other conditions: Autism Spectrum Disorder
    View official trial listing →
  • Status unknown NCT NCT03883204

    Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 3-years Follow-up

    Not yet reported Fundación Marques de Valdecilla 115 participants Est. completion 2020-12 1 site
    Other conditions: Schizophrenia, Psychotic Disorders, Psychosis
    View official trial listing →
  • Completed NCT NCT03887754

    Therapeutic Issues for Autism

    Not yet reported Minia University 80 participants Est. completion 2018-12
    Other conditions: Autism Spectrum Disorder
    View official trial listing →
  • Terminated NCT NCT03892889

    A Trial in Adult Participants With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 277 participants Est. completion 2020-09-29 68 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT03955549

    Insight Enhancement Program vs. Metacognitive Training for Psychosis in Patients With Schizophrenia: A Three-Armed Comparative Randomized Controlled Trial

    Not yet reported Agiad Psychiatry Hospital 99 participants Est. completion 2021-01-30 1 site
    Other conditions: Schizophrenia Spectrum and Other Psychotic Disorders
    View official trial listing →
  • Status unknown NCT NCT03962426

    Efficacy of Social Cognitive Training (SCT) in Recent-onset Psychosis

    Not yet reported Ludwig-Maximilians - University of Munich 66 participants Est. completion 2020-02-29 1 site
    Other conditions: Psychosis
    View official trial listing →
  • Status unknown NCT NCT03972735

    Assessment of the Effectiveness of the NECT Program

    Not yet reported Hospital Center Alpes-Isère 120 participants Est. completion 2023-04-01 11 sites
    Other conditions: Schizophrenia, Bipolar Disorder, Borderline Personality Disorder, Social Function, Self-stigma
    View official trial listing →
  • Withdrawn NCT NCT03994965

    The Sub-Sero Study

    Not yet reported Bjorn H. Ebdrup Est. completion 2024-12-04
    Other conditions: Schizophrenia, Psychosis
    View official trial listing →
  • Completed NCT NCT04002258

    Prolactin Change in Chinese Patients With Schizophrenia After Antipsychotics Treatment

    Shanghai Mental Health Center 10363 participants Est. completion 2022-10-25 1 site
    Other conditions: Schizophrenia, Antipyretics Toxicity, Prolactin Excess
    View official trial listing →
  • Completed NCT NCT04002700

    A Study to Assess Stroke Risk Among Users of Typical Versus Atypical Antipsychotics Stratified by Broad Age Group

    Janssen Research & Development, LLC 1234412 participants Est. completion 2019-05-31 1 site
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT04010864

    A Study of Antipsychotics in Individuals at Clinical High-risk for Psychosis (the SHARP-2 Study)

    Shanghai Mental Health Center 600 participants Est. completion 2022-12 1 site
    Other conditions: Clinical High-risk
    View official trial listing →
  • Completed NCT NCT04038788

    Add-on HD Hf-tRNS Over Bilateral DLPFC for Treating Patients With Schizophrenia

    Not yet reported Tri-Service General Hospital (TSGH) 36 participants Est. completion 2019-05-17 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Psychotic Symptoms, Neurocognitive Dysfunction, Insight Impaired, Quality of Life, Psychosocial Impairment, Autonomic Imbalance, EEG With Abnormally Slow Frequencies
    View official trial listing →
  • Completed NCT NCT04038957

    A Clinical Study to Investigate the Effect of an Investigational Drug as an Added Medication to an Antipsychotic, in Adults With Schizophrenia, as Measured Positron Emission Tomography (PET) Imaging

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 22 participants Est. completion 2023-06-06 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT04064476

    The Effect of Long-acting Antipsychotics on Schizophrenia Patients With Violence Risk

    Huazhong University of Science and Technology 225 participants Est. completion 2021-09-15 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT04076371

    The Treatment Efficacy of Combination Atypical Antipsychotics With Sertraline in Patients With Schizophrenia

    Not yet reported Beijing HuiLongGuan Hospital 1640 participants Est. completion 2018-12
    Other conditions: Schizophrenia
    View official trial listing →
  • Withdrawn NCT NCT04087109

    MedSafer E-care: an Automated Deprescribing Solution (E-CARE Study)

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre Est. completion 2022-01-31 1 site
    Other conditions: Polypharmacy, Deprescribing, Adverse Drug Event
    View official trial listing →
  • Status unknown NCT NCT04093518

    Estradiol as add-on to Antipsychotics

    Not yet reported Tangent Data 100 participants Est. completion 2020-11-01 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorders
    View official trial listing →
  • Status unknown NCT NCT04181346

    Pregabalin for the Prevention of Chemotherapy Induced Nausea and Vomiting

    Not yet reported Faculdade de Medicina do ABC 82 participants Est. completion 2020-02-28 1 site
    Other conditions: Nausea
    View official trial listing →
  • Terminated NCT NCT04203056

    Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode

    Not yet reported University of California, Los Angeles 15 participants Est. completion 2022-10-01 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder, Depressive Type, Schizophreniform Disorder
    View official trial listing →
  • Completed NCT NCT04218981

    Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders

    Not yet reported Central South University 200 participants Est. completion 2023-12-31 1 site Stand-alone
    Other conditions: Common Mental Disorder
    View official trial listing →
  • Status unknown NCT NCT04224441

    Repurposing Chlorpromazine in the Treatment of Glioblastoma

    Not yet reported Marco G Paggi, MD, PhD 41 participants Est. completion 2022-12-15 3 sites
    Other conditions: Glioblastoma Multiforme, MGMT-Unmethylated Glioblastoma
    View official trial listing →
  • Completed NCT NCT04271046

    STAR Caregivers - Virtual Training and Follow-up

    Not yet reported Kaiser Permanente 67 participants Est. completion 2023-09-21 1 site
    Other conditions: Alzheimer Disease, Dementia, Caregiver Burnout
    View official trial listing →
  • Completed NCT NCT04280965

    Quetiapine Augmentation of PE Therapy for the Treatment of Co-occurring PTSD and Mild Traumatic Brain Injury

    Not yet reported The University of Texas Health Science Center at San Antonio 28 participants Est. completion 2022-10-17 1 site
    Other conditions: Post Traumatic Stress Disorder
    View official trial listing →
  • Withdrawn NCT NCT04288193

    Implementation of a Pharmacist-Driven Antipsychotic Deprescribing Initiative in the PACE Setting: A Pilot Study

    Tabula Rasa HealthCare Est. completion 2022-05-18 1 site
    Other conditions: Behavioral and Psychiatric Symptoms of Dementia, Insomnia
    View official trial listing →
  • Status unknown NCT NCT04291469

    Antipsychotic Effects of Probiotics and Prebiotics on Patients With Schizophrenia

    Not yet reported First Affiliated Hospital Xi'an Jiaotong University 200 participants Est. completion 2022-12 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT04312503

    Observational Study on the Effect of Switch to Lurasidone in Subjects With Schizophrenia"

    Aziende Chimiche Riunite Angelini Francesco S.p.A 95 participants Est. completion 2022-10-31 18 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT04317807

    R33: Levetiracetam in Early Psychosis

    Not yet reported NYU Langone Health 65 participants Est. completion 2025-04-10 1 site
    Other conditions: Early Psychosis
    View official trial listing →
  • Completed NCT NCT04327843

    Reducing the Burden of Chronic Psychotic Disorders in Tanzania (CAPACITY)

    Not yet reported Case Western Reserve University 22 participants Est. completion 2020-07-30 1 site
    Other conditions: Schizophrenia, Medication Nonadherence, Schizo Affective Disorder
    View official trial listing →
  • Status unknown NCT NCT04332601

    Assessment of the Efficacy of a Fatigue Management Therapy in Schizophrenia

    Not yet reported University Hospital, Montpellier 200 participants Est. completion 2025-11
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT04373590

    Decision-making and Decision Support Among Emerging Adults With First Episode Psychosis

    Not yet reported Temple University 18 participants Est. completion 2020-08-30 1 site
    Other conditions: Early Psychosis
    View official trial listing →
  • Status unknown NCT NCT04395326

    Monitoring of Metabolic Adverse Events of Second Generation Antipsychotics in a Naive Pediatric Population

    St. Justine's Hospital 120 participants Est. completion 2025-12-31 1 site
    Other conditions: Adverse Drug Event
    View official trial listing →
  • Status unknown NCT NCT04409626

    Hyponatraemia and Mortality in Schizophrenic and Bipolar Patients: Protocol for a Bayesian Causal Inference Study

    Zealand University Hospital 31740 participants Est. completion 2020-08
    Other conditions: Hyponatremia, SIADH
    View official trial listing →
  • Terminated NCT NCT04421456

    Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment

    Not yet reported Jazz Pharmaceuticals 95 participants Est. completion 2022-03-16 39 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT04446234

    Atypical Antipsychotics Influence on the Safety of the Heart and Monitoring Indicators Model Building

    Not yet reported Shanghai Mental Health Center 350 participants Est. completion 2022-12-31 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT04461119

    Study to Determine the Safety, Tolerability, and Efficacy of Evenamide in Patients With Chronic Schizophrenia

    Not yet reported Newron Pharmaceuticals SPA 138 participants Est. completion 2021-03-13 14 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT04524403

    A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)

    Not yet reported Corcept Therapeutics 150 participants Est. completion 2022-08-25 40 sites
    Other conditions: Antipsychotic-induced Weight Gain (AIWG)
    View official trial listing →
  • Status unknown NCT NCT04528095

    SMART Design to Compare Antipsychotic Treatments in Treatment-Resistant Schizophrenia

    Not yet reported Shanghai Mental Health Center 162 participants Est. completion 2022-12 1 site
    Other conditions: Treatment-resistant Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT04529226

    Study to Compare Clozapine vs Treatment as Usual in People With Intellectual Disability & Treatment-resistant Psychosis

    Not yet reported Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 75 participants Est. completion 2025-12-30 20 sites
    Other conditions: Psychosis, Intellectual Disability
    View official trial listing →
  • Completed NCT NCT04531982

    Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia

    Not yet reported ACADIA Pharmaceuticals Inc. 454 participants Est. completion 2024-02-19 102 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT04546178

    Psychotherapy for Psychosis, Adverse Events, and Substance Misuse

    Not yet reported Nova Scotia Health Authority 19 participants Est. completion 2023-09-30 1 site
    Other conditions: Psychotic Disorders, Stress Disorders, Traumatic, Substance Use
    View official trial listing →
  • Status unknown NCT NCT04562324

    Efficacy of Electroencephalography (EEG) Neurofeedback (NF) for the Treatment of Anxiety Disorder

    Not yet reported Tianjin Anding Hospital 60 participants Est. completion 2023-11 1 site
    Other conditions: Anxiety Disorder, Healthy
    View official trial listing →
  • Status unknown NCT NCT04575103

    Monitoring of Arrhythmias in Patients Treated With Antipsychotics

    Not yet reported Herlev and Gentofte Hospital 600 participants Est. completion 2024-12-31 18 sites
    Substance use disorder Other conditions: Arrythmia, Antipsychotics and Neuroleptics Toxicity
    View official trial listing →
  • Status unknown NCT NCT04602585

    The Effect of Psycho-education on Clinical Outcomes Among Patients With a First Episode Psychosis in Central Uganda

    Not yet reported Makerere University 80 participants Est. completion 2023-10-30
    Other conditions: Psychosis
    View official trial listing →
  • Status unknown NCT NCT04700930

    CBD Cigarettes Instead of Normal Cigarettes as Innovative Treatment for Schizophrenia

    Not yet reported Psychiatric Hospital of the University of Basel 31 participants Est. completion 2021-10-31 1 site
    Other conditions: Schizophrenia and Other Psychotic Disorders, Harm Reduction
    View official trial listing →
  • Completed NCT NCT04745026

    Trial to Investigate the Safety and Efficacy of Cannabidiol Oral Solution (GWP42003-P; CBD-OS) in Children and Adolescents With Autism Spectrum Disorder

    Not yet reported Jazz Pharmaceuticals 103 participants Est. completion 2023-12-21 23 sites
    Other conditions: Autism Spectrum Disorder
    View official trial listing →
  • Withdrawn NCT NCT04761861

    Vildagliptin for Treatment of Antipsychotic-induced Dyslipidemia

    Not yet reported Sadat City University Est. completion 2025-12-31 1 site
    Other conditions: Schizophrenia, Dyslipidemias
    View official trial listing →
  • Terminated NCT NCT04771299

    Assessing the Role of Cariprazine in Improving Cognition in Euthymic Bipolar Patients

    Not yet reported Lakshmi N Yatham 1 participants Est. completion 2024-09-08 1 site
    Other conditions: Bipolar I Disorder, Cognitive Impairment
    View official trial listing →
  • Status unknown NCT NCT04807634

    Role of Intravenous Lipid Emulsion in Improving Coma of Acute Antipsychotics Poisoning

    Not yet reported Ain Shams University 30 participants Est. completion 2021-09 1 site
    Other conditions: Coma
    View official trial listing →
  • Completed NCT NCT04851691

    An Electronic Clinical Decision Support Tool to Reduce Low-value Antipsychotic Prescriptions

    Not yet reported University of California, Los Angeles 158 participants Est. completion 2023-08-14 1 site
    Other conditions: Alzheimer Disease, Dementia Alzheimers, Dementia of Alzheimer Type
    View official trial listing →
  • Completed NCT NCT04856124

    Intranasal Esketamine to Maintain the Antidepressant Response to IV Racemic Ketamine

    Psych Atlanta 10 participants Est. completion 2021-03-01 1 site
    Other conditions: Treatment Resistant Depression
    View official trial listing →
  • Completed NCT NCT04860830

    CONNEX-3: A Study to Test Whether Iclepertin Improves Learning and Memory in People With Schizophrenia

    Not yet reported Boehringer Ingelheim 609 participants Est. completion 2024-11-20 110 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT04892199

    Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?

    Not yet reported Anders Fink-Jensen, MD, DMSci 104 participants Est. completion 2026-08-01 3 sites
    Type 2 diabetes Other conditions: Metabolic Disturbance, Schizophrenia, Clozapine, GLP-1, Olanzapine
    View official trial listing →
  • Status unknown NCT NCT04895488

    Cognitive Effects of Adjuvant Vortioxetine in Early Schizophrenia

    Not yet reported, Not yet reported Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 37 participants Est. completion 2025-12-20 1 site
    Other conditions: Cognitive Impairment With Primary Psychotic Disorder, Negative Symptoms With Primary Psychotic Disorder
    View official trial listing →
  • Completed NCT NCT04898270

    Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia Patients

    Not yet reported Taichung Veterans General Hospital 30 participants Est. completion 2021-04-20 1 site
    Metabolic syndrome Other conditions: Schizophrenia; Psychosis, Flupentixol, Antipsychotic Agents, Central Nervous System Diseases, Clinical Therapy, Olanzapine, Quetiapine
    View official trial listing →
  • Completed NCT NCT04940039

    A Study to Assess the Treatment of Schizophrenia With Paliperidone Palmitate in Rwandan Healthcare Settings

    Not yet reported Janssen-Cilag International NV 93 participants Est. completion 2024-04-16 5 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Terminated NCT NCT04975035

    A Prospective, Open-ended, Multi-center Study of Schizophrenia Patients Switching to Zolodine

    Not yet reported, Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 200 participants Est. completion 2012-07-01
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT05022524

    Exploring Novel Uses of Microbiota Therapy for Managing the Side Effects of Psychiatric Pharmaceutical Interventions

    Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 10 participants Est. completion 2024-08-31 1 site
    Other conditions: Depression, Anxiety
    View official trial listing →
  • Completed NCT NCT05033119

    PROSA: Prolactin, Sex Hormones, Growth and Metabolic Biomarkers in Children and Adolescents on Antipsychotics

    Ulla Schierup Nielsen 90 participants Est. completion 2024-12-31 3 sites
    Metabolic syndrome Other conditions: Hyperprolactinemia, Puberty Disorders, Growth Disorders, Antipsychotics and Neuroleptics Toxicity
    View official trial listing →
  • Completed NCT NCT05039489

    A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia

    Not yet reported Central South University 200 participants Est. completion 2023-11-30 1 site Stand-alone
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT05110157

    Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for Schizophrenia

    Not yet reported Neurocrine Biosciences 442 participants Est. completion 2025-02-18 87 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT05146245

    Safety and Pharmacokinetics of Antipsychotics in Children 2: Studying TDM in an RCT

    Not yet reported Erasmus Medical Center 140 participants Est. completion 2024-05 1 site
    Other conditions: Autism Spectrum Disorder
    View official trial listing →
  • Completed NCT NCT05165316

    European Long-acting Antipsychotics in Schizophrenia Trial-II

    Rene Kahn 159 participants Est. completion 2026-02-13 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT05169268

    Real-life Assessment of Abilify Maintena + Rexult in Schizophrenia

    The University of Hong Kong 6 participants Est. completion 2026-01-31 1 site
    Other conditions: Schizophrenia and Related Disorders, Anxiety Depression
    View official trial listing →
  • Completed NCT NCT05172687

    The Effect of De-Prescribing Antipsychotics on Health and Quality of Life for People With Dementia

    Columbia University 336460 participants Est. completion 2018-12-31 3 sites
    Other conditions: Alzheimer Disease, Dementia, Prescribing, Off-Label
    View official trial listing →
  • Completed NCT NCT05243251

    Olanzapine Anorexia Cachexia

    Not yet reported Cairo University 164 participants Est. completion 2022-12-14 1 site
    Other conditions: Anorexia
    View official trial listing →
  • Terminated NCT NCT05259631

    Inhalational (Sevoflurane) Versus Intravenous (Propofol) Sedation in Adults With a Moderate Form of ARDS

    Not yet reported Negovsky Reanimatology Research Institute 2 participants Est. completion 2023-01-20 1 site
    Other conditions: Acute Respiratory Distress Syndrome
    View official trial listing →
  • Completed NCT NCT05281640

    Psychological Interventions for Complex PTSD And Schizophrenia-Spectrum Disorder: PICASSO Trial

    Not yet reported Edinburgh Napier University 57 participants Est. completion 2023-08-31 2 sites
    Other conditions: Psychosis, Complex Post-Traumatic Stress Disorder, Schizophrenia
    View official trial listing →
  • Completed NCT NCT05326347

    A Long-term Administration Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia

    Not yet reported Otsuka Pharmaceutical Co., Ltd. 247 participants Est. completion 2025-09-30 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Active, not recruiting NCT NCT05333003

    Semaglutide in Comorbid Schizophrenia Spectrum Disorder and Obesity

    Not yet reported Centre for Addiction and Mental Health 92 participants Est. completion 2026-08 1 site
    Other conditions: Schizophrenia Spectrum Disorders
    View official trial listing →
  • Completed NCT NCT05356013

    Caplyta in Borderline Personality Disorder

    Not yet reported University of Chicago 60 participants Est. completion 2025-12-31 1 site
    Other conditions: Borderline Personality Disorder
    View official trial listing →
  • Completed NCT NCT05390736

    Evaluating the Cost Effectiveness of STEADI

    Not yet reported National Opinion Research Center 780 participants Est. completion 2023-09-18 1 site
    Other conditions: Accidental Fall
    View official trial listing →
  • Completed NCT NCT05402111

    A Clinical Study That Will Assess How Food Moves Through the Stomach and Effects Blood Glucose Levels in Subjects With Schizophrenia Taking SEP-363856 or and Prior Antipsychotic (PA) Standard

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 31 participants Est. completion 2023-09-27 7 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Not yet recruiting NCT NCT05416658

    Shared Decision Making for Antipsychotic Medications

    Not yet reported New York State Psychiatric Institute 120 participants Est. completion 2027-06-30
    Other conditions: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorders, Delusional Disorder, Other Specified Schizophrenia Spectrum and Other Psychotic Disorder
    View official trial listing →
  • Completed NCT NCT05422131

    Clozapine Therapy Sample Collection - Method Comparison Study

    Saladax Biomedical, Inc. 153 participants Est. completion 2023-05-16 1 site
    Other conditions: Patients Prescribed Clozapine
    View official trial listing →
  • Withdrawn NCT NCT05433402

    Repurposing the Antipsychotic Drug Chlorpromazine as Adjuvant Therapeutic Agent for Resected Stage III Colon Cancer

    Not yet reported, Not yet reported Sadat City University Est. completion 2022-09-30 1 site
    Other conditions: Colon Cancer Stage III
    View official trial listing →
  • Completed NCT NCT05461885

    Value of Gym-based Exercise Training for Young Adults Receiving Antipsychotic Medication: The Vega Trial

    Not yet reported Copenhagen University Hospital, Rigshospitalet 226 participants Est. completion 2026-01-04 4 sites
    Other conditions: Affective Disorder, Psychosis
    View official trial listing →
  • Completed NCT NCT05463770

    A Clinical Study That Will Assess the Effect of SEP-363856 and Prior Antipsychotic (PA) Standard of Care on Glucose and Regulation of Insulin in Patients With Schizophrenia

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 15 participants Est. completion 2023-08-22 8 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT05473741

    Risk of Breakthrough Symptoms With Long-Acting Injectable Medications

    Centre for Addiction and Mental Health 51 participants Est. completion 2025-10-27 1 site
    Other conditions: Schizophrenia, Schizophrenia Relapse
    View official trial listing →
  • Status unknown NCT NCT05498441

    Personalized High-Definition Transcranial Direct Current Stimulation (HD-tDCS) Treatment for Major Depressive Episode

    Not yet reported Jiangsu Province Nanjing Brain Hospital 120 participants Est. completion 2024-12-31 1 site
    Other conditions: Major Depressive Episode
    View official trial listing →
  • Terminated NCT NCT05528224

    Effect of SC-ICBT for Adults With OCD:A Three-Arm Randomized Controlled Trial

    Not yet reported Shanghai Mental Health Center 46 participants Est. completion 2024-03-31 1 site
    Other conditions: Obsessive-Compulsive Disorder
    View official trial listing →
  • Status unknown NCT NCT05537558

    Precision Medicine for the Prediction of Treatment (PROMPT) Response (PROMPT)

    University Hospital Muenster 300 participants Est. completion 2024-01-09 1 site
    Other conditions: Major Depressive Disorder
    View official trial listing →
  • Completed NCT NCT05542264

    A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Body-weight Associated Parameters in Subjects With Schizophrenia

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 19 participants Est. completion 2024-02-12 4 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Not yet recruiting NCT NCT05545891

    Aripiprazole in Body Focused Repetitive Behaviors

    Not yet reported University of Chicago 100 participants Est. completion 2027-12 1 site
    Other conditions: Trichotillomania (Hair-Pulling Disorder), Dermatillomania
    View official trial listing →
  • Withdrawn NCT NCT05554627

    VA Aripiprazole vs Esketamine for Treatment Resistant Depression

    Not yet reported VA Office of Research and Development Est. completion 2023-10-27 26 sites
    Other conditions: Depressive Disorder, Major
    View official trial listing →
  • Terminated NCT NCT05603104

    Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure

    Not yet reported Dr. Inge Winter 1 participants Est. completion 2026-06-24 1 site
    Other conditions: Schizophrenia and Related Disorders, Major Depressive Disorder, Bipolar Depression
    View official trial listing →
  • Completed NCT NCT05628103

    A Clinical Study That Will Evaluate How Well SEP-363856 Works and How Safe it is in People With Schizophrenia That Switch to SEP-363856 From Their Current Antipsychotic Medication

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 101 participants Est. completion 2024-04-01 25 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT05633108

    A Study Based on the French National Health Insurance Database in Participants With Psychotic Disorders

    Eisai Co., Ltd. 579728 participants Est. completion 2023-09-30 1 site
    Other conditions: Psychotic Disorders
    View official trial listing →
  • Status unknown NCT NCT05646264

    A Study on the Efficacy of Agomelatine Combined With Antipsychotics to Treat Negative Symptoms in Schizophrenia

    Not yet reported Shanghai Mental Health Center 220 participants Est. completion 2023-08-01 1 site Stand-alone
    Other conditions: Schizophrenia, Negative Symptoms in Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT05647980

    Transmural Collaborative Care Model for CVRM and Medication Review for Patients Using Antipsychotics

    Not yet reported Radboud University Medical Center 480 participants Est. completion 2024-11-01 1 site
    Other conditions: Mental Disorders, Severe
    View official trial listing →
  • Completed NCT NCT05650788

    Exploration of Differences in Metabolite Concentrations by NMR Spectroscopy in the Ventral Striatum, Anterior Cingulate Cortex and Prefrontal Cortex in Euthymic Patients With Unipolar and Bipolar Type II Mood Disorders, as Well as in Healthy Subjects

    Not yet reported University Hospital, Clermont-Ferrand 60 participants Est. completion 2024-07-17 1 site
    Other conditions: Bipolar Disorder Type II, Mood Depressive Disorder
    View official trial listing →
  • Terminated NCT NCT05654870

    Study to Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as an Adjunctive Treatment for Schizophrenia

    Not yet reported Neurocrine Biosciences 8 participants Est. completion 2023-11-08 3 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Terminated NCT NCT05662306

    C-Cog in Early Course Schizophrenia Study

    Not yet reported University of Miami 1 participants Est. completion 2025-03-03 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT05663749

    Topiramate vs Metformin on Cardio-Metabolic Profile in Schizophrenia on Atypical Antipsychotics

    Not yet reported All India Institute of Medical Sciences, Bhubaneswar 60 participants Est. completion 2023-08-20 1 site
    Metabolic syndrome Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT05667961

    Predictors of Functional Remission in Discharged Patients With Schizophrenia After Long-term Drug Discontinuation

    Shanghai Mental Health Center 480 participants Est. completion 2025-03-31 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT05686772

    Prospective Multicenter Cohort Study Evaluating the Incidence and Risk Factors for Problem Gambling Among Young Adults With First-episode Psychosis

    Laval University 520 participants Est. completion 2023-05-01 2 sites
    Other conditions: Gambling Disorder, Psychotic Disorders
    View official trial listing →
  • Completed NCT NCT05690698

    Quetiapine Versus Haloperidol in the Management of Hyperactive Delirium

    Not yet reported Alexandria University 100 participants Est. completion 2023-07-15 1 site
    Other conditions: Hyperactive Delirium
    View official trial listing →
  • Completed NCT NCT05716802

    Dance/Movement Therapy for Bone Mineral Density in Schizophrenia

    Not yet reported Hebei Province Veterans Hospital 60 participants Est. completion 2022-07-12 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Terminated NCT NCT05741502

    An Exploratory Analysis of Immune and Inflammatory Response Associated With Clozapine

    Not yet reported Ohio State University 5 participants Est. completion 2026-01-23 1 site
    Other conditions: Treatment-resistant Schizophrenia
    View official trial listing →
  • Completed NCT NCT05741528

    An Extension Study to a Clinical Study That Will Continue to Evaluate the Effectiveness and Safety of SEP-363856 in People With Schizophrenia That Switch to SEP-363856 From Their From Their Current Antipsychotic Medication

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 75 participants Est. completion 2024-09-23 16 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Active, not recruiting NCT NCT05748990

    Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in Schizophrenia

    Not yet reported Centre for Addiction and Mental Health 20 participants Est. completion 2026-12-31 1 site
    Other conditions: Schizophrenia, Healthy
    View official trial listing →
  • Status unknown NCT NCT05762146

    Networked Drug REpurposing for Mechanism-based neuroPrOtection in Acute Ischaemic STROKE

    Not yet reported Maastricht University 28 participants Est. completion 2024-04-30 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT05766007

    Long-acting Injectable Antipsychotics for Mental Ill-Health in Pregnancy and Postpartum

    University of Liverpool 168 participants Est. completion 2025-11-21 6 sites
    Other conditions: Schizophrenia, Psychosis, Mania, Pregnancy, Drug Exposure in Utero, Drug Exposure Via Breast Milk, Antipsychotic Agents, Breastfeeding
    View official trial listing →
  • Completed NCT NCT05830708

    The Efficacy of Probiotics for the Treatment of Alcohol Use Disorder Among Adult Males

    Not yet reported Universiti Sains Malaysia 58 participants Est. completion 2024-06-30 1 site Stand-alone
    Alcohol use disorder
    View official trial listing →
  • Completed NCT NCT05838625

    Study of Two Digital Therapeutics for the Treatment of Experiential Negative Symptoms of Schizophrenia

    Not yet reported Click Therapeutics, Inc. 464 participants Est. completion 2025-07-23 54 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Not yet recruiting NCT NCT05850585

    A Study of the Efficacy of Fecal Microbiota Transplantation(FMT) in the Treatment of Schizophrenia

    Not yet reported First Affiliated Hospital Xi'an Jiaotong University 100 participants Est. completion 2026-12
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT05857566

    Effect of RDX-002 on Postprandial Triglycerides in Subjects Treated With Olanzapine

    Not yet reported Response Pharmaceuticals 24 participants Est. completion 2023-09-13 1 site
    Other conditions: Drug-induced Weight Gain
    View official trial listing →
  • Status unknown NCT NCT05872555

    Side Effects of Psychiatric Medications - a Nested Case Control Cohort Historical Prospective Study

    Mark Weiser, MD, Principal Investigator 22777 participants Est. completion 2025-01-01 1 site
    Other conditions: Psychotic Disorders
    View official trial listing →
  • Withdrawn NCT NCT05890768

    Relationship Between Efficacy of Lumateperone and Brain Glutamate and Dopamine

    Not yet reported University of New Mexico Est. completion 2024-02-28 1 site
    Other conditions: Psychosis
    View official trial listing →
  • Withdrawn NCT NCT05939765

    Pharmacologic Treatment in Legal Offenders With Schizophrenia, a Prospective Observational Mirror Image Study.

    Psychiatric University Hospital, Zurich Est. completion 2025-12-01 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Not yet recruiting NCT NCT05946486

    Evaluation of the Efficacy of Immunomodulatory Therapy in Case of Psychiatric Disorders With Proven Dysimmunity.

    Not yet reported University Hospital, Bordeaux 174 participants Est. completion 2026-12-15 9 sites
    Other conditions: Mental Disorder
    View official trial listing →
  • Status unknown NCT NCT05964790

    Safety, Tolerability, Pharmacokinetics and Efficacy Study of HS-10380 in Patients With Schizophrenia

    Not yet reported, Not yet reported Jiangsu Hansoh Pharmaceutical Co., Ltd. 112 participants Est. completion 2024-12-30
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT06011408

    Remote Monitoring and Detecting of Tardive Dyskinesia for Improving Patient Outcomes

    Not yet reported iRxReminder 300 participants Est. completion 2024-12-31 2 sites
    Other conditions: Tardive Dyskinesia
    View official trial listing →
  • Completed NCT NCT06040944

    Antipsychotic Induced Hyperprolactinemaia as Risk Factor for Periodontitis in Schizophrenic Patients

    Fayoum University 64 participants Est. completion 2022-11-01 1 site
    Other conditions: Schizophrenia Spectrum and Other Psychotic Disorders, Periodontal Diseases
    View official trial listing →
  • Status unknown NCT NCT06060886

    Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis

    Not yet reported Consorcio Centro de Investigación Biomédica en Red (CIBER) 244 participants Est. completion 2025-12-31
    MASLD Other conditions: Schizophrenia, Treatment-resistant Schizophrenia, Side Effect, Lipid Metabolism Disorders, Diabetes, Psychosis
    View official trial listing →
  • Completed NCT NCT06067984

    An Extension Study of a Second Course of a Digital Therapeutic for the Treatment of Experiential Negative Symptoms of Schizophrenia

    Not yet reported Click Therapeutics, Inc. 73 participants Est. completion 2025-08-22 1 site
    Other conditions: Schizophrenia, Negative Symptoms in Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT06107322

    Hematological Effects of Atypical Antipsychotics (AAPs) in a Geriatric Population: What is the Role of 5-HT2 Receptors

    University Hospital, Strasbourg, France 20 participants Est. completion 2024-03-23 1 site
    Other conditions: Neutropenia
    View official trial listing →
  • Withdrawn NCT NCT06107829

    Valbenazine Treatment of Tardive Dyskinesia in Adults With Intellectual/Developmental Disabilities

    Not yet reported Stephen Ruedrich Est. completion 2027-02 1 site
    Other conditions: Tardive Dyskinesia, Intellectual Disability, Developmental Disabilities
    View official trial listing →
  • Status unknown NCT NCT06125275

    Pattern of Acute Antipsychotic Drug- Toxicity in Children

    Assiut University 50 participants Est. completion 2026-02-28
    Other conditions: Antipsychotic Drug- Toxicity
    View official trial listing →
  • Completed NCT NCT06136936

    A Study to Evaluate the Overall Effects of Treatment With Abbreviated CT-156 in People With Schizophrenia

    Not yet reported Click Therapeutics, Inc. 53 participants Est. completion 2024-02-22 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT06159322

    Characterizing Response to Antipsychotics in Schizophrenia

    The Royal Ottawa Mental Health Centre 40 participants Est. completion 2024-01-30 1 site
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Status unknown NCT NCT06160869

    Effect of Acceptance and Commitment Therapy on Psychotic Severity

    Not yet reported Port Said University 76 participants Est. completion 2023-12-20 1 site
    Other conditions: Psychosis, Emotion Regulation, Recovery
    View official trial listing →
  • Completed NCT NCT06167577

    Dysbindin-antipsychotics Psychophamarcogenetics: a Mouse-human Translational Study Towards Personalized Healthcare in Bipolar Disorders

    Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 150 participants Est. completion 2023-11-08 1 site
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT06179108

    Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute Schizophrenia

    Not yet reported LB Pharmaceuticals Inc. 359 participants Est. completion 2024-12-04 25 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT06200584

    Synergistic Effect of Vitamin E & D in Reducing Risk of Effects Associated With Atypical Anti-psychotics

    Not yet reported Dr Rabia Arshad 140 participants Est. completion 2021-06-10 1 site
    Other conditions: Antipsychotics and Neuroleptics Toxicity
    View official trial listing →
  • Completed NCT NCT06236451

    Atypical Antipsychotic-induced Mitochondrial Dysfunction in Patients With Schizophrenia

    Not yet reported All India Institute of Medical Sciences, Bhubaneswar 60 participants Est. completion 2025-11-12 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT06238089

    Anti-psychotic Drug Prescribing Patterns Within Specialist Adult ID Services in England and Wales

    University of Plymouth 600 participants Est. completion 2024-04 8 sites
    Other conditions: Intellectual Disability
    View official trial listing →
  • Active, not recruiting NCT NCT06245213

    A Study of ANAVEX3-71 in Adults With Schizophrenia

    Not yet reported Anavex Life Sciences Corp. 71 participants Est. completion 2025-06-30 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Active, not recruiting NCT NCT06251635

    Effects of Antipsychotics on Brain Insulin Action in Females

    Not yet reported Centre for Addiction and Mental Health 15 participants Est. completion 2026-12-31 1 site
    Type 2 diabetes Other conditions: Insulin Resistance, Menstrual Cycle, Antipsychotics
    View official trial listing →
  • Status unknown NCT NCT06274255

    Serum Magnesium Level and Pediatric Migraine

    Mersin University 60 participants Est. completion 2024-05-15 4 sites
    Other conditions: Migraine, Magnesium, Pediatric
    View official trial listing →
  • Active, not recruiting NCT NCT06278246

    Investigating the Muscarinic System in Schizophrenia Using Positron Emission Tomography

    Centre for Addiction and Mental Health 58 participants Est. completion 2026-03 1 site
    Other conditions: Schizophrenia, Schizophreniform Disorders
    View official trial listing →
  • Status unknown NCT NCT06294353

    Study of Efficacy and Safety of WELT-ED for Eating Disorder (WCTP-ED-B-01)

    Not yet reported WELT corp 134 participants Est. completion 2024-08-30 2 sites
    Other conditions: Eating Disorders, Binge Eating, Binge-Eating Disorder
    View official trial listing →
  • Status unknown NCT NCT06301074

    The Phase I Study of HS-10509 in Chinese Adult Subjects

    Not yet reported Jiangsu Hansoh Pharmaceutical Co., Ltd. 80 participants Est. completion 2024-10 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT06326840

    Clinical Efficacy and Adverse Reactions of Antipsychotic Treatment

    Not yet reported Taipei Medical University Hospital 42 participants Est. completion 2011-06-10 1 site
    Other conditions: Metabolic Disturbance, Hyperprolactinemia, Schizophrenia
    View official trial listing →
  • Completed NCT NCT06331520

    NEPA Combined With Olanzapine, Dexamethasone-sparing for the Effect of CINV in Patients Receiving HEC Regimens

    Not yet reported Fudan University 644 participants Est. completion 2025-08-30 1 site
    Other conditions: Chemotherapy-induced Nausea and Vomiting, Highly Emetogenic Chemotherapy
    View official trial listing →
  • Active, not recruiting NCT NCT06357195

    DIAMOND-Lewy Guidelines for Antipsychotic Use in Older Patients

    Ohio State University 1000 participants Est. completion 2026-07-01 1 site
    Other conditions: Emergency Psychiatric, Cognition Disorder, Movement Disorders, Antipsychotics and Neuroleptics Toxicity, Dementia With Lewy Bodies, Alteration in Mental Status, Behavior, Aging
    View official trial listing →
  • Completed NCT NCT06410508

    Evaluation of a Brief Intervention to Improve Engagement in Early Intervention Services for Psychosis

    Not yet reported Nova Scotia Health Authority 33 participants Est. completion 2026-05-22 1 site
    Other conditions: Psychotic Disorders, Psychiatric Hospitalization, Engagement, Patient
    View official trial listing →
  • Active, not recruiting NCT NCT06433635

    Sequential Multiple Assignment Randomized Trial for Bipolar Depression

    Not yet reported Massachusetts General Hospital 2726 participants Est. completion 2030-02-28 18 sites
    Other conditions: Bipolar I Disorder, Depression
    View official trial listing →
  • Active, not recruiting NCT NCT06453174

    CLinical Utility of Early Intervention Including the 5-Step Precision Medicine (5SPM) Method in First-episode Psychosis: The CLUMP Project

    Instituto de Investigación Biomédica de Salamanca 300 participants Est. completion 2026-12-31 1 site
    Other conditions: Psychosis
    View official trial listing →
  • Active, not recruiting NCT NCT06474195

    Cue-based Intervention in Prospective Memory and Medication Adherence.

    Not yet reported University of Pittsburgh 104 participants Est. completion 2026-09-30 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Not yet recruiting NCT NCT06474286

    Prucalopride for Cognitive Functioning in Schizophrenia

    Not yet reported University of Pittsburgh 34 participants Est. completion 2028-12-31 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT06486948

    An Exploratory, Double-arm, 8-week Study to Explore the Feasibility and Acceptability of Abbreviated Treatment with CT-156 in People with Schizophrenia.

    Not yet reported Click Therapeutics, Inc. 58 participants Est. completion 2024-08-09 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Not yet recruiting NCT NCT06546475

    A Pilot Trial of Tapering Antipsychotics for Patients in Remitted Psychosis Co-administering With N-Acetylcysteine

    Not yet reported National Taiwan University Hospital 20 participants Est. completion 2027-07-31
    Other conditions: Psychosis
    View official trial listing →
  • Enrolling by invitation NCT NCT06558201

    Open Label Extension Study of NCT06221852

    Not yet reported Mclean Hospital 50 participants Est. completion 2027-12-30 1 site
    Other conditions: Bipolar I Disorder, Schizoaffective Disorder, Psychosis
    View official trial listing →
  • Status unknown NCT NCT06590298

    Evaluating the Effects of Adjunctive Aripiprazole on Weight and Metabolic Outcomes in Females

    Not yet reported Universiti Putra Malaysia 600 participants Est. completion 2025-04-10
    Metabolic syndrome Other conditions: Psychosis, Weight Gain
    View official trial listing →
  • Status unknown NCT NCT06643871

    Adapted Physical Activity Program for Patients Undergoing Antipsychotic Treatment of a First Episode of Psychosis

    Not yet reported Centre Hospitalier St Anne 40 participants Est. completion 2025-12-01
    Other conditions: Schizophrenia; Psychosis, Schizo Affective Disorder, First Episode Psychosis (FEP)
    View official trial listing →
  • Status unknown NCT NCT06650943

    Nursing Intervention in Weight and Metabolic Syndrome Management in First-episode Psychosis (MetaKOP)

    Not yet reported Hospital de Basurto 88 participants Est. completion 2026-06-30 1 site
    Metabolic syndrome Other conditions: First Episode Psychosis (FEP)
    View official trial listing →
  • Not yet recruiting NCT NCT06695676

    Effects of Lurasidone on Left Ventricle Systolic Functions

    Aydin Adnan Menderes University 62 participants Est. completion 2025-06-01 1 site
    Other conditions: Lurasidone Cardiotoxicity, Schizophrenia Patients, Bipolar Disorders
    View official trial listing →
  • Status unknown NCT NCT06703827

    Effects of Online Metacognitive Training Group on Distressing Beliefs

    Not yet reported City, University of London 72 participants Est. completion 2025-09-27 1 site
    Other conditions: Psychosis
    View official trial listing →
  • Active, not recruiting NCT NCT06754163

    Evaluating the Effect of the STEP@STAH Semaglutide Protocol on the Physical Health Measures of Atypical Antipsychotic-Treated Patients

    Not yet reported St Andrew's Healthcare 20 participants Est. completion 2027-12-30 1 site Added to GLP-1
    Other conditions: Obesity and Obesity-related Medical Conditions, Psychiatric Disorders
    View official trial listing →
  • Completed NCT NCT06787781

    Metabolic and Clinical Effect of Alpha-lipoic Acid Administration in Schizophrenic Subjects

    Not yet reported University of Messina 15 participants Est. completion 2021-12-31 1 site
    Other conditions: Metabolic Evaluation, Cardiac Complications
    View official trial listing →
  • Completed NCT NCT06807242

    Implementation of a Tool for Reduction of Cardiovascular Risk in Patients with Severe Mental Disorders ( HEALTHYHEART )

    Oslo University Hospital 270 participants Est. completion 2019-12 1 site
    Other conditions: Schizophrenic Psychoses, Schizophrenia, Severe Mental Disorder
    View official trial listing →
  • Active, not recruiting NCT NCT06838104

    Effect of Melatonin on Schizophrenic Symptoms: a Randomized Placebo-Controlled Trial

    Not yet reported Lahore General Hospital 76 participants Est. completion 2025-06-05 1 site
    Other conditions: Schizophrenia Disorders, Psychotic Disorder
    View official trial listing →
  • Active, not recruiting NCT NCT06869187

    Study of ABX-002 for the Adjunctive Treatment of Depressive Episodes Associated With Bipolar Disorder in Adults

    Not yet reported Autobahn Therapeutics, Inc. 35 participants Est. completion 2026-09-24 14 sites
    Other conditions: Bipolar Disorder Depression
    View official trial listing →
  • Withdrawn NCT NCT06878833

    A Study to Evaluate the Safety and Tolerability of Long-Acting Oral Risperidone (LYN-005) in Participants With Schizophrenia or Schizoaffective Disorder

    Not yet reported Lyndra Inc. Est. completion 2026-12-31
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Not yet recruiting NCT NCT06924255

    An 8-week Open-label Study of an Accelerated and Slower Switching to Xanomeline/Trospium Following Atypical Antipsychotic Treatment in Participants With Schizophrenia

    Not yet reported Collaborative Neuroscience Research, LLC 100 participants Est. completion 2025-12 7 sites
    Other conditions: Schizophrenia Disorders
    View official trial listing →
  • Terminated NCT NCT06949657

    Occurrence and Influencing Factors of Cognitive Impairment in Elderly Patients With Schizophrenia and

    Not yet reported Third People's Hospital, Huzhou City, Zhejiang Province, China 78 participants Est. completion 2024-09-19 1 site
    Other conditions: Schizophrenia Disorders, Cognitive Impairment, Acceptance and Commitment Therapy
    View official trial listing →
  • Completed NCT NCT06993662

    The Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective.

    Not yet reported Rakitzi, Stavroula 107 participants Est. completion 2026-08-03 1 site
    Other conditions: Anxiety, Depression, Obsessive-compulsive Disorder, Personality Disorder, Bipolar Disorder, Schizophrenia, Psychotic Disorders, PTSD
    View official trial listing →
  • Not yet recruiting NCT NCT07001878

    Cannabis Potency Effects on Brain White Matter in Early Phase Psychosis

    Not yet reported Nova Scotia Health Authority 24 participants Est. completion 2027-12-01 2 sites
    Other conditions: Psychosis, Cannabis Use
    View official trial listing →
  • Not yet recruiting NCT NCT07011693

    Switching Medication and Augmentation Strategies for SSRI-Resistant Adolescent Depression(SMART-I)

    Not yet reported Xinyu Zhou 400 participants Est. completion 2027-12 1 site
    Other conditions: Major Depressive Disorder (MDD)
    View official trial listing →
  • Not yet recruiting NCT NCT07011953

    A Clinical Trial of Adjunctive Thyroxine for Avolition in Schizophrenia

    Not yet reported Peking University 90 participants Est. completion 2027-07-01
    Other conditions: Schizophrenia, Avolition
    View official trial listing →
  • Not yet recruiting NCT NCT07024303

    Measurement of Treatment Effects

    Not yet reported Matthew J O'Brien, PhD, BCBA-D 20 participants Est. completion 2027-12-31
    Other conditions: Challenging Behavior, Autism Spectrum Disorder
    View official trial listing →
  • Active, not recruiting NCT NCT07047651

    Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR.

    Not yet reported Dr. Stavroula Rakitzi 84 participants Est. completion 2027-12-20 1 site
    Other conditions: Treatment Resistant Schizophrenia, Treatment Resistant Bipolar Disorder
    View official trial listing →
  • Not yet recruiting NCT NCT07075237

    Efficacy and Functional Recovery After Switching From Paliperidone Palmitate Injection to Oral Antipsychotics in Schizophrenia

    Not yet reported Jiangsu Province Nanjing Brain Hospital 120 participants Est. completion 2027-03 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Not yet recruiting NCT NCT07086040

    Effects of RAS in SZ

    Not yet reported Shu-Mei Wang 140 participants Est. completion 2028-07-31 1 site
    Other conditions: Schizophrenia and Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT07102069

    Pharmacogenomic and Pharmacoepigenomic Studies of Antipsychotic Drugs in First-Episode Schizophrenia

    Tianjin Anding Hospital 384 participants Est. completion 2022-09-14 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Enrolling by invitation NCT NCT07130500

    Incentives and Long-Acting Injectable Adherence After Involuntary Hospitalization

    Not yet reported Stanford University 1000 participants Est. completion 2030-03 6 sites
    Substance use disorder Other conditions: Schizophrenia Disorder, Schizoaffective Disorder, Bipolar Disorder (BD)
    View official trial listing →
  • Not yet recruiting NCT NCT07134816

    Cost-utility Study of Cognitive-behavioral Management of Auditory Hallucinations in Schizophrenic Disorder

    Not yet reported University Hospital, Montpellier 240 participants Est. completion 2028-03 1 site
    Alcohol use disorder Other conditions: Schizophrenia Spectrum
    View official trial listing →
  • Not yet recruiting NCT NCT07152184

    Study Comparing Antipsychotic Dose Reduction vs. Maintenance Treatment in Patients With Schizophrenia Spectrum Disorder: a Personalized Medicine Approach

    Not yet reported University Hospital, Strasbourg, France 288 participants Est. completion 2032-02-01
    Other conditions: Patient With Schizophrenia Spectrum Disorder, NLM Classification WM 203, Psychology:Schizophrenic Psychology, Schizophrenia Spectrum and Other Psychotic Disorders
    View official trial listing →
  • Not yet recruiting NCT NCT07153835

    Efficacy and Safety of Paliperidone in Schizophrenia - Bangladesh Study

    Not yet reported Sher-E-Bangla Medical College 505 participants Est. completion 2026-07-31 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Enrolling by invitation NCT NCT07162467

    Tryptophan-Kynurenine Pathway Metabolism in the Pathophysiology of Cognitive Impairment in Schizophrenia.

    Tianjin Anding Hospital 200 participants Est. completion 2026-06-30 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Not yet recruiting NCT NCT07206563

    Penfluridol for Relapsed/Refractory Small Cell Cancers

    Not yet reported, Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 33 participants Est. completion 2028-10-01 1 site
    Other conditions: Small Cell Carcinoma, Small Cell Carcinoma of Lung, Small Cell Lung Cancer ( SCLC ), Small Cell Cervical Carcinoma
    View official trial listing →
  • Not yet recruiting NCT NCT07252752

    Dopamine and Insulin in Psychosis

    Not yet reported Medical University of Vienna 46 participants Est. completion 2029-01-01 1 site
    Other conditions: First Episode Psychosis (FEP)
    View official trial listing →
  • Not yet recruiting NCT NCT07342764

    Dapagliflozin Versus Metformin for the Management of Antipsychotic-Induced Weight Gain: A Pragmatic Pilot Randomized Controlled Trial

    Not yet reported Sultan Qaboos University 110 participants Est. completion 2028-12 1 site
    Other conditions: Antipsychotic-induced Weight Gain (AIWG), Antipsychotic-induced Weight Gain
    View official trial listing →
  • Active, not recruiting NCT NCT07351240

    The Acupuncture Treatment Effect in Patients With Schizophrenia

    Not yet reported Calo Psychiatric Center 100 participants Est. completion 2026-12-30 1 site
    Other conditions: Mental Health
    View official trial listing →
  • Enrolling by invitation NCT NCT07356765

    Berberine in Treating Negative Symptoms of Schizophrenia: Clinical Efficacy and Mechanisms

    Not yet reported Tianjin Anding Hospital 120 participants Est. completion 2027-04-30 1 site
    Other conditions: Schizophrenia, Negative Symptoms of Schizophrenia
    View official trial listing →
  • Completed NCT NCT07359209

    Berberine Improving Cognitive Impairments in Schizophrenia

    Not yet reported Tianjin Anding Hospital 124 participants Est. completion 2026-04-23 1 site
    Other conditions: Schizophrenia Therapeutics
    View official trial listing →
  • Completed NCT NCT07371325

    Efficacy of Pediococcus Acidilactici as add-on to Antipsychotic Drugs on Metabolic Syndrome Disturbances in First-episode Psychosis and Schizophrenia Spectrum Disorders.

    Not yet reported Manuel Jesús Cuesta Zurita 36 participants Est. completion 2026-01-23 1 site
    Other conditions: SCHIZOPHRENIA 1 (Disorder), Metabolic Abnormalities, Postbiotic Supplement
    View official trial listing →
  • Not yet recruiting NCT NCT07386080

    Carbergoline for Antipsychotic Induced Hyperprolactinemia.

    Not yet reported Zealand University Hospital 146 participants Est. completion 2029-05-01 1 site
    Other conditions: Scizophrenia
    View official trial listing →
  • Not yet recruiting NCT NCT07386483

    Strategic Timing of Resistance Training to Guard Against Antipsychotic-Induced Metabolic Syndrome

    Not yet reported University College Dublin 40 participants Est. completion 2028-04-30 1 site
    Other conditions: Psychosis
    View official trial listing →
  • Completed NCT NCT07392489

    Decreasing Harms and Improving Child Health

    Not yet reported Glyn Jones-Elwyn 31 participants Est. completion 2025-02-12 4 sites
    Other conditions: Psychotropic Drugs, Psychiatric Drugs, Children, Shared Decision Making, Patient Decision Aid
    View official trial listing →
  • Completed NCT NCT07432763

    Effects of Pomegranate Seed Oil Supplementation in Patients With Advanced Dementia

    Not yet reported Panhellenic Federation of Alzheimer's Disease and Related Disorders 18 participants Est. completion 2024-10-31 1 site
    Other conditions: Urinary Tract Infections (UTIs), Urinary Tract Infection, Recurrent, Antipsychotics Discontinuation, Antipsychotics Tapering
    View official trial listing →
  • Completed NCT NCT07445217

    Predictive Validity of the Personal and Social Performance Scale for PANSS Outcomes in Schizophrenia

    Not yet reported Calo Psychiatric Center 763 participants Est. completion 2008-09-04 1 site
    Other conditions: Functional Outcomes
    View official trial listing →
  • Not yet recruiting NCT NCT07445802

    Medication Adherence in Severe Mental Illness: a Promotion Program

    Not yet reported Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 1640 participants Est. completion 2028-09
    Other conditions: Treatment Adherence and Compliance, Severe Mental Disorders, Bipolar Disorder (BD), Schizophrenia Disorder
    View official trial listing →
  • Not yet recruiting NCT NCT07446218

    Pharmacist-led Interventions in Psychiatric Patients

    Not yet reported University of Lahore 148 participants Est. completion 2026-05-31 2 sites
    Metabolic syndrome Other conditions: Mental Disorders
    View official trial listing →
  • Enrolling by invitation NCT NCT07448675

    Cognitive Impairment Characteristics and Biological Mechanisms in Untreated Severe Mental Illness

    Tianjin Anding Hospital 230 participants Est. completion 2026-06-30 1 site
    Other conditions: Patients With Severe Mental Illness
    View official trial listing →
  • Not yet recruiting NCT NCT07515222

    Efficacy of Yoga-Based Intervention in Improving Mother-Child Bonding in Maternal Depression

    Not yet reported All India Institute of Medical Sciences 52 participants Est. completion 2027-05-15
    Other conditions: Perinatal Depression, Postpartum Depression, Mother-Infant Bonding Disorder
    View official trial listing →
  • Completed NCT NCT07523256

    Effect of Curcumin Add-On Therapy on Quality of Life and IL-1β Levels in Patients With Schizophrenia

    Not yet reported Rinvil Renaldi 44 participants Est. completion 2026-01-31 1 site
    Other conditions: Schizophrenia, Psychotic Disorders
    View official trial listing →
  • Completed NCT NCT07524868

    Effect of Cognitive Behavioral Therapy on Auditory Hallucinations and NLR in Schizophrenia Patients

    Not yet reported Hasanuddin University 50 participants Est. completion 2026-01-31 1 site
    Alcohol use disorder Other conditions: Schizophrenia Patients
    View official trial listing →
  • Completed NCT NCT07541157

    Effect of Ashwagandha as Adjunct Therapy on BDNF and Cognitive Function in Schizophrenia Patients

    Not yet reported Hasanuddin University 80 participants Est. completion 2026-01-31 1 site
    Other conditions: Schizophrenia Patients
    View official trial listing →
  • Withdrawn NCT NCT07548489

    Phenobarbital for Agitated Delirium

    Not yet reported Duke University Est. completion 2027-07 1 site
    Other conditions: Agitated Delirium, Delirium Confusional State, Delirium in the Intensive Care Unit, Hyperactive Delirium
    View official trial listing →
  • Not yet recruiting NCT NCT07570875

    Evaluating the Impact of Ketogenic Therapy on Symptom Severity and Metabolic Side Effect Profile Among Individuals Living With Bipolar Disorder in A Rural Southern Catchment Area

    Not yet reported University of Alabama at Birmingham 100 participants Est. completion 2027-11 1 site
    Other conditions: Bipolar Disorder
    View official trial listing →
  • Completed NCT NCT07575516

    Effectiveness of Ashwagandha in Schizophrenia Patients on Risperidone

    Not yet reported Hasanuddin University 80 participants Est. completion 2026-01-31 1 site
    Other conditions: Schizophrenia Patients, Neuroinflammation
    View official trial listing →
  • Completed NCT NCT07609953

    Cognitive Behavioral Therapy Added to Risperidone for Schizophrenia

    Not yet reported Hasanuddin University 42 participants Est. completion 2026-01-31 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Not yet recruiting NCT NCT07656870

    Exploring the Genetics of Schizophrenia in Manitoba

    University of Manitoba 1500 participants Est. completion 2031-04 1 site
    Other conditions: Schizophrenia, Healthy (Controls)
    View official trial listing →
  • Not yet recruiting NCT NCT07665073

    Risperidone vs Cariprazine in Acute Mania

    Not yet reported Pakistan Institute of Medical Sciences 50 participants Est. completion 2028-06
    Other conditions: Bipolar 1 Disorder
    View official trial listing →
  • Not yet recruiting NCT NCT07715253

    Longitudinal PET Imaging of Antipsychotic Binding to the Dopamine-3 Receptor in Schizophrenia

    Not yet reported New York State Psychiatric Institute 100 participants Est. completion 2030-11-30
    Other conditions: Schizoaffective Disorder, Schizophreniform Disorder, Schizophrenia
    View official trial listing →
  • Not yet recruiting NCT NCT07715994

    A Computer-Assisted Tool for Objective Assessment of Extrapyramidal Symptoms

    Shanghai Mental Health Center 180 participants Est. completion 2027-04 1 site
    Other conditions: Extrapyramidal Symptoms, Drug-induced Parkinsonism, Akathisia, Drug-Induced, Tardive Dyskinesia (TD)
    View official trial listing →
  • Not yet recruiting NCT NCT07767526

    Xingqi Daozhi Decoction for Antipsychotic-Induced Constipation

    Not yet reported, Not yet reported Shanghai Mental Health Center 46 participants Est. completion 2028-12-31 1 site
    Other conditions: Schizophrenia, Antipsychotic Drug
    View official trial listing →
  • Not yet recruiting NCT NCT07770282

    Efficacy and Safety of Semaglutide Versus Placebo on Cardiometabolic Profile in Patients With Schizophrenia With Metabolic Syndrome

    Not yet reported All India Institute of Medical Sciences, Bhubaneswar 600 participants Est. completion 2030-12-30
    Metabolic syndrome Other conditions: Schizophrenia Disorder, Antipsychotic-induced Weight Gain, Cardiovascular Risk, Insulin Resistance
    View official trial listing →
  • Active, not recruiting NCT NCT07783373

    Long-Term Real-World Safety of Cobenfy in Adults With Schizophrenia

    Bristol-Myers Squibb 3000 participants Est. completion 2028-04-26 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Not yet recruiting NCT NCT07791212

    Dissecting Immunological and Autoimmune Mechanisms of Neuropsychiatric Diseases

    King's College London 300 participants Est. completion 2036-10-01 2 sites
    Other conditions: Neuropsychiatric Symptom
    View official trial listing →
  • Not yet recruiting NCT NCT07802158

    Discontinuing Psychotropic Medication Before Psychotherapy for PTSD

    Academic Centre for Dentistry in Amsterdam 100 participants Est. completion 2026-09-02
    Other conditions: Post-traumatic Stress Disorder (PTSD)
    View official trial listing →
  • Not yet recruiting NCT NCT07815587

    Ultrasound Assessment of Gluteal Muscle in Patients Receiving Depot Antipsychotics and Healthy Volunteers

    St. Olavs Hospital 60 participants Est. completion 2027-12
    Other conditions: Psychotic Disorder, SCHIZOPHRENIA 1 (Disorder), Intramuscular Injection
    View official trial listing →
  • Not yet recruiting NCT NCT07820553

    Building a Computational Model of Auditory Hallucinations

    King's College London 146 participants Est. completion 2030-08
    Other conditions: Schizophrenia / Schizoaffective Disorder, Schizophrenia and Disorders With Psychotic Feature, Psychosis, SCHIZOPHRENIA 1 (Disorder), Schizophreni-form Disorder
    View official trial listing →
  • Not yet recruiting NCT NCT07822295

    The Effect of Chronic ssrı/snrı Antidepressant Treatment on Propofol Consumption in Elective Spine Surgery

    Kocaeli City Hospital 216 participants Est. completion 2027-05-30 1 site
    Other conditions: Chronic SSRI/SNRI Use and Intraoperative Propofol Requirements
    View official trial listing →
  • Completed NCT NCT07834112

    Body Weight Changes After Switching to Lurasidone for Antipsychotic-induced Weight Gain in Bipolar Disorder

    Dong-Wook Kim 155 participants Est. completion 2025-12-31 1 site
    Other conditions: Bipolar Disorder (BD)
    View official trial listing →
  • Not yet recruiting NCT NCT07853079

    Motivational Intervention for Patients With Schizophrenia

    Not yet reported University of Geneva, Switzerland 88 participants Est. completion 2029-09-30
    Other conditions: Schizo-affective Disorder, Non Organic Psychosis, Schizophenia Disorder
    View official trial listing →
  • Active, not recruiting NCT NCT07882589

    Psychoactive Drug Use and Acute Care Use After Trauma and Out-of-Hospital Cardiac Arrest

    Azienda Usl di Bologna 52720 participants Est. completion 2027-07-30 2 sites
    Other conditions: Wounds and Injuries, Out-of-Hospital Cardiac Arrest, Traumatic Brain Injury
    View official trial listing →
  • Not yet recruiting NCT NCT07914192

    Antipsychotic Safety and Adherence in Patients With Psychiatric Disorders-An Egyptian Institution-Based Cross-Sectional Study.

    Egyptian Chinese University 250 participants Est. completion 2027-02-01
    Other conditions: Psychiatric Disorder
    View official trial listing →
  • Completed NCT NCT07917637

    Ashwagandha Added to Risperidone for Quality of Life and Inflammation in Schizophrenia

    Not yet reported Athitah Pratiwi 60 participants Est. completion 2026-06-30 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Not yet recruiting NCT NCT07921966

    Pharmacokinetics and Relative Bioavailability of Intranasal vs Intramuscular Olanzapine in Healthy Adult Participants

    Not yet reported Neurelis, Inc. 24 participants Est. completion 2027-01-14
    Other conditions: Healthy Adult Participants
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.